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Abstract
The amniocentesis dilemma: needs assessment, development and field-testing of a 
theory-based decision support intervention
Background:
Amniocentesis is the most common prenatal diagnostic procedure undertaken in the United 
Kingdom, usually performed after 15 completed weeks of pregnancy. The procedure is 
reported to have a 1 % risk of miscarriage and the results of the chromosome tests may require 
further decision making about whether to continue with the pregnancy. Deciding about 
amniocentesis is a complex and emotionally charged decision, often undertaken in a short 
period of time and, under current practice, with little systematic decision support. Decision 
Support Interventions, also known as Patient Decision Aids, have been developed to help 
individuals learn about the features and implications o f their treatment or screening options 
while improving communication with their health professionals. Those interventions are 
specifically targeted at preference-sensitive decisions with significant harms, benefits and 
uncertainty, where no screening or treatment option is objectively better than the other.
This thesis proposed to assess information and decision support needs o f pregnant women 
undertaking amniocentesis testing and to design and field-test, in collaboration with pregnant 
women and health professionals, a theory-based Decision Support Intervention for 
amniocentesis testing (amnioDex).
Methods:
A multi-method approach was adopted that included a systematic review, theoretical review, 
and qualitative analysis to develop and pilot a theory-based intervention intended for 
pregnant women facing a decision to undertake amniocentesis testing. The content areas and 
themes to be covered in the intervention were determined by a literature review and needs 
assessment conducted with pregnant women and health professionals. The prototype 
development of amnioDex (amniocentesis decision explorer) was guided by theory and 
included heuristic-based deliberation tools. Incremental prototypes of amnioDex and 
embedded deliberation tools were field-tested with lay users, health professionals and 
pregnant women facing a decision to undertake amniocentesis, using the “think-aloud” 
technique.
Results:
The amnioDex intervention was developed over a period of two years and field-tested for 
eight months.
Conclusion:
Findings from this thesis showed that it was feasible to use theory to generate a Decision 
Support Intervention acceptable to women facing amniocentesis testing and to health 
professionals counselling them. Future research needs to evaluate the effectiveness of 
amnioDex in a randomised controlled trial and to examine methods for effectively 
transferring theory into practice.
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Chapter 1
Introduction and Thesis Overview
1.1 Involving Patients in Medical Decision Making: the Patient Centred 
Approach
Medical decision making has evolved from a traditionally paternalistic model of 
decision making to a patient centred approach where shared decision making is considered 
the gold standard (Deber 1994; Emanuel and Emanuel 1992). Historically, the paternalistic 
model was recognised as the dominant approach in western medicines (Kaba and 
Sooriakumaran 2007; Parsons 1951). It assumed full authority and autonomy of the doctor, 
who provided information and made decisions without consulting the patient. The latter 
endorsed a passive role in sharing the physician’s values and complying with the decisions 
made (Benbassat et al. 1998).
Since the 1980’s, the patient’s right to be informed and to participate in medical care 
decisions has been increasingly advocated. The assumption that physicians were in the best 
position to make healthcare decisions, independently of the patient’s values, has been 
challenged. Research suggested that the experience and the consequences of an illness highly 
depended on the patient’s “biography”, individual characteristics and values (Armstrong 
1979, 1984; Mead and Bower 2000; Smith and Hoppe 1991). In the early 1990’s, there was a 
paradigm shift in medical practice from the paternalistic approach to Evidence Based 
Medicine (EBM). EBM postulates that clinical decisions (treatments, screening or diagnostic 
tests) should be justified by external clinical evidence and not by the physician’s authority or 
medical traditions. Individual expertise should be combined with best available clinical and 
scientific evidence to decide on the care of individual patients (Sackett et al. 1996).
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The patient status progressively shifted from a client and passive recipient of care to an 
active partner in medical decisions and care. The doctor-patient relationship was undergoing 
changes worldwide (Kaplan et al. 1996; Roter et al. 1997) and pressures on the NHS to 
promote patient autonomy and involvement in healthcare were rising (Smith 1998). A reform 
promoting increased patients’ rights and involvement in healthcare was published in 1991 in 
the Patient’s Charter: “you have the right to have any proposed treatment (...)  clearly 
explained to you before you decide whether to agree with it’’ (Department of Health 1991). In 
parallel, informed consent was progressively recognised as a legitimate patient’s right, where 
all patients were entitled to consent prior to any medical treatments or screening procedures 
(Sutherland et al. 1989). The legal obligation to inform patients (informed consent) combined 
with the consumer rights movement (Haug and Lavin 1983) and evolving nature of the 
physician-patient encounter prepared the transition towards shared decision making (Charles 
etal. 1997; Coulter 1999; Richards 1998).
Shared decision making is a conceptual model o f medical decision making (Emanuel 
and Emanuel 1992) increasingly recognised as an ideal consultation style, extensively 
discussed and advocated but rarely implemented (Holmes-Rovner et al. 2000). Shared 
decision making has been defined (Charles et al. 1997, p. 5) as involving at least two actors 
(physician and patient) who share information and are jointly engaged in the decision making 
process to choose a treatment/screening option which is consistent with the patient’s values 
and preferences. The literature examining patients’ willingness to share medical decisions has 
been widely criticised for the heterogeneity of the methods used and conflicting results, 
frequently imputed to the difficulty to define participation in decision making (Deber 1994). 
A review of patient participation in decision making concluded that (i) patients wanted to be 
informed of treatment alternatives (Deber et al. 1996; Strull et al. 1984) and (ii) depending on
12
the circumstances, wished to be involved in decision making (Guadagnoli and Ward 1998). 
Further evidence suggested that patients wanted to be informed and consulted during the 
medical encounter (Elwyn et al. 1999) and that patients' satisfaction increased with the 
physician’s empathy and patient-centeredness (Williams et al. 1998). Despite endless 
attempts at defining the concept, debates remain as to which medical encounter falls within or 
outside shared decision making. There is a difficulty defining patient involvement in medical 
decision making and when to adopt a shared decision making approach.
1.2 The Amniocentesis Dilemma or How to Cope With Clinical Equipoise
There is often uncertainty about the benefits o f a treatment or screening option. Godlee 
(2005) established that 47% of medical treatments were associated with insufficient scientific 
evidence. Situations of clinical equipoise are defined by genuine balance between the 
scientific evidence o f estimated harms, benefits and outcome probabilities associated with 
each option presented to the patient. In situations o f equipoise, patients’ values and 
preferences may therefore be determinant in choosing a particular course o f action and 
warrant patients’ participation in medical decision making (Elwyn et al. 2000).
Amniocentesis testing is an invasive diagnostic procedure, performed in the second 
trimester o f pregnancy, to provide foetal cells for karyotyping, that presents both harms and 
benefits. The values and preferences of the pregnant woman and her partner are dominant in 
deciding whether to accept or decline the test. Prenatal screening tests for Down’s syndrome 
(i.e., blood tests or ultrasound scan) are routinely offered to all pregnant women in the UK in 
order to determine their risk o f foetal chromosomal abnormality. Women who receive a 
higher risk result will be offered to undergo amniocentesis testing (see Chapter 3). The 
amniocentesis procedure is associated with a 1% risk o f miscarriage, although this rate may 
vary by operator (Gaudry et al. 2008; Tabor et al. 1986). There is a lack of scientific evidence
13
about the exact cause and predisposing factors of a miscarriage. Amniocentesis testing is also 
characterised by uncertain outcomes. The procedure may lead to detection of chromosomal 
abnormality, further decision making about whether to continue with the pregnancy or foetal 
loss. Approximately 4% of women undergoing amniocentesis testing will receive a diagnosis 
of foetal chromosomal abnormality (Caine et al. 2005; Han et al. 2008; Lewin et al. 2000) 
while an estimated 1% will miscarry after amniocentesis. The trade-off between the 1% 
miscarriage risk and the gain in information provided by the chromosome test results is not 
always clear for women considering amniocentesis. In addition, the chromosome tests 
performed on the amniotic fluid will identify most common chromosomal abnormalities (e.g., 
trisomy 13, 18, 21 and exchange of chromosomes) but will not diagnose small changes in 
chromosomes (e.g., microdeletions). Finally, the chromosome test results do not indicate the 
severity o f the abnormality detected. The severity o f common chromosomal problems, such 
as Down’s syndrome, is highly variable, ranging from mild learning disabilities to severe 
impairments and associated medical problems (e.g., heart conditions, leukaemia, diabetes) 
(Cleves et al. 2007; Paladini et al. 2000).
With uncertain outcomes, far-reaching-consequences, and significant harms and 
benefits, deciding whether or not to undergo amniocentesis is one of the most difficult 
decisions for pregnant women and their partner to consider (Beeson and Golbus 1979). 
Current research suggests that women receiving a high chance result of chromosomal 
abnormality and facing the decision to undergo amniocentesis generally experience acute 
stress and anxiety (Ng et al. 2004; Sarkar et al. 2008; Statham et al. 1997; Tercyak et al. 
2001). A study of pregnant women’s responses to an increased risk of carrying a baby with 
Down’s syndrome revealed that the risk information provided by the screening test results 
triggered intense reactions of anxiety and worry (Susanne et al. 2006). Further research
14
suggests that maternal stress may be associated with poor outcomes for the mother and the 
foetus (Talge et al. 2007).
Further, there are documented concerns that information and decision support available 
during the diagnostic phase of pregnancy is not sufficient (Marteau 1995; St-Jacques et al.
2008). Poor understanding of prenatal tests accepted or declined and unrealistic expectations 
have been reported (Marteau 1995; Marteau 2002). In the literature, unrealistic expectations 
have been associated with increased anxiety, pain and likelihood of litigation (Johnston and 
Vogele 1993; Petticrew et al. 2000). In addition, information provided pre-amniocentesis is 
not tailored to pregnant women’s interests, values and goals (Hunt et al. 2005) and does not 
always appear to be comprehensive (Marteau et al. 1992; Marteau 1993). The content and 
accuracy of prenatal genetic testing counselling has been documented by Bernhardt et al. 
(Bernhardt et al. 1998), indicating that specific topics were not systematically discussed with 
pregnant women (e.g., implications of test results, elective termination of pregnancy) and that 
information was sometimes inaccurate. Finally, an additional complexity is the recent 
implementation of Quantitative-Fluorescent Polymerase Chain Reaction test (QF-PCR test), a 
rapid test which provides results for specific chromosomal abnormalities (i.e., trisomy 13, 18 
and 21) in 3 working days (Onay et al. 2008). In all antenatal clinics in Wales and elsewhere 
in the UK, provided a woman’s consent is obtained, both QF-PCR and a full karyotype tests 
will be carried out on all amniotic fluid samples. There are unresolved issues surrounding the 
introduction of this service and the information required by both health professionals and 
pregnant women prior to the collection and analysis of foetal material and after the results are 
available (see Chapter 3). There is therefore scope for investigating and addressing women’s 
information, decision support and emotional needs associated with amniocentesis testing.
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13 Decision Support Interventions
Decision Support Interventions (DESIs) for patients (Elwyn et al. 2009a), also known 
as Patient Decision Aids, are designed to help individuals leam about the features, issues and 
implications of their treatment or screening options while improving communication with 
their healthcare providers (Estabrooks et al. 2001; Molenaar et al. 2000; O'Connor et al. 
1999a). According to the Cochrane systematic review of decision aids, “Decision aids differ 
from usual health education materials because of their detailed, specific, and personalised 
focus on options and outcomes for the purpose of preparing people for decision making” 
(O'Connor et al. 2006, p. 2). DESIs have been specifically developed for preference-sensitive 
decisions (O'Connor et al. 2003a; Wennberg 1991) with significant harms, benefits, and 
equipoise, where no screening or treatment option is objectively better than the other. DESIs 
do not aim to replace the physician/patient interaction but intend to supplement medical 
counselling. Pioneer decision aids appeared 30 years ago, in the form of consultations 
structured by decision analysis (Pauker and Pauker 1979), preference elicitation techniques 
(Llewellyn-Thomas et al. 1982; O'Connor et al. 1985) and shared decision making 
programmes (Kasper et al. 1992).
Over the past 10 years, an increasing number of DESIs have been developed, in a 
variety of formats (paper, audio, video, web-based), addressing over 23 clinical decisions 
(O’Connor et al. 2006). In 2006, it was estimated that DESIs were accessed about 9 million 
times, principally online (O'Connor et al. 2007a). The Cochrane systematic review of 
decision aids for patients facing health treatments and screening decisions (O'Connor et al. 
2001; O'Connor et al. 2006) examined the results of 55 randomised controlled trials of DESIs 
(2009 update) addressing 23 screening or treatment decisions. The findings revealed that 
DESIs increased knowledge, realistic expectations, participation in decision making and
16
reduced decisional conflict and indecision post-intervention compared to usual practice. 
However, further research suggested that while knowledge may be increased, DESIs did not 
significantly influence treatment or screening decisions (Estabrooks et al. 2001). Molenar et 
al. established that the DESI’s effect on satisfaction with the decision, decision uncertainty 
and health outcomes was limited and rarely evaluated (Molenaar et al. 2000). Furthermore, 
the heterogeneity of formats, decisions addressed and methods used to develop and evaluate 
those interventions (e.g., controlled versus non-controlled studies) may bias the assessment of 
DESIs’ effectiveness (Molenaar et al. 2000).
Multiple measures of DESIs’ effectiveness have been developed but no consensus 
exists as to which measures should be used to optimally assess their effect (Elwyn et al. 
2009b). Difficulties measuring DESIs’ effectiveness are related to the lack of consensus on 
the aims of those interventions and criteria on which their effectiveness should be assessed 
(Kennedy 2003). There have been multiple attempts at defining a good decision and several 
definitions of decision quality have been put forward (Ratliff et al. 1999; Sepucha et al. 
2007). Sepucha et al. defined decision quality as “the extent to which the implemented 
decision reflects the considered preferences of a well-informed patient” (Sepucha et al. 2007, 
p. 262). While definitions exist, there is currently no well-validated measure of decision 
quality, able to determine the match between patients’ values and treatment (or screening) 
decisions (Sepucha et al. 2008; Kennedy 2003). Elwyn et al. established that existing 
measures of decision quality were post-hoc measurements which focussed on two key 
constructs: knowledge (making an informed choice) and preferences (the decision must be 
consistent with the patient’s preferences). They exposed several limitations to current 
definitions and post-hoc measures of decision quality (Elwyn et al. 2009b). The duration of 
decision making is indeterminate. The difficulty therefore arises as to when to measure
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decision quality and for how long. In addition, measuring the quality of decisions according 
to the outcomes (i.e., post-hoc) is not a relevant standpoint. Current research directions in this 
area are therefore moving towards a process measure of decision making: the measure of 
deliberation (Elwyn et al. 2009b). Finally, measures of DESIs’ effectiveness have been 
criticised for their inability to measure the DESI’s impact on health status and well-being 
(Entwistle et al. 1998).
DESIs are complex interventions which can potentially influence patients’ treatment or 
screening decisions. It is therefore imperative to ensure that those interventions are unbiased 
and safe for patients to use. A set of internationally accepted standards has been developed by 
the International Patient Decision Aids Standards (IPDAS) collaboration to assess the quality 
and potential biases o f existing DESIs (Elwyn et al. 2006). The IPDAS collaboration 
developed a checklist for the assessment of DESIs using an online Delphi process where 122 
stakeholders from 14 countries rated 80 criteria divided into 12 quality domains. The IPDAS 
checklist assessed whether the intervention featured relevant components and had been 
rigorously developed and evaluated. The checklist did not provide quantitative assessments 
about the DESI’s quality. The IPDAS instrument (IPDASi) was subsequently developed and 
validated to achieve a detailed quality assessment o f existing DESIs (Elwyn et al. 2009c). 
The validated version of IPDASi comprised 47 items divided in 10 domains (see Chapter 4). 
IPDASi was validated using dual rater assessment of 30 DESIs developed by five major 
producers. The findings showed that IPDASi could effectively measure DESIs’ quality 
provided adequate rater calibration training was undertaken pre-assessment (Elwyn et al. 
2009c).
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As noted previously, in the absence of conclusive scientific evidence towards one 
treatment option or the other, patients’ values, preferences and biography play a crucial role 
in deciding on a specific course of action. Most recent accounts of research directions in 
DESI development define DESIs as “interventions that describe and justify the conditions 
where equipoise exists for both clinicians and patients (dual equipoise), provide information 
about options which help people to deliberate about counterfactuals, construct and forecast 
preferences about short, intermediate and long-term outcomes which have relevant 
consequences” (Elwyn et al. 2009a, in submission). DESIs can therefore be conceptualised as 
including a core component of information about options, associated harms and benefits, and 
a deliberation component, namely strategies or methods designed to facilitate the expression 
and clarification of patients’ values (Elwyn et al. 2009d). Such methods or strategies have 
been developed to assist patients in structuring their preferences to achieve decision making, 
and have been described in a number of ways: value/attribute/preference elicitation 
(Feldman-Stewart et al. 2006), value-clarification exercises or preference-clarification 
exercises (O'Connor et al. 1999b) etc. Llewellyn-Thomas (2009) exposed four prerequisites 
to the development and use of value-clarification or deliberation strategies. First, deliberation 
strategies should be made available to patients who have not yet chosen a specific course of 
action and/or wish to be involved in their healthcare decisions. Second, the provider’s views 
and values should not be imposed upon the patient/user’s deliberation. Third, deliberation 
strategies should ideally avoid framing biases. Finally, those methods may be used in 
iteration, to account for the fact that preferences may not remain constant over time.
This thesis’ aims were to (i) understand the information and decision support needs of 
women who have been offered an amniocentesis, and (ii) design and pilot, in collaboration 
with pregnant women and their health professionals, a theory-based DESI capable of
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addressing these needs. The following section presents an overview of the issues discussed in 
this thesis.
1.4 Thesis Overview
1.4.1 Identifying Evidence and Theoretical Basis (Chapters 2,3 and 4)
The conceptual and practical development of the amnioDex intervention was informed 
by the Medical Research Council (MRC) framework for design and evaluation of complex 
interventions (Campbell et al. 2000; Craig et al. 2008). According to this framework, best 
available evidence should be identified through high quality systematic reviews. The 
theoretical basis underlying the intervention development should also be examined in the pre- 
clinical phase of development. Best available evidence and relevant theory should then be 
combined to define the intervention’s components (phase 1: modelling). For best practice, 
qualitative testing (e.g., focus groups, surveys) may be used to determine and develop 
intervention components. The intervention should be developed in phase 2, where 
acceptability and feasibility issues will be concurrently examined. Pilot studies should be 
conducted before evaluating the intervention to verify its acceptability, usability and 
feasibility (phase 3).
While theories or models of behaviour change have been commonly applied to the
development of behavioural interventions (Abraham and Michie 2008; Serlachius and Sutton
2009), little attention has been given to the theoretical underpinnings of interventions
designed to support decision making. Decision making theories exist and their applications
have improved our understanding of how individuals make decisions. They attempt to
explain and predict how individuals make complex decisions and describe the factors or
situations likely to impair the decision-making process and lead to poor decision outcomes
and decisional regret. It would therefore seem appropriate to integrate theoretical constructs
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into the development of information and deliberation components embedded in DESIs, in the 
anticipation of significant impact on the decision quality and outcomes. The aim of Chapter 2 
was to undertake a theoretical review of models and theories underlying the development of 
DESIs included in the Cochrane systematic review of patient decision aids (O'Connor et al. 
2006). This chapter examined the extent to which theory guided the conception, prototype 
development and evaluation of selected DESIs, with a view to embed theory-based 
information and deliberation components in the development of amnioDex.
As noted previously, DESIs have been specifically developed to help individuals make 
preference-sensitive decisions, characterised by uncertain outcomes and limited scientific 
evidence. The decision to undertake amniocentesis involves complex information, uncertain 
outcomes and far-reaching consequences, at a time of emotional upheaval. Chapter 3 
described the complexity, clinical characteristics, and equipoise associated with 
amniocentesis testing while examining existing arrangements for informing and supporting 
pregnant women (and their partners) facing a decision to undertake amniocentesis. The aim 
of Chapter 4 was to conduct a systematic review of existing DESIs for amniocentesis testing, 
using the IPDAS instrument to critically appraise the quality of interventions included for 
review.
1.4.2 Needs Assessment and Prototype Development (Chapters 5,6 and 7)
To comply with the MRC framework and IPDAS quality criteria, a qualitative 
methodological approach was adopted to determine the content of the intervention and to 
asses potential users’ and health professionals’ needs. The aim of Chapter 5 was to assess 
information and decision support needs of pregnant women facing a decision to undertake 
amniocentesis testing using semi-structured interviews. The direct assessment of pregnant 
women’s needs related to amniocentesis testing was completed by the professionals’
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evaluation of information and decision support needed prior to deciding about amniocentesis 
(Chapter 6). Based on the literature reviews and needs assessment conducted with relevant 
stakeholders, the intervention was developed. Chapter 7 described the conceptual, theoretical 
and practical development o f amnioDex: a web-based decision explorer for women 
considering amniocentesis testing. Normative decision making theories, such as expected 
utility theory, do not normally account for the individual’s emotional, cognitive, 
environmental and/or time constraints. Normative theories are derived from mathematical 
models and assume unbounded rationality: unlimited computational capacities, knowledge 
and time (Todd and Gigerenzer 2000). By contrast, descriptive theories or models of decision 
making recognise that decision makers have limited reasoning and computational abilities 
and examine ways of overcoming these difficulties. Interventions designed to facilitate 
decision making processes, such as amnioDex, may benefit from building on key concepts of 
how individuals actually make decisions under risk. In the clinical context of amniocentesis 
testing, where high emotional demands and complex information limit people’s capacity to 
quantify utilities of options, the assumption was made that descriptive models of decision 
making would fit this specific context better than normative theories. Two descriptive 
theories of decision making were therefore chosen to guide the development of amnioDex: 
prospect theory and differentiation and consolidation theory (Chapter 7).
1.4.3 Qualitative Field-Testing of AmnioDex and Deliberation Components (Chapters 
8 and 9)
In order to investigate potential usability and acceptability issues associated with the 
evaluation and implementation of amnioDex, the intervention was piloted with relevant 
stakeholders. The aim of Chapter 8 was to develop deliberation tools based on models of 
bounded rationality (i.e., heuristics) and to field-test these tools with relevant stakeholders
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while Chapter 9 examined the overall usability and acceptability of the amnioDex 
intervention piloted with lay users, pregnant women and health professionals.
Finally, the main findings, clinical implications of this thesis and future research 
directions will be discussed in Chapter 10.
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Chapter 2
Theoretical Review
2.1 Introduction
The purpose of this chapter was to review and critically appraise the theoretical 
underpinnings of DESIs included in a Cochrane systematic review. Decision making theories 
exist and their applications have improved our understanding of how individuals make 
decisions. However, the use of decision making theories for the development of DESIs seems 
relatively rare in practice. Over the past decade, the conceptual and theoretical basis of DESIs 
has remained largely unexplored (O'Connor et al. 2007b). In spite of criteria for the design 
and evaluations o f DESIs being developed (Elwyn et al. 2006), the necessity to adhere to 
conceptual or theoretical frameworks relevant to decision making has not yet been 
recognised. Most interventions in this field appear to have been developed in a practical 
manner, using a wide range of media, timeframes and purposes (Entwistle et al. 1998).
A literature review of 547 studies of health technologies ranging from the comparison 
of information mediums to the use of DESIs revealed that 82 % o f the interventions did not 
make use o f any theory or model of decision making (Bekker et al. 1999). Among 
interventions that explicitly referred to theory, there was little account of how a chosen theory 
was subsequently applied to the practical design of health technologies. Similarly, Bowen et 
al. (2006) investigated the theoretical basis of interventions promoting patient’s informed 
decision making in the clinical context of cancer screening. The findings showed that 5 out of 
14 interventions referred to a theoretical framework but did not specify how selected theories 
had shaped the design of the intervention. None of the articles reporting the development and 
evaluation of the interventions commented on the utility of the chosen theoretical foundation.
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There is no clear description of a deliberate avoidance of theory nor is there detailed 
attention to how some, albeit a minority, used a specific theory for design, development and 
evaluation of DESIs. Furthermore, the impact of theory on the DESI’s efficacy has not been 
formally assessed. Interventions that are based on theory may be more efficient and reliable 
than interventions developed without relevant theoretical framework. However, for the time 
being, empirical evidence is missing in this area. The aim of the research presented in this 
chapter was to describe and analyse rigorously developed DESIs in order to determine the 
contribution of theories or models of decision making to their conception, design, 
development and evaluation. As a sample frame, 55 published randomised controlled trials of 
DESIs included in the Cochrane systematic review were selected for review (O'Connor et al.
2006).
2.2 Methods
The sample frame included 55 trials of patient decision aids for people facing health 
treatment or screening decisions, included in the Cochrane systematic review. The 
assumption was made that DESIs evaluated by randomised controlled trials included in a 
Cochrane review would have been among those most rigorously developed. In the Cochrane 
review, 22,778 citations were identified and 55 randomised controlled trials of DESIs were 
selected for review. The interventions focussed on 23 screening and treatment decisions in 
various clinical contexts. The DESIs were evaluated in randomised controlled trials and 
compared to usual care (usual verbal information or routine information leaflet) or to simpler 
decision tools.
All interventions to be considered received independent dual rating (M-A D and MS). 
All full text articles reporting the development and evaluation of the DESIs in a randomised
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controlled trial were reviewed. All relevant articles were rigorously analysed to assess the 
degree to which each chosen decision making theory or model had informed the conception, 
prototype development, field-testing (if applicable) and evaluation of the intervention. For the 
purpose of this review, field-testing was defined as the process whereby the prototype DESI 
is shown to potential users who comment on its content and usability prior to evaluation 
(Evans et al. 2007). Any mention of a theoretical framework in the text or in the reference list 
was independently noted by each reviewer. The nature and category of the identified 
theoretical framework were then discussed between raters, who met on a fortnightly basis 
until all citations had been reviewed. The agreement between raters regarding the theoretical 
review of articles was examined. After a theoretical framework was identified and named, the 
authors of the article were contacted to investigate how theory had guided the design and 
evaluation of their interventions. They were informed that the theoretical review would be 
based on their published work if they did not provide a reply within two months.
23 Results
In total, 78 full text articles reporting the development and evaluation of DESIs in a 
randomised controlled trial were reviewed. The 55 trials of patient decision aids for people 
facing health treatment or screening decisions were included in the Cochrane systematic 
review. However, the authors noted that three interventions (Gatellari and Ward 2003; Green 
et al. 2004a; O'Connor et al. 1998a) had been evaluated in two or more trials (Dodin et al. 
2001; Gatellari and Ward 2005; Green et al. 2005; Legare et al. 2003; O'Connor et al. 1998b). 
There may have been small changes between versions but the assumption was made that the 
theoretical framework would remain the same. The present chapter was therefore based on 
the analysis of 50 DESIs and their associated publications. The consistency between raters on 
the theoretical review of all 78 citations was high (96%).
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23.1 Prevalence of “Atheoretical” Interventions
The analysis revealed that 17 out of 50 interventions referred to a theory or model of 
decision making: the majority of which could be categorised as normative theories (see 
Figure 2.1). Ten theories or models of decision making were identified. As far as could be 
determined, the rigorous analysis of all 78 citations revealed that the conception, prototype 
development and evaluation of 33 DESIs were not based on any theoretical foundation. All 
17 authors of the theory-based interventions were contacted and asked to provide additional 
information regarding the use of theory in conceiving, developing and evaluating the 
intervention. Seven authors answered and provided additional information on the use of their 
chosen theoretical framework.
23.2 Normative Theories of Decision Making
Table 2.1 shows the theory-driven DESIs. Five interventions referred to decision 
analysis (i.e., expected utility theory) (Bekker et al. 2003; Clancy et al. 1988; Holmes-Rovner 
et al. 1999; Montgomery et al. 2003; Rothert et al. 1997; Van Roosmalen et al. 2004). 
Decision analysis is an operationalisation of the expected utility theory (Howard and 
Matheson 1984), derived from the expected utility hypothesis. Expected utility theory is a 
normative theory of decision making, originally formulated in 1738 by Bernoulli and later 
developed by Von Neumann and Morgenstem (Kahneman and Tversky 1979; Pratt et al. 
1964; Von Neumann and Morgenstem 1944). Normative theories of decision making specify 
how individuals should process information and make a decision under what are presumed 
ideal conditions. The decision analytic method and decision tree have been widely used in 
designing DESIs for the past 10 years (Magee 1964). Decision analysis was first applied to 
patient counselling in 1979 (Pauker and Pauker 1979).
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Table 2.1 Characteristics o f  Theory-Driven Decision Support Interventions Included fo r  Review
Theoretical
foundation
DESI component 
Informed by 
theory
First author, 
Year
Health decision 
addressed in 
DESI
Format
Decision analytic 
method based on the 
expected utility theory
Conception
Prototype development 
Evaluation
Bekker 2004 
(Bekker et al. 2004)
Prenatal diagnosis 
for Down’s 
syndrome
Decision analysis plus 
consultation
Decision analytic 
method based on the 
expected utility theory
Conception
Prototype development 
Evaluation
Clancy 1988 
(Clancy et al. 1988)
Hepatitis B vaccine Leaflet & decision 
analysis
Decision analytic 
method based on the 
expected utility theory
Conception
Prototype development 
Evaluation
Montgomery 2003 
(Montgomery et al. 
2003)
Hypertension
treatment
Decision analysis
Decision analytic 
method based on the 
expected utility theory
Conception
Prototype development 
Evaluation
Rothert 1997 
(Rothert et al. 1997)
Hormone
replacement
therapy
Discussion or 
personalised decision 
exercise
Decision analytic 
method based on the 
expected utility theory
Conception 
Prototype development 
Evaluation
Van Roosmalen 2004 
(Van Roosmalen et 
al. 2004)
Treatment options 
for BRCA1/2 
mutation carriers
Video & leaflet with 
decision analysis
Multiple attribute and 
multiple criteria 
decision making 
theories
Conception
Prototype development 
Evaluation
Dolan 2002 
(Dolan and Frisina 
2002)
Colon cancer 
screening
Standardised interview 
(using analytic 
hierarchy process) & 
leaflet
Ottawa decision support 
framework
Conception 
Evaluation (partial use 
of the theories)
Drake 1999 
(Drake 1999)
Prenatal diagnostic 
testing
Audiotape & booklet
Ottawa decision support 
framework
Conception
Prototype development 
Evaluation (partial use)
Lalonde 2004 
(Lalonde et al. 2004)
Cardiovascular 
health treatment
Video & booklet
Ottawa decision support 
framework
Conception
Prototype development 
Evaluation (partial use)
O’Connor 1998 
(O'Connor et al. 
1998)
Hormone
replacement
therapy
Audiotape & booklet
Ottawa decision support 
framework
Conception
Prototype development 
Evaluation (partial use)
Shorten 2005 
(Shorten et al. 2005)
Birthing options 
after previous 
caesarean
Booklet
Combination of 
behavioural models of 
decision making
Poor use of theory Lerman 1997 
(Lerman et al. 1997)
Breast cancer 
genetic testing
Discussion & 
counselling
Cognitive-social health 
information processing 
model (C-SHIP)
Conception
Prototype development 
Evaluation
Miller 1996 
(Miller et al. 1996)
Breast cancer 
genetic testing
Discussion & leaflet
The preventive health 
Model
Conception
Prototype development
Myers 2005 
(Myers et al. 2005)
Prostate Specific 
Antigen (PSA) 
testing
Discussion & leaflet
Social cognitive theory Conception (partial use) 
Prototype development 
(partial use)
Evaluation
Partin 2004 
(Partin et al. 2004)
PSA testing Video
Health belief model Early conception 
Evaluation
Schapira 2000 
(Shapira and 
VanRuiswyk 2000)
Prostate cancer 
screening
Booklet
The transthcoretical 
model
Poor use of theory Pignone 2000 
(Pignone et al. 2000)
Colon cancer 
screening
Video
Empowerment model Early conception Davison 1997 
(Davison and Degner 
1997)
Prostate cancer 
treatment
Written information 
package & audiotape 
of medical consultation 
& discussion
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Figure 2.1 Theories and Models o f Decision Making Identified in the Review
Social cognitive 
theory
Combination of 
behavioural 
theories
Preventive health 
model
Transtheoretical 
model of behaviour 
change
C-SH1P
model
Expected utility 
theory
Empowerment
model
Multiple criteria and 
multiple attribute 
utility theory
33 DESIs which did 
not refer to theory
17 DESIs based on 
theory
10 theories or models of 
decision making
50 DESIs identified
Ottawa decision 
support 
framework
Health belief 
model
Cochrane systematic re\ie\v of patient decision aids 
for people facing health screening or treatment 
decisions
In the context of DESI development, decision makers are expected to specify the utility of 
available options on a numerical scale and multiply this number by their outcome 
probabilities to identify the option with the highest expected utility. In contrast to other 
theoretical frameworks, the theory and mechanisms of decision analysis (decision trees and 
subjective expected utility calculations) provided a recognisable architecture for the DESI 
development.
Based on the analysis of all related publications and contact with authors, decision 
analysis appeared to have informed the early conception of all DESIs citing this theory: a 
decision analytic consultation for prenatal diagnostic testing for Down’s syndrome (Bekker et 
al. 2004), a leaflet coupled with individualised decision analysis for hepatitis B vaccine
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(Clancy et al. 1988), a computerised self-completed interview for hypertension treatment 
(Montgomery et al. 2003), a discussion or individualised decision exercise for hormone 
replacement therapy (Rothert et al. 1997) and a video and leaflet addressing treatment options 
for BRCA1/2 mutation carriers (Van Roosmalen et al. 2004).
In all publications, decision analysis (based on subjective expected utility theory) was 
described as the theoretical framework supporting the conception and design of the 
intervention. Decision analysis also guided the prototype development of the interventions. 
Based on the publications reviewed, all interventions used a decision tree and relied on the 
utility analysis o f available health options. There is no data about whether the DESIs were 
rigorously field-tested and found acceptable by patients and clinicians. The evaluation of all 
DESIs referring to decision analysis seemed to be guided by theory. The outcome 
measurements assessed the match between the option considered optimal (based on utility 
calculations) and the patient's final decision.
One intervention for colon cancer screening, combining an interview with a leaflet 
(Dolan and Frisina 2002) explicitly referred to the multiple criteria decision making (Zeleny 
1982) and multiple attribute utility theory (Hwang and Yoon 1981). Multiple criteria decision 
making and multiple attribute utility theories are normative theories of decision making 
derived from mathematical theories of multiple criteria or multiple attributes problem solving 
(Dyer et al. 1992). Contrary to the subjective expected utility theory, they do not elicit 
patients' values using decision analytic trees but frequently resort to an analytic hierarchy 
process (Saaty 1990). The analytic hierarchy process places options in a comparison matrix 
of paired attributes, thus allowing the decision maker to compare the consistency of 
preferences. The multiple criteria decision making and multiple attribute utility theories did
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provide the conceptual framework for designing and developing the intervention. However, 
there was no evidence of field-testing prior to evaluation. The evaluation of the DESI seemed 
to be informed by theory since the outcome measures (decision process and decision 
outcomes assessing the match between the screening plans and patients’ final screening 
choice) matched the key constructs of the multiple criteria decision making and multiple 
attribute utility theories.
233 The Ottawa Decision Support Framework
Four DESIs referred to the Ottawa decision support framework: an audiotape and 
booklet DESI for prenatal diagnostic testing (Drake et al. 1999), a video and booklet DESI 
for cardiovascular health treatment (Lalonde et al. 2004), an audiotape and booklet 
intervention for hormone replacement therapy (O'Connor et al. 1998a) and a booklet 
providing information about birthing options after previous caesarean (Shorten et al. 2005). 
The Ottawa decision support framework is a combination of several decision making theories 
including the expectancy value model, decision analysis (described earlier), prospect theory, 
the conflict theory model of decision making and social support theories (Keeney and Raiffa 
1976; Norbeck 1988). The expectancy value model assumes that individuals who have to 
make a choice between two or more options with significant harms and benefits are more 
likely to opt for the option with the highest expected values and success (Fishbein 1975). 
Prospect theory postulates that most decision makers do not normally behave in accordance 
with the axioms of expected utility theory (Kahneman and Tversky 1979). Prospect theory 
distinguishes two phases in the choice process: editing and evaluating. The editing phase 
consists of analysing the offered prospects before evaluating them and choosing the prospect 
of highest value (evaluating phase). This theory also assumes that the choice between two 
courses of actions is biased by the way in which the choices are described or framed. For 
instance, prospect theory demonstrated that losses loom larger than gains (Tversky and
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Kahneman 1992). This has led to significant attention being given to risk communication 
formats. The conflict theory model of decision making assumes that making a decision 
generates stress, uncertainty and conflict within the choice situation (Janis and Mann 1977). 
The decision maker would therefore cope with stress and uncertainty through the search for, 
and evaluation of information and alternatives.
Based on the analysis of all related publications and contact with authors, the Ottawa 
decision support framework appeared to have informed the early conception and design of all 
the interventions naming this theoretical framework. The prototype development of three out 
of four DESIs (Lalonde et al. 2004; O’Connor et al. 1998a; Shorten et al. 2005) was guided 
by some of the theories included in the Ottawa decision support framework and appeared 
primarily informed by the conflict theory model of decision making and the expectancy value 
model. The prototype development of all interventions naming this framework did not appear 
to be based on all theories included in the Ottawa decision support framework. The transfer 
of the theoretical constructs of the expectancy value model and the conflict theory model of 
decision making into the design of the intervention was mainly identifiable as a value- 
clanfication exercise. None of the related publications specified whether field-testing had 
been carried out prior to evaluation. Finally, the DESIs’ evaluation seemed to be guided by 
some but not all of the theories included in the Ottawa decision support framework, namely 
the expectancy value model and the conflict theory model of decision making. Decisional 
conflict, measured using the decisional conflict scale (O’Connor 1995), was the main 
outcome measurement that appeared to be informed by the Ottawa decision support 
framework.
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23.4 Combination of Decision Making Theories
An education intervention for breast cancer genetic testing (Lerman et al. 1997) used 
a combination of behavioural models of decision making: the theory of reasoned action 
(Fishbein 1980), the consumer behaviour model (Engel et al. 1978) and the conflict theory 
model of decision making (Janis and Mann 1977). The theory of reasoned action assumes that 
the intention to engage in behaviour is determined by the decision maker’s attitudes as well 
as the subjective norms of significant others regarding this behaviour. The consumer 
behaviour model is a model of consumer decision making process that identifies a set of 
variables that shape decision making such as individual differences, environmental influences 
or psychological processes. The analysis of all articles reporting the DESI’s development and 
evaluation did not provide any evidence that behavioural models of decision making guided 
the design and prototype development of the intervention. The publications did not mention 
whether the intervention had been rigorously field-tested and found acceptable by patients 
and clinicians. The evaluation was not explicitly informed by behavioural models of decision 
making. Apart from knowledge, a very common if not systematic outcome measure in DESI 
evaluation, the outcome variables did not relate to the chosen theoretical framework.
One intervention combining a leaflet with a discussion about the pros and cons of 
breast cancer genetic testing referred to the cognitive-social health information processing 
model (C-SH1P) (Miller et al. 1996). It postulates that decision makers generally favour a 
systematic processing of information where both cognitive and emotional components (i.e., 
individual perception of risk, knowledge, beliefs, and expectancies) are integrated into the 
decision making process. In their publications, the authors thoroughly described the C-SHIP 
model as the theoretical framework supporting the DESI’s design (Miller et al. 2005; Miller 
et al. 1996). The educational intervention they developed appeared to be strongly anchored in
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the C-SHIP model. Most theoretical constructs were addressed and integrated into the 
concrete development of the intervention. There was a lack of information as to whether the 
intervention had been rigorously field-tested and found acceptable by patients and clinicians. 
In the evaluation, the outcome measurements were related to all major components of the C- 
SHIP model and therefore matched theory.
One intervention combining a consultation and a leaflet for Prostate Specific Antigen 
(PSA) testing referred to the preventive health model (Myers et al. 2005; Myers and Wolf 
1990). This model was developed by the DESI’s developers and took constructs from the 
health belief model, the theory of reasoned actions and the social cognitive theory. This 
model identifies a series of internal and external factors (e.g., socio-cultural background, 
cognitive and affective representations associated with the disease or condition) that strongly 
influence people’s intention to act on their health. The preventive health model was 
comprehensively described in the publications reporting the development and evaluation of 
the intervention and seemed to have informed its early conception and prototype 
development. The decision education session designed to elicit patients’ values was based on 
the key constructs o f the preventive health model: preference clarification, cognitive 
evaluation, affective evaluation and social evaluation. There was no evidence of field-testing. 
The evaluation of the tool was partially informed by the preventive health model. Only one 
key principle of the model (personal preference) was related to the primary outcome measure: 
a screening decision preference score.
2.3.5 Cognitive and Social Theories of Decision Making
A video-based intervention for PSA testing (Partin et al. 2004) referred to social 
cognitive theory (Bandura 1986). This model describes the developmental changes that 
individuals undergo over the course of their existence and is structured around the concept of
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agency. The DESTs early conception and prototype development were partly informed by 
social cognitive theory. The pamphlet they designed explicitly addressed one key construct of 
social cognitive theory: cognitive processes (e.g., knowledge and attitudes). However, the 
intervention did not seem to integrate other key dimensions of social cognitive theory (e.g., 
environmental factors). The publications did not mention whether the intervention had been 
rigorously field-tested and found acceptable by patients and clinicians. The evaluation was 
predominantly driven by theory. The outcome measurements integrated three dimensions of 
the social cognitive theory: knowledge (of screening), patient characteristics (demographics 
and health status) and behaviour (screening uptake). As far as could be determined, there was 
no explicit measure of environmental factors, which is considered a key construct of social 
cognitive theory.
One intervention offering a booklet for prostate cancer screening (Shapira and 
VanRuiswyk 2000) mentioned the health belief model (Rosenstock 1974). This model 
describes the factors that influence and determine preventive healthcare behaviours. The 
perception of susceptibility, seriousness, benefits, and barriers associated with each health 
option is assumed to influence decision making. The health belief model appeared to have 
informed the DESI’s early conception. The developers conducted focus groups where the 
health belief model was used to probe participants about their knowledge and feelings 
regarding prostate cancer screening. However, analysis of the associated publications did not 
provide any evidence of the transfer of the key theoretical constructs (i.e., susceptibility, 
seriousness, benefits, and barriers associated with each health option) into the development of 
the intervention. None of the related publications specified whether field-testing had been 
conducted. The evaluation seemed to be informed by the health belief model. The outcome 
measurements (i.e., knowledge, natural history of prostate cancer, perceptions of available
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screening tests and intended screening behaviour) were related to all major dimensions of the 
health belief model.
2.3.6 Behavioural Theories
An intervention combining a video and brochures for colon cancer screening (Pignone 
et al. 2000) referred to the transtheoretical model of behaviour change (Prochaska and Velicer 
1997). This model of intentional change has taken constructs from 18 major theories of 
psychotherapy and behaviour change. Prochaska’s model describes how people acquire or 
modify a behaviour using emotional, cognitive and behavioural components. It is organised 
in stages (i.e., the five stages of change): precontemplation, contemplation, preparation, 
action and maintenance. The early conception of the intervention was partially informed by 
the model. The colon cancer brochures were explicitly based on the transtheoretical model of 
behaviour change. However, the 11-minute educational video did not explicitly rely on 
theory. There was a lack of data as to whether the DESI had been field-tested. Based on the 
publications, there was no evidence that the evaluation had been explicitly informed by the 
transtheoretical model of behaviour change.
One DESI for prostate cancer treatment (Davison and Degner 1997) referred to the 
empowerment model (Conger 1989), derived from management and psychology theories. 
Empowerment is the process of enhancing individuals’ belief in their self-efficacy and 
includes five stages (Conger and Kanungo 1988). When given sufficient decisional power, 
individuals are more likely to assume an active role in decision making and to achieve their 
desired outcomes. The empowerment model, thoroughly described by the DESI’s authors, 
seemed to have informed the early conception of the intervention. However, the five stages of 
empowerment described in the model did not explicitly guide the prototype development. 
There was no evidence whether field-testing had been carried out. The evaluation of the
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intervention was not explicitly informed by theory since none of the outcome measurements 
(i.e., sociodemographic variables, preferred roles, levels of anxiety and levels of depression) 
directly related to the process of empowerment.
To summarise, the early conception and preliminary design of 17 out of 50 DESIs 
were explicitly informed by theory. Further analysis revealed significant variations in the 
extent to which theory guided the prototype development, field-testing and evaluation of the 
interventions. The prototype development of 13 out of 17 interventions appeared to be 
informed by theory. However, the data analysis suggested important variations in the degree 
to which theoretical constructs were applied to the practical development of the intervention. 
The evaluation of 14 out of 17 DESIs was partially informed by theory and most likely 
reflected the difficulty to use and apply key theoretical constructs in a substantive manner. 
None of the 17 DESIs reviewed explicitly reported field-testing the intervention prior to 
evaluation. The transfer of key theoretical constructs into the design of DESIs is a subject that 
requires further attention (Elwyn et al. 2009d).
2.4 Discussion
The analysis of 50 DESIs evaluated by randomised controlled trial revealed that only 
a third had described the contribution of decision making theories or models to their design, 
development and evaluation. All reviewed citations held little evidence that DESI developers 
were basing the intervention design, construction and evaluation on their chosen theoretical 
framework. Further analysis revealed that all theory-based interventions were evaluated 
without prior field-testing, therefore raising the issue of the validity and usability of 
interventions that have not been tested with patients or health professionals (Evans et al.
2007). It was also uncommon for outcome measurements to be based on theoretically derived 
hypotheses. The exceptions were DESIs based on subjective expected utility theory since this
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theoretical framework provided an explicit architecture (i.e., decision tree) for the 
development and, to an extent, the evaluation of the intervention. However, the validity and 
appropriateness of decision analysis based interventions have been questioned. While 
decision analysis has been widely applied to treatment or screening decisions, substantial 
obstacles need overcoming for decision analytic interventions to be useful and adapted to 
clinical settings and patients’ needs. The lack of theory-based outcome measurements needs 
to be seen in the wider context of DESI development and evaluation. It is worth noting that 
difficulties developing and validating widely accepted outcome measurements are inherent to 
this field. There is a lack of consensus on the criteria on which the efficacy of DESIs should 
be judged, and no measure is yet able to accurately assess decision quality (Kennedy 2003). 
Difficulties developing and validating accepted measures of DESIs’ effectiveness may 
explain the aforementioned tendency to develop atheoretical outcome measurements. Further 
research is needed into exploring how relevant theoretical frameworks can guide the 
development of outcome measurements.
The analysis of all published material indicated that 66% of interventions included in 
this review did not explicitly rely on theories or models of decision making and could 
therefore be described as atheoretical interventions. Other conceptual frameworks might have 
informed the DESI’s early conception but decision making theories were not mentioned in 
any publications reviewed. The assumption was therefore made that 33 out of 50 
interventions (66%) were not informed by theory. The findings are consistent with previous 
research and confirm the tendency to develop and implement DESIs without solid theoretical 
underpinnings (Bekker et al. 1999; Bowen et al. 2006).
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Strengths of this theoretical review were the quality of the sampling frame and 
inclusion criteria. All interventions were evaluated in a randomised controlled trial and 
included in a Cochrane review. It was therefore presumed that all interventions selected for 
review had been rigorously developed. All 78 citations were rated by 2 independent 
reviewers. Two limitations need to be considered. The sampling frame only included 
interventions evaluated in randomised controlled trials. Independent or commercial DESI 
developers were not included in this sample since it was assumed that highest quality 
interventions would have been submitted to evaluation. The bias generated by the specificity 
of the sampling frame, which could also be described as a methodological strength, could be 
addressed by including a wider range of interventions, produced by smaller developers and 
not evaluated in randomised controlled trials. A further limitation lies in the assumption that 
some DESI developers might have used theory in conceptualising the intervention but did not 
mention it in publications. However, the assumption was made that if theory had played a 
crucial role in developing the intervention, related publications would have specified how 
theory had informed its conception.
2.5 Conclusion
This chapter draws attention to the difficulty to integrate theories or models of 
decision making into the prototype development and evaluation of DESIs. With the exception 
of subjective expected utility theory, the initial effort to use theoretical frameworks in the 
early stages of the DESI conception became impoverished when developing and evaluating 
prototypes. The lack of theoretical basis underpinning the development and evaluation of 
DESIs points to a paradox. Technologies intended to facilitate decision making processes do 
not build on key concepts of how individuals make decisions. However, theories or models of 
decision making do attempt to explain and predict how individuals make complex decisions. 
They describe the factors or situations likely to impair the decision making process and/or
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lead to poor decision outcomes and decisional regret. It would therefore seem legitimate to 
integrate theoretical constructs into the development and evaluation of DESIs in the 
anticipation of significant impact on decision quality and outcomes. Using theories to 
develop DESIs may prove beneficial to decision makers provided appropriate theories are 
used and are correctly transferred into practice.
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Chapter 3
Amniocentesis Testing
3.1 Introduction
Amniocentesis is an invasive diagnostic procedure, involving complex information, 
potential harms, benefits and far-reaching consequences. Facing amniocentesis testing 
generally triggers heightened stress and anxiety, at a time of increased sensitivity (Ng et al. 
2004; Robinson et al. 1984; Sarkar et al. 2006; Sarkar et al. 2008). There is no single best 
decision. Pregnant women and their partners are sole decision makers as to what is best for 
them and their baby. The decision to undertake amniocentesis testing is highly dependent on 
values and preferences and prone to high decisional conflict. As discussed in Chapter 1, 
DESIs designed to support decision making and facilitate the trade-off between options have 
been specifically developed for preference-sensitive decisions such as amniocentesis testing. 
Deciding about amniocentesis should be the result of an informed choice, determined by the 
expectant parents’ preferences and attitudes to the risks involved and how possible harms and 
benefits are valued and evaluated (Marteau 1995). In addition, achieving informed choice is a 
cornerstone of the British National Health Service (NHS) and becomes especially relevant in 
decisions involving ethical considerations such as amniocentesis testing. Expectant parents 
ought to be informed about the benefits, potential harms and implications of amniocentesis 
before deciding whether or not to have the test. The aim of this chapter was to address the 
complexity and clinical characteristics of amniocentesis testing and to demonstrate why 
decision making could be facilitated by DESIs.
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3.2 Screening for Down’s Syndrome
Over the past decades, advanced maternal age (e.g., >35) has been the most common 
indication for amniocentesis testing (Palo et al. 1994). In the United Kingdom, screening tests 
for Down’s syndrome are currently offered as part of routine clinical practice to all pregnant 
women (Sailer and Canick 2008), in order to determine their chance of foetal chromosomal 
abnormality. Prenatal screening tests for Down’s syndrome will identify women with a 
higher risk of having a foetus with a chromosomal abnormality but cannot provide a 
diagnosis of chromosomal abnormality. Only invasive prenatal diagnostic tests (i.e., 
amniocentesis testing or chorionic villus sampling) are able to detect and diagnose the most 
common foetal chromosomal abnormalities. Prenatal screening tests for Down’s syndrome 
include ultrasound scans (i.e., nuchal translucency scan) and maternal serum screening tests. 
Maternal serum screening tests (generally undertaken between 10 and 18 weeks of 
pregnancy) measure up to four biochemical markers in the blood (i.e., a-fetoprotein, oestriol, 
inhibin a, beta-hCG, human chorionic gonadotropin) and combine the blood test measures 
with maternal age, gestational age and weight in order to determine an adjusted chance of 
foetal chromosomal abnormality (Cate and Ball 1999). The nuchal translucency scan is a non 
invasive test based on ultrasound examination, usually performed between 10 and 13 weeks 
of pregnancy, to measure the thickness of fluid at the back of the baby’s neck. Increased 
foetal nuchal translucency (i.e., thickness of fluid in the skin of the baby’s neck) is associated 
with a wide range of chromosomal abnormalities including Down’s syndrome (Nicolaides
2004).
The NHS routinely offers second trimester maternal serum screening tests for Down’s 
syndrome to all pregnant women between 14 and 18 weeks of pregnancy (Weisz and Rodeck 
2006), with variations between England, Scotland, Wales and Northern Ireland. The nuchal
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translucency scan is not routinely offered as part of the NHS screening programme but may 
be undertaken privately. The detection rates (i.e., detection of foetus with Down’s syndrome) 
of maternal serum screening tests vary between 60% and 75% depending on the number of 
biochemical markers measured in the blood and there is a 5% false positive rate (Wald et al. 
2003). The detection rate of the nuchal translucency scan is 72% with a 5% false positive rate 
(MacRae et al. 2008). The National Institute for Clinical Excellence (NICE) recommends that 
by April 2007, screening tests for Down’s syndrome should provide a detection rate of 75% 
with a false positive rate lower than 3%. In Wales, screening tests for Down’s syndrome are 
currently performed using the triple test, a maternal serum screening test measuring three 
biochemical markers in the blood (60% detection rate for a 5% false positive rate). In the 
NHS, to distinguish between high risk and low risk maternal serum screening test results, the 
cut-off of 1 in 250 is used (e.g., a result of 1 in 251 would be considered a low risk result and 
amniocentesis would not be offered). All women whose screening test result falls between 1 
in 2 (50%) and 1 in 250 chance (0.4%) of having a baby with Down’s syndrome will be 
offered to undergo amniocentesis testing (NHS Antenatal and Newborn Screening 
Programmes 2009). About 5% to 10% of women who undertake screening tests for Down’s 
syndrome receive a high risk result and are offered to undergo amniocentesis testing to 
confirm the presence of abnormality (see Figure 3.1) (Benn et al. 2006; Gidiri et al. 2007).
The low predictive value of prenatal screening tests implies that a considerable number 
of women will be offered an amniocentesis while carrying a baby which does not have a 
chromosomal abnormality (i.e., false positive result). Conversely, women who receive a 
normal screening test result may carry a baby with a chromosomal abnormality (i.e., false 
negative result). It is generally accepted that undergoing screening tests (for Down’s 
syndrome or any other condition) should be the result of an informed choice
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Figure 3.1 Schematic Representation o f the Prenatal Testing Process
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commonly described as a decision based on comprehensive information and consistent with 
the expectant parents’ values and attitudes (General Medical Council 1999; National 
Screening Committee 2000; Royal College of Obstetricians and Gynaecologists 1993; 
Marteau et al. 2001). As stated in the 2000 report of the Department of Health: “There is a 
responsibility to ensure that people who accept an invitation [for screening] do so on the basis 
of informed choice” (Department of Health 2000, p. 2). The sensitivity, specificity and 
implications of the screening test results, such as the possible offer of an amniocentesis, 
should be fully understood by pregnant women before they undertake prenatal screening 
(Marteau 1995). Current research suggests that decisions to undertake screening tests for 
Down’s syndrome are not always fully informed (Green et al. 2004b; Van den Berg et al. 
2006; Van den Berg et al. 2005). Dormandy et al. (2006) revealed that over half of pregnant 
women undergoing Down’s syndrome screening did not make an informed choice.
Furthermore, pregnant women commonly undertake screening tests for Down's 
syndrome without realising the sequence of events triggered by uptake of this test (Baillie et 
al. 2000). Undertaking non-invasive screening tests for Down’s syndrome may lead to further 
invasive tests, detection of foetal chromosomal abnormality and difficult decisions about the 
pregnancy and life with an affected child (Dormandy et al. 2006; Jaques et al. 2004a). 
Women are generally not prepared to receive a high chance result and often report a poor 
understanding of prenatal screening tests offered and undergone (Marteau 1994a; Marteau 
1995; Smith et al. 1994). The decisions to undertake prenatal screening and amniocentesis 
testing are closely related. Further information should be provided pre-screening and 
informed choice achieved, to avoid heightened stress and anxiety when facing a decision to 
undertake amniocentesis (Green et al. 2004b).
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3.3 The Amniocentesis Procedure and Chromosome Tests
Amniocentesis is the most common prenatal diagnostic procedure undertaken in the 
United Kingdom. The procedure is generally performed after 15 completed weeks of 
pregnancy, to provide foetal cells for karyotyping (Abbott and Benn 2002; Evans and Wapner
2005). It is estimated that 5 to 10% of pregnant women in the UK are offered prenatal 
diagnostic procedures (i.e., amniocentesis or chorionic villus sampling). Chorionic villus 
sampling (CVS) is another method of obtaining foetal genetic material, performed in the first 
trimester o f pregnancy (10-14 weeks), by withdrawing placental tissue rather than foetal cells 
from amniotic fluid (Brun et al. 2003). The CVS procedure is not routinely offered in the 
NHS and involves different risks (Caughey et al. 2006). For the purpose of this thesis, the 
focus is on amniocentesis testing.
The amniocentesis procedure consists of withdrawing 15 millilitres of amniotic fluid 
from the amniotic sac, in the uterus, under continuous ultrasound guidance. The procedure is 
reported to have a 1% risk of miscarriage although this may vary by operator (Gaudry et al. 
2008; Odibo et al. 2008; Papantoniou et al. 2001). The best estimate of the rate of miscarriage 
following an amniocentesis is based on a randomised controlled trial conducted in 1986, 
among 4606 low risk women (Tabor et al. 1986). The miscarriage rate in the amniocentesis 
group exceeded the control group by 1%, which is the national figure normally quoted in 
counselling (Royal College of Obstetricians and Gynaecologists 2005). Amniocentesis may 
also be associated with a risk, albeit low and not quantified, of foetal trauma, rupture of 
membranes, foetal cutaneous lesions and maternal infections (Borrelli et al. 2006; Palo et al. 
1994; Vilar Coromina et al. 2007).
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It is estimated that between 40% and 80% of women who are offered an amniocentesis 
will undertake the test (Lesser and Rabinowitz 2001; Sharda and Phadke 2007; Sjogren and 
Uddenberg 1988). Following the procedure, chromosomal assessment will be performed on 
the amniotic sample. Traditionally, a full karyotype analysis is systematically performed on 
foetal cells after cell culture (Ogilvie 2003). It involves carefully examining the structure and 
number of all chromosome pairs, and usually takes a minimum of 10 working days 
(Warburton 1991). A karyotype analysis can identify aneuploidy such as trisomy 21, 18 or 13 
but may also detect other abnormalities such as exchange of material between chromosomes. 
The classic karyotype analysis will not detect changes in single genes, microdeletions and 
other small changes in chromosomes. Since 1980, the karyotyping procedure has been the 
gold standard of prenatal diagnosis worldwide. Where minor chromosomal abnormalities are 
detected after karyotype analysis, the question arises as to what threshold termination of 
pregnancy should be considered. While the karyotype test identifies most chromosomal 
abnormalities, it cannot provide information about the phenotypic consequences or severity 
of the abnormality diagnosed. The severity of a particular chromosomal abnormality such as 
Down’s syndrome for example, is extremely variable and cannot be predicted. Women 
should be informed about the range of chromosomal abnormalities tested for and uncertainty 
accompanying the diagnosis. Given the number and complexity of chromosomal 
abnormalities potentially detected, the question arises as to how much information is too 
much information? In other words, when deciding about amniocentesis, is there a need for 
extensive information about all abnormalities tested for, or would this lead to information 
overload?
A recent development in Wales, and elsewhere in the UK, is the implementation of a 
rapid genetic test; Quantitative-Fluorescent Polymerase Chain Reaction test (QF-PCR test),
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which provides results for the three most common chromosomal abnormalities: Down’s, 
Edwards’ and Patau’s syndromes in 3 working days (Levett et al. 2001; Mann et al. 2008). 
The National Screening Committee recommends that the QF-PCR test alone is performed on 
all amniotic samples following a higher screening test result, as happens in England. In 
Wales, both QF-PCR and karyotype tests are systematically performed. Women who 
undertake amniocentesis testing in Wales will receive a result for Down’s, Patau’s and 
Edwards’ syndromes after 3 working days and the full karyotype result after two weeks. 
Pregnant women considering an amniocentesis should be aware that after a normal QF-PCR 
result, the karyotype analysis may detect further abnormalities. The implementation of the 
QF-PCR test and detection of a wider range of chromosomal abnormalities in different 
timeframes requires an updated approach to information provision.
When an abnormality is found, expectant parents will have to decide between 
continuing the pregnancy and preparing for the birth of a baby diagnosed with a genetic 
abnormality or ending the pregnancy (Asch 1999; Pryde et al. 1993; Verp et al. 1988; Yilmaz 
et al. 2008). Termination rates following an amniocentesis vary. A study examining the 
determinants of parental decisions revealed that 93% of couples with severe foetal prognosis 
(e.g., trisomy 21, 18, 13) terminated the pregnancy while 27% of couples with questionable 
prognosis (e.g., mosaic 45, x, sex chromosome trisomy) opted for a termination (Drugan et al. 
1990). The presumed or perceived severity of the chromosomal abnormalities was a 
determining factor of parental decision to terminate the pregnancy. Before deciding to 
undertake amniocentesis, women, and their partners, should be informed about the range of 
abnormalities tested for, and option to terminate the pregnancy as this may have a significant 
impact on their decision and post-decision outcomes (i.e., regret, cognitive dissonance and 
decisional conflict) (Priest et al. 1998).
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3.4 Existing Information and Decision Support Arrangements
In the literature, the information, decisional needs and psychological impact of 
invasive diagnostic procedures such as amniocentesis have rarely been documented (Marteau 
1995; Rostant et al. 2003; St-Jacques et al. 2008). Further, the few studies examining 
decisional and informational issues surrounding prenatal testing have not specifically 
addressed the decision to undertake amniocentesis (Potter et al. 2008). The decision to 
undertake screening and diagnostic tests have commonly been confounded. There is limited 
research on how best to provide information on amniocentesis testing. A qualitative study on 
the perspectives of physicians and pregnant women with regards to amniocentesis testing 
revealed that the information provided to women did not address their own interests (Hunt et 
al. 2005). Pregnant women and physicians reported divergent concerns and approaches to the 
amniocentesis decision. Physicians were concerned with following pre-established 
communication strategies or protocols and provided explanations about the relative risks of 
amniocentesis and characteristics of the tests. Pregnant women were primarily concerned 
about coping with stress and anxiety and protecting the pregnancy.
In 1995, a review of informed decision about prenatal testing highlighted the lack of 
understanding of women undergoing or declining prenatal tests (screening and diagnostic 
tests) (Marteau 1995). This finding is consistent with a recent systematic review of women’s 
decisional needs in the diagnostic phase of pregnancy, which confirmed that pregnant women 
considering prenatal testing generally lacked information (St-Jacques et al. 2008). Further 
research suggested that the risks associated with prenatal testing and the range of 
abnormalities tested for were particularly misunderstood (Cederholm et al. 1999). A study of 
women’s knowledge about prenatal testing revealed that 35% of women undertaking 
diagnostic tests did not mention (when asked in a questionnaire) that amniocentesis was
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testing for Down’s syndrome (Jaques et al. 2004). In addition, expectations regarding 
amniocentesis or prenatal testing are often unrealistic (Marteau 2002). A study of 
amniocentesis related pains showed that expected pain and anxiety levels before the test were 
significantly higher than pain and anxiety levels reported post-procedure (Ferber et al. 2002).
Furthermore, the information women receive when offered amniocentesis testing is 
complex, specialised and potentially overwhelming. The amniocentesis decision generally 
involves heightened stress and anxiety (Sun et al. 2008; Susanne et al. 2006). Research 
suggests that maternal stress in women facing amniocentesis testing is higher than the norms 
of psychiatric and female surgical patients (Johnston 1980; Robinson et al. 1984) and could 
be associated with poor outcomes (i.e., gestational complication, foetal growth retardation) 
for the mother and foetus (Glover et al. 2008; Reading 1983; Talge et al. 2007). 
Understanding the risks (e.g., risk of miscarriage or chromosomal abnormality) and 
processing complex probabilistic information and numerical data at a time of increased 
sensitivity is difficult. To achieve decision making, most women will need to balance the risk 
of miscarriage (1 %) against their individual risk of foetal chromosomal abnormality, based 
on the screening test results (1 in 250 or more) (Gidiri et al. 2007; Sailer and Canick 2008). 
The risk of miscarriage is expressed out of a 100 and the screening test result may be 
anything between 1 in 2 to 1 in 250 chance of having a baby with Down’s syndrome. For 
instance, for a screening test result of 1 in 250 (0.4%), the risk of miscarriage (1%) is higher 
than the risk of having a baby with Down’s syndrome. Women facing a decision to undertake 
amniocentesis should be able to accurately balance the risk of miscarriage against the 
screening test result. Comparing probabilities with multiple denominators at a time of 
heightened stress may be difficult and overwhelming (Quagliarini et al. 1998). Difficulties 
comprehending probabilistic information in the diagnostic phase of pregnancy have been
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documented previously (Kuppermann et al. 2006; Pilnick et al. 2004). In addition, research 
shows that individual differences in processing numerical information exist and significantly 
affect performance (Booth and Siegler 2006). The ability to process complex numerical 
information significantly decreases under high-pressure or stress conditions (Beilock and 
Decaro 2007). Finally, discussing the implications o f amniocentesis testing and abnormalities 
potentially detected requires expert genetic knowledge. There is documented evidence that 
health professionals who counsel women about amniocentesis testing do not always have 
sufficient specialised knowledge to provide specific but simple information about genetic 
testing and chromosomal abnormalities tested for (Hunt et al. 2005; Williams et al. 2002a).
3.5 Summary
This chapter discussed the complexity of the screening process, information provided, 
risks and implications associated with amniocentesis testing. Over 30,000 pregnant women in 
the UK every year face a decision to accept or decline amniocentesis testing (Benn et al. 
2006; Gidiri et al. 2007). This decision involves uncertainty, far reaching consequences and 
complex probabilistic information that has to be weighed against the couple’s values and 
attitudes, at a time of heightened stress and anxiety. Considering amniocentesis testing also 
involves understanding the possible consequences and limitations of the chromosome tests.
Current research highlights the lack of information and understanding of women 
undertaking or declining prenatal testing for Down’s syndrome. The associated risks and 
range of chromosomal abnormalities tested for are particularly misunderstood. Informed 
choice is not systematically achieved and existing information and decision support is not 
always responsive to women’s needs and concerns. There is scope for developing 
interventions capable of addressing their information needs, providing decision support and 
alleviating emotional strain experienced in the diagnostic phase of pregnancy.
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Chapter 4
Review of Decision Support Interventions for Amniocentesis
4.1 Introduction
The decision to undertake amniocentesis testing is often associated with a lack of 
information and understanding of the test purposes and consequences. Deciding about 
amniocentesis should be determined by the expectant parents’ awareness of the purposes of 
the test, their attitudes to the risks involved and how harms and benefits are valued (Hunt et 
al. 2005; St-Jacques et al. 2008). Difficult decisions such as these should involve parents in 
choosing the option that is consistent with their knowledge, values and preferences. To 
achieve these goals, DESIs intended to support individuals who face difficult health decisions 
for them or others in their families have been developed.
As highlighted in Chapter 1, DESIs’ characteristics and effectiveness have been 
examined in several systematic and interpretative reviews, therefore highlighting the variable 
effect and outcome measurements used to assess their efficacy (O’Connor et al. 2001; 
Molenaar et al. 2000; Estabrooks et al. 2001). DESIs have been developed using a variety of 
formats, purposes and timeframes to address a wide array of preference-sensitive decisions: 
breast cancer surgery, PSA testing, hormone replacement therapy etc. To date, DESIs for 
amniocentesis have not been formally reviewed nor evaluated. The aim of this chapter was to 
identify, describe and assess the quality and effectiveness of DESIs for amniocentesis and 
examine their use and implementation in clinical practice. To meet the stated aims, the review 
was organised around three questions:
1. How many DESIs for amniocentesis exist and what are their aims?
2. Do DESIs for amniocentesis meet published quality standards?
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3. What is the effectiveness of DESIs for amniocentesis?
4.2 Methods
4.2.1 Definitions
For the purpose of this chapter, DESIs were defined as: “Interventions designed to 
help people make specific and deliberative choices among options by providing information 
on the options and outcomes relevant to a person’s health status’’ (O'Connor et al. 2006, p. 2). 
Based on the Cochrane review (O'Connor et al. 2006) and International Patient Decision Aids 
Standards instrument (IPDASi), four essential criteria allowing the distinction between 
information leaflets and DESIs were identified. Accordingly, a DESI should:
1. State the decision to be addressed and deliberated upon;
2. Provide information about the options, their harms, benefits and the associated 
probabilities of the decision outcomes;
3. Enable patients to express and clarify their values, attitudes, preferences in regard to the 
decision;
4. Provide structured guidance in achieving decision making (step-by-step way to make a 
decision).
Two out of four criteria (criteria 1 and 2) were used in selecting the DESIs for review. 
Therefore, interventions that explicitly addressed the decision to have amniocentesis and 
provided information about the harms, benefits and outcomes probabilities associated with 
each option were included in the review.
4.2.2 Literature Search Strategy
Ten electronic databases were searched until June 2009: Medline (1966-2009), 
Medline In-Process, PubMed (2009), Embase (1980-2009), British Nursing Index (1994-Jun 
2009), CINAHL (1982-Jun 2009), all EBM Reviews (2009), PsycINFO (1806-2009), Science
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Citation Index Expanded (1970-2009), Social Sciences Citation Index (1970-2009). A list of 
key words and subject headings (MeSH words in PubMed) was written in Ovid and run in 
each database (see Table 4.1). DESIs for amniocentesis where reports had not been published 
in peer-reviewed journals or had not been evaluated in a trial, were identified through manual 
check of reference lists from published papers, internet search and manual check of the A-Z 
list of decision aids developed by the Ottawa Health Decision Centre (Ottawa Hospital 
Research Institute 1996). All major DESI developers such as the Ottawa Health Decision 
Centre, Healthwise, Mayo Clinic, Midwives Information and Resource Service (MIDIRS), 
Foundation for Informed Medical Decision Making (FIMDM) and Intelihealth (Harvard 
Medical School) were contacted.
4.2.3 Study Inclusion and Exclusion Criteria
Studies were included if they (i) considered DESIs that focussed on the decision to 
undertake amniocentesis (regardless of age and pathway of entry); or (ii) considered the 
decision to undertake amniocentesis as well as other prenatal screening tests or other 
available diagnostic tests such as CVS. Only interventions that could be classified as DESIs, 
as opposed to information leaflets, were included in this review (see Definitions section). 
Studies were excluded if they (i) considered DESIs that exclusively focussed on prenatal 
screening tests or CVS without addressing the decision to undertake amniocentesis; (ii) 
addressed a choice between amniocentesis and CVS (see Figure 4.1).
4.2.4 DESI Assessment
After having identified interventions that met the inclusion criteria, DESI developers 
were contacted by email to obtain a copy of the intervention and information on its current 
use and implementation in clinical settings. Information about (i) the DESI characteristics, 
aims, and current use, (ii) the DESI quality against published standards and (iii) efficacy, was
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Table 4.1 Literature Search Strategy
Amniocentesis Decision support technique
Prenatal diagnosis Patient decision aid
Antenatal diagnosis Decision aid
Prenatal testing Decision explorer
Antenatal testing Decision tool 
Decision support 
Decisions 
Decision making 
Software
Decision support systems
Computer assisted
Information systems
Computer assisted decision support
systems
Genetic counselling
1 All terms in the first column were combined with terms in the second column
F igure 4.1 Selection Process o f Decision Support Interventions Includedfor Review
DESIs identified 
through database 
search n=6
DESIs identified 
through contact with 
authors and internet 
search n=5
DESIs retrieved for detailed 
evaluation 
n=l 1
DESIs not centred on 
amniocentesis n=2
- Harris et al. (2001)
- Kuppermann (2009)
DESIs comparing 
amniocentesis and CVS 
n=l
- Heckerling et al. (1994)
DESIs that did not meet 
the primary inclusion 
criteria 
n=3
DESIs that did not meet 
the secondary inclusion 
criterion 
n=2
- Intelihealth (2005)
- MIDIRS (2005)
DESIs included in the review 
n=6
- Bekker et al. (2004)
- Drake et al. (1999)
- Healthwise (2006)
- Ferber et al. (2002)
- Pauker et al. (1979)
- Nagle et al. (2008)
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collected to address the aforementioned research questions. First, a content analysis was 
performed to determine the specific features, the aims, the current use and implementation of 
each intervention. Second, the DESIs were rated against the IPDAS instrument (IPDASi) 
domains to assess the quality o f essential components (see Appendix 1). The number of 
published DESIs has tripled since 1999 (O'Connor et al. 2007a) and there is a growing 
concern that development has been independent of relevant theoretical frameworks. 
However, the IPDASi domains do not include an item on the contribution of theory to the 
DESI development. Therefore, associated publications were independently examined and 
DESI developers were contacted to ascertain the theoretical underpinnings of each DESI. 
Third, the efficacy of the DESIs was determined by assessing evaluation methods and impact 
on decision outcomes.
The IPDASi (www.ipdasi.org) was developed and validated by an international group 
of researchers working to assess the quality of DESIs (Elwyn et al. 2009c; Elwyn et al. 2006). 
The author was trained to perform IPDASi ratings before assessment. IPDASi is a set of 47 
quality criteria (or items) addressing 10 domains that should ideally be covered in a DESI: 
Information, Test, Probabilities, Values, Guidance, Development, Evidence, Disclosure, Plain 
Language, Evaluation. The Information domain assesses the quality of information provided 
on the decision at stake, the options available and the positive and negative features of each 
option (8 items). The Test domain assesses the extent to which specific features of the 
diagnostic or screening investigation (e.g., rate of false positive or false negative results) are 
described in the intervention (9 items). The Probabilities domain examines how probabilistic 
information is presented and framed (8 items). The Values domain assesses whether the 
intervention facilitates the expression and clarification of the expectant parents’ values with 
regards to the decision (5 items). The Guidance domain examines the extent to which the
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intervention provides structured guidance in helping expectant parents achieve decision 
making (2 items). The Development domain evaluates the quality of the DESI development 
process by specifically looking at the involvement of patients and professionals, use of field 
test and expert review (6 items). The Evidence domain assesses the quality of the research 
evidence used in developing the intervention (5 items). The Disclosure domain appraises the 
transparency of the funding and author disclosure (2 items). The Plain Language domain 
assesses the DESI’s clarity and readability levels (1 item). Finally, the Evaluation domain 
assesses the impact o f the intervention on decision outcomes (1 item). Each item was rated on 
a scale from 1 = strongly disagree to 4 = strongly agree. Domain and total IPDASi percentage 
scores were calculated, first, by summing relevant items and then dividing by the number of 
items per domain, in order to account for the unequal number of items per domain. The 
IPDASi is enclosed in Appendix 1.
4.3 Results
4.3.1 Selection of DESIs
The literature search and contact with authors identified 11 interventions. After 
assessment of their content and/or available publications, five interventions were excluded. 
Three interventions did not focus on the decision to undertake amniocentesis. The 
intervention by Heckerling et al. was excluded since it compared amniocentesis testing and 
CVS (Heckerling et al. 1999; Heckerling et al. 1994). The intervention by Harris et al. 
focussed on prenatal screening tests without specifically addressing the decision to undertake 
amniocentesis and was therefore excluded (Harris et al. 2001). The intervention by 
Kuppermann et al. was excluded as it offered a comparison between prenatal screening tests 
and diagnostic tests without specifically addressing the decision to undertake amniocentesis 
(Kuppermann et al. 2009). Two interventions were classified as information leaflets and
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excluded from the review after content analysis revealed that the interventions did not meet 
the criteria one and two of a DESI (see Definitions, p. 52) (InteliHealth 2005; MIDIRS 2005).
4.3.2 How Many DESIs for Amniocentesis Exist and What Are Their Aims?
Six DESIs for amniocentesis were examined in the review: (1) a decision analytic 
consultation by Bekker et al. (Bekker et al. 2004), (2) an intervention developed by Drake et 
al. combining an audiotape and a booklet entitled: “Making choices: prenatal testing” (Drake 
et al. 1999), (3) “the amniocentesis report”, a booklet downloaded from the internet produced 
by Ferber et al. (Ferber and Sicherman 2001), (4) a web-based DESI for amniocentesis 
developed by the Healthwise group entitled: “Should I have an amniocentesis?” (Healthwise 
2006), (5) a DESI for prenatal testing developed by Nagle et al. (Nagle et al. 2008), and (6) a 
decision analytic model developed by Pauker et al. (Pauker and Pauker 1979, Pauker and 
Pauker 1987). Three out of six interventions were developed in the USA (Ferber and 
Sicherman 2001; Healthwise 2006; Pauker and Pauker 1979), one in Canada (Drake et al. 
1999), one in Australia (Nagle et al. 2008) and one in the United Kingdom (Bekker et al. 
2004). Two out of six interventions were available on the internet (Ferber and Sicherman 
2001; Healthwise 2006) although one of the DESIs’ availability was subject to payment 
(Ferber and Sicherman 2001). Based on the Ottawa A to Z inventory and contact with 
authors, it was ascertained that two of six DESIs were used (2008) in clinical settings: 
Pauker’s decision analysis consultation (Pauker and Pauker 1979) and the intervention for 
prenatal testing of foetal abnormalities developed by Nagle et al. (Nagle et al. 2008). At the 
time of assessment, Pauker’s decision analysis consultation was used in routine genetic 
counselling at Harvard Vanguard Medical Associates across eastern Massachusetts, USA. 
The DESI by Nagle et al. was used by maternity care clinicians as part of a state-wide 
education programme in Victoria, Australia. The interventions are listed in Table 4.2 and 
described according to their name, decision considered, format, use and location, theoretical
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Tabic 4.2 Characteristics o f Decision Support Interventions for Amniocentesis Included for Review
Authors Title Decision Format, use and location Theoretical
framework
Outcome measures
Bekker et al. 
(2004)
Decision analysis 
consultation
Prenatal diagnostic testing 
(amniocentesis and CVS)
Routine consultation structured by decision 
analysis, used in an additional information 
consultation offered to women after a high 
chance maternal scrum screening test result for 
Down’s syndrome.
DESI developed in the UK.
Expected utility theory Consultation length 
Informed decision making 
Test choice
Drake et al. (1999) 
Hunter et al. (2005)
Making choices: 
prenatal testing
Prenatal testing:
- Maternal serum screening
- Ultrasound scan
- Amniocentesis + CVS
Workbook and audiotape, used in a genetic 
counselling consultation, including a discussion 
with a genetic counsellor.
DESI developed in Canada.
Ottawa decision 
support framework
Knowledge
Anxiety
Decisional conflict 
Intervention satisfaction
Ferber and 
Sicherman 
(2001)
The amniocentesis 
report, decision guide 
for expectant parents 
and healthcare 
professionals
Amniocentesis testing Web-based DESI 
www.amnioccntesis.orc 
DESI can be downloaded in 
PDF format online or shipped worldwide. 
Minimal fee: $5.05.
DESI developed in the USA.
No theory No evaluation
Healthwise 
(last update 2006)
Should I have 
an amniocentesis?
Amniocentesis testing Web-based DESI
www.wcbmd.conVbabv/should-i-have-an-
amniocentesis
Open Access (free of charge).
DESI developed in the USA.
No theory No evaluation
Nagle et al. 
(2006)
A decision aid for 
prenatal testing of foetal 
abnormalities
Prenatal testing:
-Maternal serum screening 
-Second trimester 
ultrasound scan,
- Amniocentesis + CVS
24-page booklet
DESI given to women in early pregnancy by 
their GP.
DESI developed in Australia.
Ottawa decision 
support framework
Informed choice 
Decisional conflict 
Anxiety 
Depression
Attitudes to the foetus/pregnancy 
Satisfaction with the DESI
Pauker and Pauker 
(1979)
A decision analytic 
model to counsel 
parents about 
amniocentesis
Amniocentesis testing Routine consultation structured by 
decision analysis.
Method used in a routine genetic counselling 
session for prenatal diagnosis.
DESI developed in the USA.
Expected utility theory Assessed cost of elective abortion
Assessed cost of spontaneous
abortion
Actual decision
Decision suggested
by decision analytic model
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framework and outcome measurements (when applicable). The DESIs varied in their content 
and approach.
The decision analysis consultation developed by Bekker et al. was based on Pauker 
and Pauker's decision analytic model and designed to help parents clarify and express their 
values (Bekker et al. 2004). The consultation was articulated around the use of a decision tree 
displaying test options and consequences, and a lottery technique designed to facilitate the 
trade off between options by eliciting the maximum utility (the “goodness” of each option 
and consequences). The lottery technique consisted of asking questions to compare the 
options (accepting or declining amniocentesis) on each attribute (e.g., chance of having a 
baby with Down’s syndrome) by varying the gamble figure: “If we told you the chance of the 
baby having Down’s syndrome was fifty per cent, and the chance of the baby not having 
Down’s syndrome was fifty per cent, would you choose to carry on with or terminate the 
pregnancy?” (Bekker et al. 2004, p. 267). Finally, a graph combining the expectant parents’ 
best utility and the results of the screening test was used to identify the option with the 
highest expected utility. From a rational standpoint, the option with the highest expected 
value should correspond to the best possible option.
The DESI by Drake et al., making a choice: prenatal testing, provided information 
about maternal serum screening tests, ultrasound scans, CVS and amniocentesis testing. The 
aim of the intervention was to improve knowledge, decrease decisional conflict, and decrease 
anxiety levels associated with prenatal testing. It consisted of a 35-page illustrated workbook, 
a 45-minute audiotape and a worksheet. The worksheet gave expectant parents the 
opportunity to clarify the reasons for undertaking or declining prenatal tests and provided a 
concrete basis for discussing the options with health professionals.
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The amniocentesis report by Ferber et al., a decision guide for expectant parents and 
healthcare professionals, was a 16-page booklet providing structured information on 
amniocentesis testing, its potential risks and implications (Ferber and Sicherman 2001). The 
amniocentesis report was designed to provide unbiased information on amniocentesis testing 
in order to help expectant parents make an informed decision. The intervention was divided 
into six sections: (1) What is amniocentesis and how is it done, (2) Nature and accuracy of 
the amniocentesis results, (3) What are the benefits of amniocentesis, (4) What are the costs 
of amniocentesis (relevant to the United States), (5) Making the amniocentesis decision and 
(6) Alternative procedures.
The web-based DESI produced by Healthwise was an interactive website entitled: 
Should I have an amniocentesis? (Healthwise 2006). The intervention was designed to help 
expectant parents understand their choices regarding amniocentesis testing. The intervention 
was divided into four sections: (1) an introduction to amniocentesis testing, (2) medical 
information about the amniocentesis procedure, harms and benefits, (3) a section comparing 
the reasons to accept or decline an amniocentesis and (4) a worksheet for patients to clarify 
their ideas and values about amniocentesis testing.
The DESI for prenatal testing by Nagle et al. was a 24-page booklet containing 
graphic design elements (i.e., diagram, images, charts and dot points) and information about 
maternal serum screening, second trimester ultrasound scan, CVS and amniocentesis testing 
(Nagle et al. 2008). The intervention was designed to assist women in making an informed 
choice about amniocentesis and to reduce decisional conflict. It provided information on the 
reasons for being offered prenatal testing, the range of prenatal tests available and the results
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and implications of each test. The intervention included scenarios of pregnant women’s 
experiences, a worksheet to weigh up the pros and cons of each option and a list of additional 
information resources available. Finally, it included a risk report sheet presenting the risks 
estimates of having a baby affected with Down’s syndrome, based on the expectant mother’s 
age and gestation.
The decision analytic DESI developed by Pauker and Pauker was used to counsel 
parents about amniocentesis testing during the consultation and required the assistance of a 
physician (Pauker and Pauker 1979). The intervention was designed to help parents assess 
their values and attitudes about the outcomes of options and make a logical decision about 
amniocentesis (guided by decision analysis). The decision analytic model was used during 
the consultation and involved a lottery technique where the following outcomes were 
considered: miscarriage, detection of chromosomal abnormality and being faced with 
diagnostic errors. Prospective parents were asked to assign a utility (on a scale from 0 to 100) 
to the potential outcomes of both available options: undertaking or declining amniocentesis.
4.3.3 Do DESIs for Amniocentesis Meet Published Quality Standards?
Five out of six DESIs were rated against all IPDASi domains to assess their quality 
(see Table 4.3). The evaluation of the prenatal testing booklet developed by Nagle et al. was 
exclusively based on the analysis of published papers since the developers declined to 
provide a copy of the intervention.
First, the quality of the information provided and scores on the IPDAS instrument 
varied according to the type of information assessed (Information domain, Test domain, 
Probabilities domain, and Plain Language domain). Scores on the Information domain (i.e., 
information about the index decision and options available) reached 73.7% on average. Most
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Tabic 4.3 Average IPDASi Ratings o f Decision Support Interventions for Amniocentesis
IPDASi Domains Decision analysis 
consultation
Bekker et al. (2004)
Making choices: 
prenatal testing
Drake et al. (1999) 
Hunter et al. (2005)
The amniocentesis 
report
Ferber and Sicherman 
(2001)
Should I have an 
amniocentesis?
Healthwise 
(last update 2006)
A decision analytic 
model
Pauker and Pauker 
( l 979)
Average scores 
per domain
Information 68.72 75.0 65.6 84.4 75.0 73.7
Test 55.5 63.9 55.5 50.0 83.3 61.6
Probabilities 65.6 56.2 43.7 40.6 68.7 55.0
Values 55.0 75.0 35.0 55.0 45.0 53.0
Guidance 100.0 100.0 50.0 100.0 50.0 80.0
Development 58.3 50.0 45.8 33.3 66.7 50.8
Evidence 80.0 60.0 40.0 95.0 55.0 66.0
Disclosure 75.0 75.0 62.5 87.5 62.5 72.5
Plain language 50.0 50.0 25.0 50.0 25.0 40.0
Evaluation 100.0 100.0 25.0 25.0 50.0 60.0
Average score per 
DESI
70.8 70.5 44.8 62.1 58.1
2 Scores on the IPDAS instrument in percents
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DESIs for amniocentesis showed very little variation regarding the provision of standard 
information and positive and negative features of options. Scores on the Test domain 
(evaluating the specific features of a diagnostic test) were on average lower (61.6%) than 
scores on the information domain. Three DESIs did not include full information on the false 
positive and false negative results associated with the tests and scored significantly lower on 
this domain than other interventions evaluated (Bekker et al. 2004; Ferber and Sicherman 
2001; Healthwise 2006). Scores on the Probabilities domain reached 55% on average. Most 
DESIs provided little information about the outcome probabilities associated with the 
options. Scores on the Plain Language domain reached 40% on average. Most interventions 
did not use plain language throughout and did not report readability levels.
Second, the IPDASi evaluation revealed score differences in domains assessing the 
guidance provided to clarify values and achieve decision making. The average score on the 
Values domain was 53%. Three interventions only explicitly enabled expectant parents to 
express and clarify their values (Bekker et al. 2004; Drake et al. 1999; Healthwise 2006). In 
contrast, average scores on the Guidance domain reached 80%. Three DESIs reached the 
highest score by providing a step-by step-way to make a decision and worksheets designed to 
structure the expectant parents’ decision making process (Bekker et al. 2004; Drake et al. 
1999; Healthwise 2006).
Third, IPDASi scores concerning the process of DESI development and evaluation 
were variable. On the Development domain, scores reached 50.8% on average. The 
development process rarely involved the target population: pregnant women (and their 
partners) who had been offered an amniocentesis. According to the IPDAS standards, the 
development process should ideally involve (i) a needs assessment with expectant parents and
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relevant professionals, (ii) a patient and experts review of the intervention, and (iii) field- 
testing before evaluation. Most DESIs were based on literature reviews, expert reviews by 
researchers or occasionally health professionals, and omitted expectant parents’ needs 
assessment or review. Finally, only two out of six DESIs were explicitly field-tested with 
pregnant women who had been offered an amniocentesis (Drake et al. 1999; Nagle et al. 
2008). Scores on the Evidence domain (assessing the scientific validity of the intervention) 
reached 66% on average. The development of three DESIs was explicitly based on research 
evidence (i.e., citations to studies used) (Bekker et al. 2004; Drake et al. 1999; Healthwise 
2006). Scores on the Evaluation domain reached 60% on average. Four interventions were 
evaluated in a trial, including the DESI by Nagle et al., not otherwise rated on the IPDAS 
instrument (Bekker et al. 2004; Drake et al. 1999; Nagle et al. 2008; Pauker and Pauker 
1979). Two DESIs were reported to help patients make a decision that was ideally consistent 
with their values and preferences (Bekker et al. 2004; Drake et al. 1999). Finally, most 
interventions acknowledged funders/sponsors and contributors. The average score on the 
Disclosure domain was 72.5%.
Since the IPDAS instrument does not assess the contribution of theory to the DESI 
design and development, the theoretical underpinnings of all DESIs selected for review were 
independently assessed. Four out of six DESIs mentioned the contribution of a theoretical 
framework in developing the intervention (Bekker et al. 2004; Drake et al. 1999; Nagle et al. 
2008; Pauker and Pauker 1987). Operationalised as decision analysis, expected utility theory 
guided the design and use of two DESIs for amniocentesis (Bekker et al. 2004; Pauker and 
Pauker 1987). Two interventions relied on the Ottawa decision support framework (Drake et 
al. 1999; Nagle et al. 2008). As described in Chapter 3, the Ottawa decision support 
framework combines social support and cognitive psychology theories such as the
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expectancy value model (Fishbein and Ajzen 1975), prospect theory (Kahneman 2003) and 
the conflict theory model of decision making (Janis and Mann 1977). There is as yet no 
evidence about the influence that theory-based design has on outcomes. However, two out of 
three theory-based DESIs had higher IPDASi scores (70.8% and 70.5%) than interventions 
that did not rely on theories or models of decision making (Bekker et al. 2004; Drake et al. 
1999).
4.3.4 What is the Effectiveness of Existing DESIs?
Three out o f six DESIs were evaluated using randomised controlled trials (Bekker et 
al. 2004; Hunter et al. 2005; Nagle et al. 2006). One intervention was evaluated in a pilot 
study (Pauker and Pauker 1979). The decision analysis consultation by Bekker et al. was 
evaluated in a randomised controlled trial of 117 pregnant women offered amniocentesis 
testing and randomised to a routine consultation or a decision analysis consultation. The risk 
perception of the screening test result, subjective expected utility (generated by the decision 
analytic method), knowledge of prenatal tests for Down’s syndrome, consultation quality, 
decisional conflict (O’Connor 1995) and anxiety (Marteau and Bekker 1992) were measured. 
Informed decision making was also measured by applying a coding frame to the interview 
transcripts (Bekker 2003). The intervention reduced decisional conflict, improved informed 
decision making, and led to a more realistic evaluation of information. However, the decision 
analysis consultation did not significantly impact on consultation satisfaction, knowledge or 
anxiety when compared to the control group. The latter finding is consistent with the results 
of similar evaluations (O'Connor et al. 2001).
The DESI by Drake et al. was evaluated in a randomised controlled trial of three 
counselling methods for prenatal diagnostic testing (Hunter et al. 2005) and one before and 
after study (Drake et al. 1999). Hunter’s randomised controlled trial of three counselling
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methods for prenatal diagnosis (i.e., individual counselling, group counselling and use of a 
DESI) assessed the following outcome measures: knowledge (Goel et al. 1996), decisional 
conflict (O’Connor 1995), anxiety (Spielberger et al. 1970) and satisfaction with intervention 
(Shiloh et al. 1990) in a sample of 350 women (and 225 partners) who had been offered 
prenatal diagnosis testing because of advanced maternal age (Hunter et al. 2005). Compared 
to other counselling methods, the DESI was least efficient at improving knowledge, although 
knowledge increased compared to the pre-counselling phase. The DESI did not significantly 
diminish state anxiety. However, scores on the Decisional Conflict Scale were significantly 
reduced. The satisfaction with the DESI was high but not higher than alternative counselling 
methods (e.g., group counselling). Second, Drake’s before and after study evaluated the 
DESI’s impact on knowledge (Goel et al. 1996), decisional conflict (O’Connor 1995), 
anxiety (Spielberger et al. 1970) and intervention acceptability (Barry et al. 1995) in a sample 
of 21 women (and 17 partners) (Drake et al. 1999). The DESI was reported to have 
significantly increased knowledge and decreased decisional conflict scores but did not 
modify state anxiety level. The findings were not compared with a control group.
The DESI by Nagle et al. was evaluated in a cluster randomised controlled trial where 
55 general practitioners were randomised to provide women (n=338) with the DESI (i.e., 
intervention group) or a pamphlet (i.e., control group) (Nagle et al. 2008). The following 
outcome measures were assessed: informed choice (Marteau et al. 2001), decisional conflict 
(O’Connor 1995), anxiety (Marteau and Bekker 1992), depression (Cox et al. 1996), attitudes 
to the foetus/pregnancy (Reading et al. 1984) and satisfaction with the DESI or pamphlet. 
The results showed that more women made an informed choice when given the DESI than 
when given the pamphlet. The satisfaction with the intervention was significantly higher in 
the intervention group (i.e., use of DESI). Decisional conflict scores were low in both
67
intervention and control groups. There were no significant differences on the secondary 
outcomes: anxiety, depression or attitudes to the pregnancy/foetus.
The decision analysis intervention by Pauker et al. was evaluated in a pilot study with 
90 women (and 35 partners) who were offered an amniocentesis (Pauker and Pauker 1979). 
The evaluation consisted of assessing women’s or couples’ attitudes towards elective 
abortion and spontaneous abortion (i.e., miscarriage after an amniocentesis). The expected 
subjective utility (generated by the decision analytic method, based on their assessed 
attitudes), and actual decision to accept or decline amniocentesis testing were examined. 
Most pregnant women made a decision that was consistent with their attitudes towards 
miscarriage and elective pregnancy termination. However, choices made by some couples 
conflicted with their stated values. The findings showed that the final decision was, in 
general, not consistent with the choice suggested by decision analysis. The reliability of the 
findings could be questioned by the absence of a control group.
Finally, two DESIs were not evaluated in a trial but low scores on IPDASi suggest 
domains that could be improved (Ferber and Sicherman 2001; Healthwise 2006) (see Table 
4.3). The amniocentesis report scored the lowest on IPDASi (total adjusted score: 44.8%).
4.4 Discussion
Six DESIs for amniocentesis were identified. Their quality was variable across IPDASi 
domains with lower scores on the Probabilities, Values, Development and Plain Language 
domains. The evaluations in randomised controlled trials or before and after studies had 
considerable scope for improvement. Only a small proportion of DESIs for amniocentesis 
were used and implemented in clinical settings. This reflects the emergent nature of the field
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of shared decision making and DESI development, and highlights the need for rigorously 
developed interventions.
Existing DESIs for amniocentesis represent a small proportion of the total number of 
interventions developed in other healthcare contexts worldwide (over 500) (O'Connor et al. 
2007a). There may be several reasons to account for the scarcity of DESIs for amniocentesis. 
First, the amniocentesis decision may not be perceived as generating as much anxiety and 
decisional conflict as screening or treatment decisions for directly life-threatening conditions. 
However, there is ample evidence that amniocentesis generates peak levels of anxiety at a 
time of heightened sensitivity (Glover et al. 2008; Sarkar et al. 2006; St-Jacques et al. 2008) 
and that maternal stress may be associated with poor outcomes for the mother and foetus (i.e., 
gestational complication, foetal growth retardation) (Nakamura et al. 2008; Reading 1983). 
Second, the difficulty to assess the decision making process surrounding amniocentesis 
testing may account for the small proportion of interventions available. Only 5 to 10% of 
women who undertake prenatal screening tests will be offered an amniocentesis (Benn et al. 
2006; Gidiri et al. 2007). Given heightened levels of stress and anxiety, approaching women 
at the early stage of the decision making process to inform DESI development may be 
difficult.
Findings of this review revealed that existing DESIs for amniocentesis were barely 
used or implemented in routine clinical practice. Interventions that were primarily developed 
by researchers (i.e., lack of user involvement) might be unable to meet the practical 
requirements and decision support needs of patients and professionals who are expected to 
use those interventions. The lack of user involvement in DESI development is a plausible 
explanation to recurrent implementation difficulties encountered in this field (Holmes-Rovner
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et al. 2000; Silvia et al. 2008). A systematic review of barriers and facilitators to DESI 
implementation suggested that the lack of applicability between shared decision making 
interventions, patients’ characteristics and the clinical situation, was an important barrier to 
implementation (Gravel et al. 2006). Elwyn et al. used the normalisation process model (May 
et al. 2007) to illustrate the influence of principal stakeholders (patients, physicians, 
managers) and their respective knowledge, in using and implementing DESIs (Elwyn et al. 
2008). These results point to the need to involve physicians and patients at all stages of 
development in order to produce interventions that have better goodness-of-fit with the 
clinical situations they intend to support.
The IPDASi evaluation emphasised the variable quality across interventions and 
domains. Most DESIs were effective and reliable information resources (see IPDASi scores 
on the information domain). They provided adequate information on the amniocentesis 
decision, on the features of a diagnostic test, guided expectant parents in making a decision 
and used scientific evidence. However, the communication of outcome probabilities, the 
expression and clarification of values, the development process, the evaluation and the use of 
plain language could be significantly improved. Lower scores on those domains may reflect 
the complexity and specialisation of the domains’ requirements combined with the recent 
development, inexperience and implementation difficulties in the field of shared decision 
making (and DESI development). This analysis subsequently revealed that most interventions 
had a theoretical origin, a finding inconsistent with existing DESI reviews (Bekker et al. 
1999; Bowen et al. 2006).
The DESIs’ evaluations in trials of varying size and methods revealed poor quality 
evaluations and pointed to the difficulty to assess DESIs’ effectiveness. The match between
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their stated goals and the results of the evaluation was poor. Most DESIs were shown to 
facilitate information processing but failed to reduce emotional burdens associated with the 
amniocentesis decision (e.g., anxiety) and did not systematically increase knowledge. This 
may reflect a growing tendency to develop DESIs in short timeframes and promote their use 
on the internet without rigorously evaluating their impact on decision making outcomes. This 
raises concerns as to the use of poor quality interventions by expectant parents who are 
expected to make high stake decisions at a time of considerable emotional upheaval.
Systematic reviews conducted in other healthcare contexts corroborate our findings 
(Evans et al. 2005; Volk et al. 2007; Williams et al. 2008). Systematic reviews of prostate 
cancer screening revealed that DESIs increased knowledge but did not impact on other 
decision outcomes nor reduced emotional burdens (Evans et al. 2005; Volk et al. 2007). A 
systematic review of interactive decision aids for breast cancer genetic testing identified a 
small number of poor quality interventions which had rarely been evaluated and implemented 
in clinical settings (Williams et al. 2008). The IPDASi scores of DESIs for breast cancer 
genetic testing reached lowest scores on the same domains as DESIs for amniocentesis (i.e., 
communication of outcome probabilities, value expression and clarification, development 
process and evaluation).
4.5 Conclusion
This chapter discussed the quality, effectiveness and implementation of existing DESIs 
for amniocentesis testing. Compared with other healthcare contexts (e.g., breast cancer, heart 
disease), little attention has been given to the decision to undertake amniocentesis testing. 
However, the complexity of the information provided, the high stakes of the decision, and 
associated emotional strain emphasise the need for high quality DESIs. The DESIs’ 
assessment against the IPDASi domains suggested that the development process, presentation
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of probabilistic information and elicitation of patients’ values could be significantly 
improved. Only one DESI for amniocentesis had been developed in the UK and was not used 
or implemented in clinical settings. Further, the majority of DESIs included in this review 
were developed without patients’ and professionals’ involvement (e.g., needs assessment, 
field-testing). Interventions that are developed for a specific group of users (e.g., pregnant 
women considering amniocentesis testing) should be tailored to their information and 
decision support needs. There is therefore room for developing a DESI for amniocentesis 
tailored to the UK practice and policies, using a systematic development process and adapted 
theoretical framework.
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Chapter 5
User Perspective
5.1 Introduction
Pregnant women facing a decision to undertake amniocentesis generally report peak 
levels of stress and anxiety (Sarkar et al., 2006). As noted previously, between 5 to 10% of 
pregnant women in the UK will face a decision to undertake amniocentesis. Assessing the 
needs of a small proportion of pregnant women at a time of acute stress and sensitivity may 
prove difficult. To date, research on how best to provide information on amniocentesis testing 
is limited and associated information and decisional needs have rarely been documented 
(Marteau 1995; St-Jacques et al. 2008; Hunt et al. 2005). Studies investigating information 
and decision needs associated with prenatal testing have not specifically addressed the 
decision to undertake amniocentesis testing (St-Jacques et al. 2008). The amniocentesis 
decision has generally been confounded with the decision to undertake prenatal screening 
tests. Although those decisions are closely related, amniocentesis is an invasive procedure 
that involves risks, far reaching consequences, complex information and uncertainty. The 
information and decision support needs associated with this procedure differ from those 
associated with prenatal screening tests. There is therefore scope for evaluating specific 
information and decision support needs associated with the amniocentesis decision.
The quality criteria produced by the IPDAS collaboration specify that the DESI 
development should include a needs assessment with individuals who are currently facing the 
decision. In the clinical context of amniocentesis testing, conducting users’ need assessment, 
also known as user perspective, involves examining the specific decision needs of women 
who have been offered amniocentesis testing. Assessing user perspectives while they face the
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decision is essential in determining the content of the intervention and ensuring that women’s 
basic information and decision support needs are addressed. The aim of this chapter was to 
assess pregnant women’s information and decision support needs associated with 
amniocentesis testing.
5.2 Methods
5.2.1 Participants
A qualitative study design was adopted using semi-structured interviews with
pregnant women who had been offered amniocentesis testing. Pregnant women were
identified and approached by midwives or screening midwives in two participating antenatal
clinics (University Hospital Wales and Llandough Hospital, Cardiff). In addition, to ensure
that the views of women who had experienced chromosomal abnormality (after having
accepted or declined an amniocentesis) were represented, an advert was posted in the journal
of the Down’s Syndrome Association. The advert described the study and invited women
who had been offered amniocentesis testing to take part in a phone interview, by contacting
the researcher (author of this thesis) to ask any questions they had about the project and to
agree a telephone interview date. In the antenatal clinics, women (any age) who had been
offered an amniocentesis after screening tests for Down’s syndrome, advanced maternal age
or mid-pregnancy ultrasound scan, were informed of the study by midwives. Information
leaflets describing the study were distributed by the midwives during the counselling session
where women were offered an amniocentesis. Women interested in taking part gave verbal
agreement for their contact details to be passed onto the research team. They were later
contacted by a researcher to answer any questions they had about the project and to agree an
interview date. Pregnant women were not invited into the study if they had been offered
another diagnostic test, such as CVS, since this procedure involves different risks. In the
journal o f the Down’s Syndrome Association, the research advert was directed to all women
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who had been offered an amniocentesis (whether or not they accepted the test) and who 
received a diagnosis of chromosomal abnormality. The study protocol and materials were 
reviewed and approved by the research and development committees of the participating 
sites, by the School o f Psychology Ethics Committee (Cardiff University) and by the National 
Research Ethics Service.
5.2.2 Data Collection
Interviews with pregnant women were carried out in the antenatal clinics, at the 
participant’s home or over the phone, from May 2007 to February 2008. The semi-structured 
interview schedule consisted of 13 open-ended questions exploring women’s experience of 
the amniocentesis decision, their information and decision support needs and how 
information and risks should be framed to facilitate understanding. Their reasons for 
accepting or declining amniocentesis, and their attitudes (e.g., satisfaction, regret, 
misunderstanding etc) following the decision were examined. Special attention was paid to 
new topics emerging such as the difficulties women faced in making their decision, the 
influence of others (e.g., partners, family) or the satisfaction/dissatisfaction with the 
information and support provided (see Appendix 2 for interview schedules). All interviews 
were recorded digitally and transcribed by the same researcher (author of this thesis).
5.2.3 Data Analysis
The transcribed interviews were coded using a two-step thematic content analysis
derived from descriptive phenomenology (Denzin and Lincoln 2000; Holloway 2005; Pope et
al. 2000), assisted by the computer software ATLAS-ti (ATLAS-ti 5.2). First, the transcripts
were coded to identify information, decision support and emotional needs. In a second and
more detailed analysis, the interview transcripts were coded according to all the themes
discussed in the interviews, including spontaneously emerging themes. Similar codes were
merged and subsequently grouped into families of codes and networks. Six interview
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transcripts chosen for being representative of the overall sample, were coded by two 
independent raters (M-A D and MS) in order to ensure reliability of coding and to agree the 
themes and family of codes for all remaining interview transcripts. Discrepancies among 
raters were discussed until agreement was reached.
5.3 Results
In the participating antenatal clinics, 18 women who had recently been offered an 
amniocentesis were recruited and 12 agreed to be interviewed. The reasons for declining the 
interview were the impossibility of making an appointment after the counselling session 
(n=4), the lack of time (n=l), and the stress and anxiety associated with this decision (n=l). 
Participants were interviewed in the antenatal clinics (75%) or at the participant’s home 
(25%). Most women attended the interview alone (66.7%) and four women came with their 
partners (33.3%). Participants were interviewed within two weeks after they had been offered 
to undertake amniocentesis. Among women who were approached through the journal of the 
Down’s Syndrome Association, seven women were recruited and five took part in a 
telephone interview. Two women had been offered CVS (first trimester diagnostic test) and 
were therefore excluded from the study. Women were interviewed between one and seven 
years after having been offered amniocentesis testing. Interviews lasted between 10 and 50 
minutes (23 minutes on average).
In total, 17 pregnant women who had been offered amniocentesis took part in the study. 
Ten women decided to undergo amniocentesis and seven declined the test. Among women 
who undertook amniocentesis, seven women received a normal result and three women 
received a diagnosis of Down’s syndrome. Among women who received a diagnosis of foetal 
chromosomal abnormality, one pregnant woman out of three decided to terminate the 
pregnancy. Five out of seven women who declined an amniocentesis had a healthy baby and
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two women had a baby with Down’s syndrome. The mean age of women in the sample was
36.4 years (range 28-47 years, standard deviation 6.6). Most women were British (n=15), one 
was Turkish and one was Indian. The demographic characteristics of the participants are 
summarised in Table 5.1.
5.3.1 Information Needs
Twelve out of 17 participants described the amniocentesis experience as a stressful, 
complex and upsetting decision making process. For those who undertook prenatal screening, 
the high chance result and subsequent offer of an amniocentesis was a shock, generating 
intense strain and anxiety.
“They rang me at 8:30 at night and told me that the screening gave me a result o f 1 in 10 which for 
somebody o f my age should have been 1 in 600. I was completely shocked, obviously, I didn’t expect 
anything like this and I didn’t even know what Down’s syndrome was.” (F, age 33, declined 
amniocentesis)
Five out of 17 participants were satisfied with the overall information and decision support 
provided. All remaining participants (n=12) expressed various unmet information and 
decision support needs (see Table 5.2).
Most pregnant women felt that more detailed information about the risks involved; the 
risk of miscarriage, the risk factors for miscarrying and other associated risks (e.g., infections, 
long term consequences) should be provided. They reported the need for increased 
consistency regarding the miscarriage rate as it was misleading to be given different 
percentages. The national miscarriage rate is one in a 100 procedure (1%) but most antenatal 
clinics will quote a local rate, generally lower than the national rate but based on limited 
scientific evidence (Gaudry et al. 2008; Tabor et al. 1986). Regarding the overall quantity of 
information provided, women’s opinions diverged. Some women experienced information
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Table 5.1 Characteristics o f  Pregnant Women Interviewed (User Perspective)
Characteristics Sample size
Amniocentesis
- Accepted 10
- Declined 7
Marital status
- Married 15
- Cohabiting 2
Number of existing children
-0 6
- 1 8
- 2 3
Existing children with a chromosome disorder 2
Obstetric History
- Previous miscarriage 2
- Previous amniocenteses 2
- In vitro fertilisation pregnancy 1
Outcome post-amniocentesis in n=10 women 
who had the test
- Miscarriage 0
- Normal result 7
- Down’s syndrome diagnosed 3
- Termination of pregnancy 1
Outcome when amniocentesis declined (n=7)
- Miscarriage 0
- Healthy baby 5
- Baby with Down’s syndrome 2
T able 5.2 Themes Identified in Interviews With Pregnant Women (User Perspective)
Themes Sub-themes
Inform ation  needs - In fo rm ation  about the risks
- In form ation  abou t the procedure
- In form ation  about the screening tests
- P ersonalised  inform ation
E m otion  and  dec ision  support - H eigh tened  stress and anxiety
- A ddressing  em otional d ifficulties
R eason - R easons fo r accep ting  an am niocentesis
- R easons for declin ing  an am niocentesis
D ecision  m aking  process - D ecid ing  w ith  a partner
- O utcom es (e.g., satisfaction , regret)
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overload while others lacked information and actively looked for further information 
elsewhere (e.g., internet, books).
“I found particularly that when I was going to the appointments you get so much information 
bombarded that you can’t get it all in.” (F, age 28, undertook amniocentesis)
“The information I had clearly wasn’t enough because I did search on internet. I didn’t have enough for 
me to make a definitive decision in my mind. I did have to go away and do a bit more research.” (F, 
age 36, declined amniocentesis)
Regarding the procedure, participants were generally satisfied with the quantity of 
information provided but would have liked more information about the results, consequences 
and implications of an amniocentesis (i.e., abnormalities detected, termination of pregnancy). 
Women reported difficulties understanding what the test may or may not detect and lacked 
information about the characteristics and timeframes of each test (i.e., PCR test and 
karyotype test).
“We were a bit confused about what the second test was for, because I thought originally that the first 
test, showed you pretty much whether it was ok or not, but actually it wasn’t, it was a definite no for 
Down’s syndrome but I couldn’t work out what the second test was for.” (F, age 32, undertook 
amniocentesis)
Prior to undertaking prenatal screening for Down’s syndrome, 8 out of 17 women 
would have liked more information about the screening tests available, their purpose, the 
uncertainty associated with the results, and the implications of a high chance result (i.e., 
amniocentesis testing offered). Three women who undertook prenatal screening and were 
subsequently offered amniocentesis regretted their screening decision and blamed it on a lack 
of information pre-screening test. They did not expect to receive an increased risk result.
“For me, that was a terrible rollercoaster, and I wish I ’d never even had the blood test. So I do feel that 
before you even have the blood test, more information should be given. Don’t have the blood test if 
you don’t know the rest o f the consequences.” (F, age 35, declined amniocentesis)
Most women interviewed wished to receive information tailored to their individual 
needs and presented in multiple ways to account for individual differences (e.g., educational 
levels, ethnic backgrounds, culture).
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I personally found that just having the figures was enough, that was fine, you could work it out on the 
figures. The midwife did show us some graphs, you know with coloured dots and so forth which I ’m 
sure would be useful for other people as well cause everybody visualises these things differently, don’t 
they?” (F, age 36, declined amniocentesis)
Women interviewed felt that both verbal and written information should be provided as the 
stress and anxiety experienced during the counselling session significantly limited their 
capacity to assimilate and recall complex information. Most participants believed that 
probabilistic information would be better understood if framed in multiple ways, using 
diagrams, flow charts, percentages and frequencies with identical denominators to facilitate 
the comparison between the risk of chromosomal abnormality and the risk of miscarriage. 
Visual elements such as images, videos (e.g., video of the amniocentesis procedure) should 
be made available to women, provided viewing remains optional. Five participants expressed 
the need to know about other women/couples’ experiences, to be informed about support 
groups or reliable internet forums.
“It might be an idea if  perhaps; you could even see an amniocentesis procedure, so you know the whole 
stage o f what is involved. And I think the kind o f consequences o f having it, because you are still going 
to be faced with a situation of: Right, ok now, am I going to do something about it or am I just going to 
live with the information till the baby is bom? I think it would be good if  you had people’s experiences 
o f the whole process and how they dealt with it.” (F, age 35, declined amniocentesis)
While unmet information needs were indentified, most women reported satisfaction with the 
counselling provided and interaction with their healthcare professionals.
5.3.2 Emotions and Decision Support
Most women reported heightened stress and anxiety. The emotional stress and worry 
experienced between the offer of an amniocentesis and the results of the chromosome tests, 
(or until the birth, for women who declined an amniocentesis) were reported to fluctuate but 
never disappeared. Peak levels of anxiety were reported immediately after a high risk 
screening test result or offer of an amniocentesis, and when waiting for the chromosome tests 
results. Nine out of 17 women experienced great difficulties dealing with overwhelming 
stress, anxiety or regret while being pregnant, when they never anticipated facing such a
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difficult decision. In addition, amniocentesis related anxiety seemed exacerbated by the 
increased sensitivity most women experienced at this stage of the pregnancy.
“It is a very stressful time, a very worrying time and I think that perhaps people who deal with it every 
day don’t realise what the average person is going through.” (F, age 28, undertook amniocentesis)
“1 was really upset. I was told about the figure which was 1 in 220, which 1 understand is quite a low 
risk but sometimes I don’t think you see that anyway, you just think o f Down’s syndrome, what would 
I do next basically, even though it was still a small risk, I was still really worried and it was a horrible 
horrible experience.” (F, age 34, undertook amniocentesis)
Most women felt that emotional difficulties should be addressed and more decision 
support made available through support groups or relevant charities. Some women felt that 
decision support could also be provided through discussion with their partner, family, friends, 
or healthcare providers. Three women reported that unbiased decision support should be 
provided whatever the decision may be. Two women felt forced into having an amniocentesis 
and received little support, if not disapproval, for declining the test or continuing the 
pregnancy. Three women felt that health professionals lacked neutrality regarding disability 
and pregnancy termination.
“It was all negative at the time, I have either got a Down’s syndrome baby that I may have to abort or I 
am going to have a miscarriage o f a healthy baby. That was all I could see at that point.” (F, age 32, 
undertook amniocentesis)
“My experience has been on both occasions that you are expected to screen for abnormality and do 
something about it, which isn’t always how people think, not how I think. It would go against my belief 
really, to do that. In my experience, there are a lot o f  judgements made.” (F, age 47, declined 
amniocentesis)
5.3.3 Reasons for Accepting/Declining an Amniocentesis
In total, 24 reasons to accept or decline amniocentesis were reported. Amongst 10 
women who undertook amniocentesis, six participants chose to have the test to find out if the 
baby had a problem and avoid recurrent stress and anxiety for the rest of the pregnancy. Five 
women opted for an amniocentesis as they felt incapable or unwilling to look after a disabled 
child. Three out of 10 women undertook the test to have the option to terminate the
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pregnancy if a problem was found. Three women had an amniocentesis to prepare for the 
birth of a baby with a chromosomal abnormality. Three out of 10 women decided to have the 
test as they already had children and were concerned about the impact of a disabled child on 
siblings. Women’s reported reasons for or against an amniocentesis are presented in Table 
5.3.
All women who declined an amniocentesis (n=7) based their decision on the risk of 
miscarriage and conviction that they would not terminate the pregnancy if a problem was 
found. Additional reasons for declining the test were medical complications such as bleeding 
during the pregnancy or twin pregnancy (n=2), previous obstetric history such as an in vitro 
fertilisation (IVF) pregnancy or difficulties getting pregnant (n=2) and the risk of miscarriage 
being higher than the risk of chromosomal abnormality (n=2).
5.3.4 Making a Decision
When deciding about amniocentesis, four out of 17 women disagreed with their 
partners.
“My husband was very keen for me to have the test. Over the time, I decided I didn’t really want this 
test. So, it was very difficult, it did cause conflicts between us because obviously, at the end o f the day, 
it is my body and I don’t want to be in a position where I am feeling guilty, if  anything happened. So 
that was a difficulty, it really was.” (F, age 35, declined amniocentesis)
All women who decided to have an amniocentesis, including women who received a 
diagnosis of chromosomal abnormality, reported no regret. Despite weeks of constant worry, 
none of them regretted having had an amniocentesis.
“I am happy that we went ahead with it, the results were clear so we got reassurance from that. Because 
up until that point, I don’t feel that we could have started planning adequately for the baby.” (F, age 39, 
undertook amniocentesis)
Women whose amniocentesis results showed Down’s syndrome (n=3) felt positive about 
their decision, as the test enabled them to prepare for the birth of a disabled child or to
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Table 5.3 Pregnant Women’s Reasons Influencing Decision Making About Amniocentesis
Reasons reported by pregnant women
Reasons for accepting amniocentesis Reasons for declining amniocentesis
- To find out if the baby has a problem (stress 
of not knowing)
- To avoid anything that may harm the baby 
(risk of miscarriage)
- Capacity/willingness to look after a disabled 
child
- View on termination (would not terminate the 
pregnancy if problem was found)
- To have the option to terminate pregnancy - Capacity/willingness to look after a disabled 
child
- To prepare if a problem is found - Medical complication/Obstetric history
- Existing children - Previous miscarriage
- Family history of chromosome disorder - Difficulty getting pregnant (IVF pregnancy)
- Risk of miscarriage compared to risk of a 
problem
- Risk of miscarriage compared to risk of a 
problem
- Knowledge and/or experience of children 
with Down’s syndrome
- Knowledge and/or experience of children 
with Down’s syndrome
- Partner’s views - Partner’s view
- Age -Age
- Obstetrician’s expertise in conducting 
amniocenteses
- Religious beliefs
- Views of friends, family - Views of friends, family
- Adjusted risk compared to risk in similar age 
group
- Adjusted risk compared to risk in similar age 
group
- Difference between the woman’s screening 
result and screening cut-off limit
- Difference between the woman’s screening 
result and screening cut-off limit
- Previous amniocentesis - Previous amniocentesis
- Existing child with Down’s syndrome - Existing child with Down’s syndrome
- Anomalies detected on the mid-pregnancy 
scan
- Practical reasons (husband away, unable to 
rest for a few days)
terminate the pregnancy. All women who decided not to have an amniocentesis were satisfied 
with their decision and did not experience regret. However, most women reported recurrent 
anxiety regarding the risk to give birth to a baby with a chromosomal abnormality.
“I feel that I’ve made the right decision. I suppose I am a little bit nervous. It is a worry I’ve got to be 
honest with you, it’s gonna be 6 months o f worry thinking what if.” (F, age 39, declined amniocentesis)
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5.3.5 Synthesis
Most women reported significant emotional and cognitive difficulties making a 
decision about amniocentesis testing (i.e., stress, anxiety, difficulty assimilating 
probabilistic information and information overload). They felt that the provision of better 
services would reduce the emotional challenges of this period. They unanimously 
highlighted the need to address decision difficulties by providing personalised and 
interactive information, presented in multiple ways (e.g., numbers, diagrams, videos, 
women’s experiences), in order to account for individual differences in processing complex 
information. Most women felt that emotional difficulties should be addressed and that 
decisional and emotional support should be made available through support groups, relevant 
charities, or other interventions. Women wished to receive comprehensive information 
about the risks involved, the results of the chromosome tests and potential consequences of 
an amniocentesis. The majority of women interviewed wished to be informed about the 
termination of pregnancy. Finally, they highlighted the need to provide detailed information 
about amniocentesis before the screening tests, as existing information and consent 
arrangements appeared insufficient.
5.4 Discussion
The findings revealed pregnant women’s unmet needs for information, decision and 
emotional support when deciding about amniocentesis testing. Significant decision making 
difficulties were reported (e.g., difficulty assimilating probabilistic information, information 
overload). Pregnant women also highlighted elevated stress and anxiety that was triggered by 
the decision and its aftermath, and expressed the need for reinforced emotional and decisional 
support.
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While a minority of women were satisfied with the overall information and support 
provided, most participants expressed the need for personalised and interactive information 
(e.g., images, video clips or forums). Potter et al. (2008) described the importance of 
women’s values and of different types of knowledge in deciding about prenatal testing. 
Pregnant women highlighted the need for testimonials from others facing a similar dilemma. 
Previous studies suggested that watching or hearing experiences of women who have made a 
decision about prenatal testing and have experienced different outcomes (e.g., healthy baby, 
miscarriage, detection of chromosomal abnormality) was considered beneficial in making a 
decision (Moyer et al. 1999; St-Jacques et al. 2008). In addition, women believed that 
information should be framed in multiple ways to address individual differences in 
processing complex information and to facilitate understanding. Difficulties understanding 
probabilistic information and making sense of the risks have been extensively documented 
(Kuppermann et al. 2006; Howe et al. 2000). Pilnick et al. (2004) pointed to the difficulties 
and stress experienced by women attempting to make sense of the nature and significance of 
screening test results. They concluded that difficulties understanding risks figures and 
probabilities may be eased by adequate non-directive counselling. Further research suggested 
that the way in which risk information was framed influenced decisions to accept or decline 
amniocentesis testing (Marteau 1989). Marteau established that pregnant women were more 
likely to have an amniocentesis if the risk of foetal chromosomal abnormality was framed 
negatively (i.e., 5% or 1 in 20 chance of having a baby with Down’s syndrome) rather than 
positively (i.e., 95% chance that there is no abnormality).
Further, the majority of women interviewed wished to receive comprehensive 
information about the risks involved and implications of amniocentesis (i.e., termination of 
pregnancy and chromosome abnormalities potentially detected). Research showed that health
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professionals counselling women about prenatal testing generally focussed on the prenatal 
testing process rather than on the condition being screened or tested for (Williams et al. 
2002a). Observations of routine antenatal consultations revealed that information about the 
range of abnormalities tested for was generally not provided by obstetricians (Marteau et al. 
1993). Further research showed that elective termination of pregnancy was not routinely 
mentioned or discussed with women who had been offered an amniocentesis (Bernhardt et al. 
1998).
Pursuant to prenatal testing policies in the UK, accepting or declining amniocentesis 
should be the result of an informed choice. Nonetheless, several participants felt pressured 
into undertaking prenatal testing. They considered that health professionals’ attitudes lacked 
neutrality and non-directiveness. This finding is consistent with previous study of prenatal 
testing decisions, where participants pointed to health professionals’ pressure to undertake the 
tests (Potter et al. 2007). Further research highlighted health professionals’ tendency to shape 
women’s understanding and uptake of prenatal screening and diagnostic tests (Press and 
Browner 1997). A questionnaire and interview study of 211 women undergoing 
amniocentesis or CVS indicated that most participants found it difficult to decline prenatal 
diagnostic tests when offered (Sjogren and Uddenberg 1988). While women did not generally 
report external pressures to undertake prenatal diagnostic tests, they highlighted the difficulty 
to opt out, once amniocentesis or CVS had been offered. This may be related to social 
pressures to conform to normality and use technologies which are increasingly routinised and 
presented as non-controversial (Sjogren and Uddenberg 1987). Since the technology exists 
and is widely available, there is an implicit pressure to undertake those tests (Ettorre 2000). 
Pregnant women may also feel that undertaking prenatal testing is part of their parental duty 
and societal responsibility to engender non-diseased and genetically normal off springs.
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The decision to undertake amniocentesis was associated with recurrent stress and 
anxiety. Heightened anxiety was reported after a higher chance screening test result and prior 
to receiving amniocentesis results, as has been documented previously (Beeson and Golbus 
1979; Cederholm et al. 2001; Michelacci et al. 1984; Sun et al. 2008; Susanne et al. 2006). 
Women consistently reported the need for further emotional support. Emotional difficulties 
associated with prenatal testing have been extensively documented and are consistent with 
the present finding (St-Jacques 2008; Susanne et al. 2006). Emotional difficulties and ways of 
coping with extreme anxiety may be addressed in a DESI, by providing contact details of 
relevant support groups and charities or by enabling women to communicate with others in a 
similar situation (e.g., message board). In addition, several women reported difficulties 
agreeing with their partners, which in turn, triggered increased stress and anxiety. A study of 
women’s attitudes towards prenatal diagnostic procedures showed that 38% of women 
interviewed reported divergent opinions between partners (Potter et al. 2008). Finally, several 
women reported regretting the decision to undertake screening tests for Down’s syndrome. 
Press and Browner (1997) revealed that 85% of women considering prenatal diagnostic tests 
could not precisely articulate the reasons for undertaking prenatal screening tests for Down’s 
syndrome. Further research suggested that pregnant women undertaking screening tests for 
Down’s syndrome did not fully comprehend the potential consequences and implications of 
the test (Baillie et al. 2000). A lack of understanding of the consequences and reasons for 
undertaking prenatal screening may lead to increased emotional stress and regret in the case 
of an increased risk of foetal chromosomal abnormality and subsequent offer of invasive 
diagnostic tests.
The risk of miscarriage was the most often reported reason for declining an 
amniocentesis while finding out if the baby had a problem was the most common reason for
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undertaking the test, as has been reported previously (Cederholm et al. 1999; Priest et al. 
1998). In the literature, the most commonly reported reason for undertaking prenatal testing 
is maternal age (Cederholm et al. 1999; Kukulu et al. 2006; Moyer et al. 1999). Given 
screening tests for Down’s syndrome are routinely offered to pregnant women in the UK, 
factors such as the influence of existing children, the possibility of having options if a 
problem is found and pregnant women’s views on termination or on disability, had a stronger 
impact on women’s decisions than maternal age.
The strengths of this study were the heterogeneity of the sample and semi-structured 
format of the interviews. The interview sample included women who declined the test, 
women who received normal and abnormal amniocentesis results, women with experience of 
chromosomal abnormality or pregnancy termination. The structure of the interview gave 
women freedom to broaden the themes of the interview schedule while still focussing on the 
decision making process.
Limitations of the study were the differences between the sample of patients recruited 
in the antenatal clinics and recruited through the Journal of the Down’s Syndrome 
Association. Women recruited through the Down’s Syndrome Association were interviewed 
between one and seven years after having been offered an amniocentesis. The proportion of 
women receiving a diagnosis of chromosomal abnormality was therefore higher than in the 
general population. In addition, the passage of time, involving a possible change in clinical 
practice and provision of information, is likely to introduce biases. Finally, women recruited 
through the journal were self-selected from a specific population whereas women recruited 
consecutively in the clinic were systematically approached by screening midwives, and this 
may have introduced biases.
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5.5 Conclusion
This chapter presented a qualitative assessment of information and decision support 
needs of women facing amniocentesis testing, with the objective to develop a DESI for 
amniocentesis. The majority of women interviewed highlighted information and decision 
support needs which could be addressed in a web-based intervention: neutral, balanced and 
interactive information, testimonials from women who faced a similar dilemma, probabilistic 
information framed in multiple ways etc. Participants expressed the need for further 
information pre-screening as several women admitted regretting their screening decision. The 
offer of an amniocentesis and subsequent test results were often associated with heightened 
stress and profound worry. Women did not anticipate to be offered an amniocentesis and 
were generally unprepared to face a decision with far reaching consequences and uncertain 
outcomes. Greater attention should be diverted to unmet emotional and decision support 
needs as they appear from these interviews, to be as important as unmet information needs. 
There is scope for developing interventions that provide non-directive and evidence-based 
information but also address emotional and decisional difficulties, with the aim to enable 
pregnant women to make an informed choice; one that is consistent with their values and 
preferences.
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Chapter 6
Stakeholder Analysis
6.1 Introduction
Deciding whether or not to undergo amniocentesis is a complex and highly distressing 
decision, often undertaken with little systematic decision support. DESIs have been 
developed to support individuals when they face complex healthcare decisions such as 
amniocentesis testing. According to the IPDAS collaboration, the first step in developing 
DESIs is a needs assessment with health professionals from relevant disciplines (Elwyn et al. 
2006). In the clinical context of amniocentesis testing, conducting a needs assessment, also 
known as stakeholder analysis, involves examining the professionals’ evaluation of women’s 
information and decision support needs associated with amniocentesis testing. Stakeholders 
include all health professionals who inform and counsel women about amniocentesis testing 
or have an in depth understanding of the prenatal testing process. While a stakeholder 
analysis does not replace the direct assessment of potential users’ needs (i.e., needs 
assessment with women facing amniocentesis testing), it offers a general overview of 
commonly reported needs. It also involves assessing the counselling needs and difficulties 
professionals may experience when advising women about amniocentesis testing. Such 
analysis is essential in ensuring that the DESI’s content is clinically accurate, consistent with 
professionals’ daily practice, and therefore acceptable in conjunction with existing 
counselling.
With a view to develop a DESI for amniocentesis testing, the aim of this chapter was to 
examine health professionals’ evaluation of women’s information and decision support
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needs, and to determine how the provision of information and communication of risks can be 
improved and tailored to current practice.
6.2 Methods
6.2.1 Participants
A qualitative approach was adopted. Information and decision support needs were 
assessed using in-depth semi-structured interviews with health professionals who counsel 
women about amniocentesis testing. A convenience sample of health professionals was 
approached and recruited in two antenatal clinics in Wales (University Hospital of Wales and 
Llandough hospital). To ensure a breadth of responses, professionals from different 
specialities were recruited: obstetrics, midwifery, genetics and counselling. Professionals 
from the Policy and Public Health sector as well as professionals from relevant charities were 
recruited through networking and steering group meetings in England and Wales. The study 
protocol and materials were reviewed and approved by the research and development 
committees of the participating sites and by the National Research Ethics Service. In total, 20 
professionals were invited to take part. This included consultants in obstetrics and 
gynaecology, midwives, screening midwifes, geneticists, coordinators of the national 
antenatal screening programme, and directors from charities.
6.2.2 Data Collection
Semi-structured interviews with stakeholders were carried out in antenatal clinics or 
over the phone from April to September 2007. The interview schedule was structured around 
11 open-ended questions investigating the professionals’ assessment of women’s information 
and decision support needs, their difficulties in making a decision, the factors they took into 
account when deciding and their attitudes post-decision. Potential issues and difficulties 
arising when counselling women about amniocentesis testing were also investigated. Special
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attention was paid to the professionals’ opinions and preferences regarding the presentation 
of information, framing of outcome probabilities and portrayal of risks. Interviews were 
conducted until data saturation was reached. All interviews were recorded digitally and 
transcribed by the same researcher (author of this thesis) (see Appendix 3 for interview 
schedules).
6.2.3 Data Analysis
The qualitative analysis was as described in Chapter 5 (p. 74). The list of codes and an 
example of coded interview transcript are enclosed in Appendix 3. To ensure reliability of 
coding, six interview transcripts were coded by two independent raters (see Chapter 5).
6.3 Results
Twenty health professionals were recruited and 17 were interviewed. The sample 
consisted of six consultants in obstetrics and gynaecology, four midwives, one screening 
midwife, two geneticists, two coordinators of the national antenatal screening programme, the 
local director of the Down’s Syndrome Association, and the director of a national charity 
supporting parents during the antenatal testing process. Interviews lasted between 11 and 52 
minutes (27 minutes on average). Five themes were identified in the interviews: information 
needs, emotions and decision support, reasons for accepting/declining an amniocentesis, 
perceptions and counselling difficulties (see Table 6.1).
6.3.1 Information Needs
Primarily, most professionals believed that pregnant women needed to understand the 
harms, benefits and implications of each option and be aware of the risk of miscarriage. Some 
health professionals insisted on the necessity to balance and make sense of the risk of 
miscarriage against the risk of chromosomal abnormality. Professionals were inconsistent on
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Table 6.1 Themes Identified in Interviews With Health Professionals (Stakeholder Analysis)
Themes Sub-themes
Perceived information needs
- Detailed information about the procedure
- Consequences/implications of an 
amniocentesis
- Screening test purposes
- Multiple framing of probabilistic information
- Lack of consensus around the risks involved
Perceived emotional and decision making 
difficulties
- Peak anxiety levels
- Ways of providing decision support
Professionals’ evaluation of pregnant women’s 
reasons for accepting/declining an amniocentesis - Women/professionals consistency
Other issues and perceptions
- Issues encountered when deciding with a 
partner
- Improved understanding
Counselling difficulties - Time constraints- Specialised knowledge
the risk of miscarriage to quote (i.e., local rate or national rate). Paradoxically, they insisted 
on the need to provide consistent information across professionals.
“We quote a 1% risk o f miscarriage, a 1 in 100 and that is the Welsh national risk so that is the only 
figure that we can give them and again it is not discerning between foetuses that have chromosomal 
abnormalities and those that have not.” (F, midwife)
“Well, the national Welsh recommendation is 1 in 100 and our unit figure is 1 in 300. So I usually say 
to them, it’s between half and 1 percent and that sort o f  covers everything. I think, within our unit, I 
don’t see why we shouldn’t be using our own figures. If that is what the risk is in our unit, that is what 
the risk is in our unit!” (F, consultant obstetrician & gynaecologist)
Health professionals felt that practical and detailed information about the amniocentesis 
procedure, its consequences and implications should be offered to women and their partners. 
Eight professionals reported that information about the results, the type of abnormality
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detected by each specific test and timescales of the QF-PCR and karyotype test results should 
be provided systematically.
“They need to know that the PCR is available within I think 3 working days, isn’t it? and that it only 
gives a limited result and that other things may come back after that, that it’s only excluding three basic 
trisomies so we need to make them clear that a good result at the end o f the three days is good but it’s 
not saying everything is fine.” (F, consultant obstetrician & gynaecologist)
Two professionals believed that women should be aware that amniocentesis testing 
does not only test for Down’s syndrome but may detect a wider range of chromosomal 
abnormalities. Four professionals highlighted the need to specify that a normal amniocentesis 
result cannot guarantee a healthy baby. While the chromosome tests conducted on the 
amniotic sample will detect the most common chromosomal abnormalities, changes in single 
genes or microdeletions will not be diagnosed.
“It’s getting them to understand that you can have all o f the tests done and have a very disabled baby 
bom. The tests answer the question that has been asked: Are chromosomes 18,13 and 21 structurally 
normal? And the answer is yes. That doesn’t say the baby is normal. And I think that is the key 
sentence and that’s the thing they don’t like us for; understandable.” (F, geneticist)
Furthermore, two professionals highlighted the need to specify that the chromosome tests will 
not provide information about the severity of the abnormalities detected.
“No tests will tell you how affected a child is going to be by Down’s syndrome. What families actually 
want to know is: is my child with Down’s syndrome going to be a very able child? Will he go to 
mainstream education? ( ...)  And o f course, there is no way o f knowing that and I think that’s the thing 
that lots o f  families find particularly difficult when they are making that decision.” (F, midwife)
There was no consistency among professionals on the amount of information needed 
about potential chromosomal abnormalities and whether or not to raise the issue of elective 
pregnancy termination. Given amniocentesis is performed between 15 to 18 weeks of 
pregnancy, elective pregnancy termination involves induction of miscarriage and labour. 
Eight professionals believed that informing women about the procedure of terminating a 
pregnancy was essential before women consent to amniocentesis testing. Four professionals
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felt that information about elective termination of pregnancy was unnecessary at this early 
decision making stage and could be provided later, to avoid information overload.
“I think health professionals should anticipate that level o f  not understanding and be very explicit about 
what a termination o f pregnancy is and how you do a termination, because women may not understand, 
and are consenting to things they don’t understand.” (F, coordinator o f the national antenatal screening 
programme)
“I think that’s just one step too far o f the process. If  you start describing the whole process including 
the details o f how you do a termination, it’s too much to take in.” (M, consultant obstetrician & 
gynaecologist)
Most professionals underlined the necessity to understand the screening test purposes, 
results and implications (i.e., deciding about amniocentesis, possible diagnosis of 
abnormality, decision to continue/terminate the pregnancy) before embarking on prenatal 
screening for Down’s syndrome. Six professionals reported that the false positive and false 
negative results associated with prenatal screening, especially relevant with maternal serum 
screening tests, should be communicated and understood.
“With the screening test, low risk is not no risk and this is what I always tell them. Similarly, some o f 
the highest chance results are going to be wrong, it’s not a definitive test. Initially, not everybody 
understands that, but I do, I make a big thing of it actually.” (F, midwife)
Regarding the presentation and framing of information, most professionals 
highlighted the need to present information in multiple ways and to use different formats. The 
majority of professionals felt that information should be tailored to women’s individual needs 
and account for individual differences in processing information.
“Different women have different needs, some are very numeric and some are not. I think you just got 
to ask the women really, how do they normally make decisions? If they normally make decisions in 
their heads, sort o f comparing, sort of red apples and green apples, then you can do it that way.” (F, 
coordinator antenatal screening programme)
“You can’t generalise at all. You get the neuroscientist who wants to know everything, even about the 
technique o f culturing the cells, and what would happen if  they had a positive result, and exactly how 
the termination is done. And you get the other woman who comes into the room and says: I want an 
amniocentesis and don’t tell me anything more, I just want it done.” (F, consultant obstetrician & 
gynaecologist)
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Similarly, professionals highlighted the need to gradually provide different levels of 
information, from the basic essential information to the specialised, peripheral information 
that some women were asking for. Preferred methods for communicating risks varied from 
one professional to another: hard facts only, analogies, diagrams, flow charts etc. Some 
professionals used verbal analogies while others preferred visual aids such as diagrams or 
flow charts.
“It’s not easy doing this, it depends on the individual. Very often, when they are sitting there with their 
husband, I ’ll talk about things like, horse racing, betting, because 100 to 1 in betting... the husband will 
go, oh yeah, no chance! But, they will understand the risk, they’ve seen that sort o f risk, you know, in a 
betting shop.” (M, consultant obstetrician & gynaecologist)
“When you are talking about risks o f amniocentesis, risks o f Down’s, I think the visuals, I don’t know 
what they’re called, but the little cards that the midwives have, which show what a risk o f 1 in 100 
means in terms o f little spots, one o f the spots is red and the rest are black. I think that’s quite a good 
visual impact o f  how risky your procedure is.” (F, consultant obstetrician & gynaecologist)
“The dots, I think, are widely used by the midwives, the screening midwives. I use the analogy o f days 
o f  the week, or days o f the month, or days o f the year. I think a lot o f people find that a lot easier to 
follow.” (M, consultant obstetrician & gynaecologist)
Furthermore, most professionals highlighted the need to provide updated information, 
using precise but simple language. A minority of professionals suggested that women should 
be given enough time to decide and should be reminded of the possibility of changing their 
mind at any time. One professional believed that people would assimilate more information if 
they were given more time to decide.
“As with anybody who is getting bad news, the key thing they need is time. I think it’s no good just 
telling them what they need to hear. It’s giving them the time to understand what they need to hear 
because people view risk in different ways and, hear it in different ways.” (F, geneticist)
6.3.2 Emotions and Decision Support
Most health professionals recognised that the amniocentesis decision was associated 
with heightened stress, anxiety and subsequent difficulty to assimilate information. They 
believed that women experienced highest anxiety levels at the time of the screening test 
results.
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“It’s just shock, horror, because they were two fit, healthy people. Why was that happening to them? 
They want answers, they want to know why. They wouldn’t have had the test I don’t think if they 
thought it was going to come back as high risk.” (F, midwife)
Four professionals felt that prompting women to reflect on the reasons for having/not having 
an amniocentesis (e.g., for reassurance, to be able to terminate the pregnancy if a problem is 
found) would facilitate decision making:
“1 say: what would you do? Would you terminate the pregnancy or is it just for your information? 
because that’s what they need to know, isn’t it? They need to use that as part o f their decision and very 
often they don’t know.” (F, screening midwife).
Alternatively, some professionals felt that the impact of a disabled child on the 
expectant parents’ life and family should be discussed and explicitly addressed during 
counselling. Finally, helping pregnant women decide what the worst possible outcome would 
be: to give birth to a child with a chromosomal abnormality, to miscarry a healthy baby or to 
terminate a pregnancy following a diagnosis of chromosomal abnormality, was perceived to 
facilitate decision making. Four professionals reported the tendency for women to ask what 
the professionals would do.
“I often get asked: what do I think they should do? And I always decline to actually give any kind o f 
weighed personal opinion on that. The truth is, I don’t actually know what I would do myself faced 
with that decision. And secondly, the birth o f a child with Down’s syndrome is likely to mean 
something very different to different people, it wouldn’t be right for a health professional to try to tell 
somebody what’s right for them.” (M, consultant in obstetrics)
6.3.3 Reasons for Accepting/Declining an Amniocentesis
Based on their experience with the amniocentesis decision, health professionals 
identified 25 reasons presumably affecting women’s decision about amniocentesis. They 
believed that reasons most commonly influencing the decision to undertake amniocentesis 
were: the risk of miscarriage, existing children, knowledge or experience of Down’s 
syndrome, and perceived capacity to look after a disabled child. Other frequently reported 
reasons are listed in Table 6.2. The consistency between the reasons reported by women (see
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Table 6.2 Professionals ’ Assessment o f  Women’s Reasons fo r  or Against Amniocentesis
Reasons reported by health professionals
Reasons for accepting amniocentesis Reasons for declining amniocentesis
- To find out if the baby has a problem (stress of 
not knowing)*
- To avoid anything that may harm the baby 
(risk of miscarriage)*
- Capacity/willingness to look after a disabled 
child*
- Capacity/willingness to look after a 
disabled child*
- Knowledge and/or experience of children with 
Down’s syndrome*
- Knowledge and/or experience of children 
with Down’s syndrome*
- Existing children* - View on termination*
- To prepare if a problem is found* - Previous miscarriage*
- Partner’s views* - Partner’s views*
- Risk of miscarriage compared to risk of a 
problem*
- Risk of miscarriage compared to risk of a 
problem*
- To have the option to terminate pregnancy* - Medical complication/Obstetric history*
- Family history of chromosome disorder* - Difficulty getting pregnant*
- Age* - Age*
- Obstetrician’s expertise in conducting 
amniocenteses*
- Religious beliefs*
- Views of friends, family* - Views of friends, family*
- Concerns about people’s reactions - Concerns about people’s reactions
- Cultural characteristics - Cultural characteristics
- Knowledge about amniocentesis - Knowledge about amniocentesis
- Couple’s stability - Couple’s stability
- Previous amniocentesis* - Previous amniocentesis*
- Professionals’ influence - Professionals’ influence
- Existing child with Down’s syndrome*
* Reasons reported by both pregnant women and health professionals
Chapter 5) and professionals was high. Twenty out of 24 reasons reported by pregnant 
women were consistent with health professionals’ assessment. However, women identified 
several reasons or factors which were not recognised as influential reasons by health 
professionals. Specifically, pregnant women felt that their individual risk of foetal 
abnormality compared to the risk in a similar age group, the difference between their 
individual screening result and the screening cut-off limit, and the anomalies detected on the 
mid-pregnancy scan, may influence their decision about amniocentesis.
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6.3.4 Professionals’ Perceptions of the Amniocentesis Decision
Five professionals noted significant decision making difficulties between spouses 
(e.g., conflicts, incapacity to decide together) and believed that health professionals should 
act as facilitators. Three professionals observed that men generally left the decision to 
women.
“The other problem sometimes is when there are slightly different thresholds between the couple and 
it’s interesting. Most o f the time, it tends to be the women who are more likely to go ahead with the 
testing.” (M, consultant in obstetrics)
As a consequence of improved information and decision support over the past five 
years, some professionals believed that women were better informed. Three professionals felt 
that women had a good understanding of the procedure and of Down’s syndrome. However, 
two professionals noted significant difficulties dealing with statistics and understanding the 
limitations of amniocentesis testing. Three professionals felt that making a decision in a short 
time frame and balancing the risk of miscarriage against the risk of a problem could prove 
difficult. Two health professionals believed that women experienced information overload.
6.3.5 Counselling Difficulties
Finally, health professionals reported communication and counselling difficulties. 
Three health professionals reported difficulties dealing with specialised genetic information 
and occasional lack of research evidence. Research evidence surrounding the cause of 
miscarriage following amniocentesis is poor and health professionals did not always have 
answers to women’s concerns.
“It’s quite specialist counselling. People that know little about something, quite often have quite a lot to 
say. So GPs, obstetricians, midwives may all have plenty to say about the little bit o f knowledge they 
have, whereas the geneticists who really understand... hum, you know, for the woman, her view has 
already been prejudiced.” (F, consultant obstetrician & gynaecologist)
“The evidence based is not very good and again it’s hard to tell women that you’re doing a routine 
procedure and actually we can’t tell them exactly when it’s most likely to miscarry, what the symptoms 
would be, what sorts o f women are most likely to miscarry, the data is not there or not that we found.” 
(F, coordinator antenatal screening programme)
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Three professionals experienced difficulties providing specific information about 
amniocentesis testing (e.g., detailed information about Down’s syndrome and other 
abnormalities) within the time constraints of the consultation.
“It’s quite difficult in a short consultation to get over the range o f abnormalities.” (M, consultant
obstetrician & gynaecologist)
6.3.6 Synthesis
Health professionals highlighted the need to understand the risks associated with 
amniocentesis testing (e.g., risk of miscarriage, risk of infection), and the characteristics and 
limitations of chromosome test results. Most health professionals underlined women’s 
cognitive and emotional difficulties deciding about amniocentesis testing (e.g., stress, 
anxiety, difficulty assimilating probabilistic information and information overload). They 
unanimously highlighted the need to address women’s information needs by providing 
personalised and interactive information, presented in multiple ways (e.g., numbers, diagrams 
and videos of women’s experiences). Professionals were inconsistent regarding the 
miscarriage rate to quote (i.e., local or national rate), and whether or not to describe the 
termination of pregnancy. They insisted on the necessity to provide detailed information 
about amniocentesis before the screening tests, as existing information and consent 
arrangements seemed insufficient.
6.4 Discussion
The present findings indicated variations in the evaluation of women’s information 
and decision support needs and a tendency to prioritise information provision over emotional 
support. The assessment of women’s information needs considerably varied between 
healthcare professionals.
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Healthcare providers expressed divergent opinions regarding the nature and quantity 
of information needed about the risk of miscarriage, chromosomal abnormalities tested for, 
termination of pregnancy and uncertainty associated with the tests. Previous work showed 
that health professionals from different specialities had differing approaches and attitudes to 
chromosomal abnormalities (Marteau et al. 1994). Divergent opinions with regards to the 
provision of information may be explained by limitations of current policies and guidelines 
(i.e., miscarriage rate) but may also be imputed to gaps in health professionals’ general or 
specialised knowledge (i.e., genetics). Indeed, several health professionals reported 
difficulties dealing with specialised genetic information. Existing research on professionals’ 
knowledge about prenatal genetic testing corroborates our findings by revealing inadequate 
knowledge related to the presentation and meaning of prenatal screening test results (Carroll 
et al. 1997; Sadler 1997; Wilkins-Haug et al. 1999). Marteau et al. (1993) established that 
obstetricians counselling women about amniocentesis testing occasionally provided women 
with incorrect information. Further research has shown that health professionals tended to 
overestimate their own levels of knowledge (Hunter et al. 1998; Tracey et al. 1997).
Health professionals held strong views and control over the nature of information 
communicated (or not) to women facing a decision to undergo amniocentesis testing. Several 
professionals strongly believed that the issue of elective termination of pregnancy should not 
be addressed or even mentioned to pregnant women considering an amniocentesis. Others felt 
that pregnant women should be fully informed about the termination procedure and made 
aware that it involved induced labour as this may affect their decision. Professionals’ 
attitudes with regards to specific topics (termination of pregnancy, range of abnormalities 
tested for) may be described as paternalistic. Possible factors influencing health 
professionals’ attitudes and control over specific information topics include societal pressures
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to conform and minimise human differences and complex ethical dilemmas associated with 
amniocentesis testing and elective termination of pregnancy (Garel et al. 2002; Strauss 2002). 
It has also been argued that the prospect and range of foetal abnormalities may be too 
distressing or alarming for health professionals and pregnant women to discuss in detail 
(Marteau 1993). Finally, professionals reported counselling difficulties, including time 
constraints and occasional lack of specialist knowledge, as has been previously documented 
(Hunt et al. 2005; Marteau 1993; Williams et al. 2002b). Their counselling difficulties and 
lack of specialist knowledge may be addressed by DESIs.
As highlighted in Chapter 5, pregnant women reported important decision making 
difficulties (e.g., difficulty assimilating probabilistic information, information overload). 
Both women and health professionals emphasised a period of elevated stress and anxiety that 
was triggered by the decision and its aftermath. However, the need to reinforce and 
strengthen existing emotional and decision support highlighted by the majority of women 
interviewed, was only identified by a minority of professionals. Instead, professionals insisted 
on providing comprehensive information about the screening tests, the risks, the results and 
implications of amniocentesis testing. They identified areas where efficient information 
provision was essential but tended to underestimate existing emotional and decision support 
needs. This may reflect areas of expertise that health professionals feel most competent in 
carrying out and a genuine gap in understanding of patients’ emotional needs. These results 
also indicated a gap in perception between users and providers on emotional and decision 
support needs of couples considering amniocentesis and are consistent with existing literature 
in this area (Hunt et al. 2005; St-Jacques et al. 2008).
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6.5 Conclusion
This chapter discussed the professionals’ assessment of women’s information and 
decision support needs associated with amniocentesis testing. There is scope for improving 
the framing of information and risk communication, for providing consistent information 
across professionals and tailoring information provision to individual needs and differences. 
Existing information and decision support for women considering amniocentesis testing 
could benefit from high quality DESIs offered as a supplement to routine information and 
counselling.
Furthermore, the data collected with health professionals highlighted concerns about 
the quality of information provided to women prior to prenatal screening tests and about the 
validity of consent obtained. Information about the characteristics, limitations and 
consequences (i.e., further invasive diagnostic tests offered) of prenatal screening tests should 
be provided to women and addressed in a DESI for amniocentesis testing. Finally, with the 
objective to answer patients’ needs and to create DESIs which are accepted by patients and 
implemented by healthcare providers in clinical settings, DESIs should be developed in 
collaboration with both patients and professionals. Those interventions do not aim to replace 
but supplement face to face interactions with health-professionals.
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Chapter 7
Prototype Development
7.1 Introduction
While DESIs propose to guide and facilitate decision making, they do not normally 
build on theoretical descriptions and explanations of how individuals make decisions. DESIs 
have been researched and developed for over a decade but their theoretical underpinnings 
have only been examined in recent years (Bekker et al. 1999; Bowen et al. 2006).
Decision making theories exist and have increased our understanding of how 
individuals make decisions or ought to make decisions that lead to optimal outcomes. 
Theories or models of decision making are divided into normative or prescriptive theories, 
that address how individuals should ideally make decisions, and descriptive theories, that 
describe how individuals achieve decision making in real-world situations (Baron 2000). 
Normative models or theories of decision making specify from a rational standpoint how a 
decision should be made to achieve the best possible goals or outcomes, under ideal 
conditions. Descriptive theories provide a factual and behavioural account of how people 
make decisions in normal settings. They often involve heuristics or rules of thumb. Although 
empirical evidence on the impact of theory-based interventions is missing, it is hypothesised 
that more extensive use of decision making theory would facilitate progress towards helping 
individuals make difficult healthcare decisions (Bekker et al. 1999). The aim of this chapter 
was to describe the theoretical foundations underlying the development of amnioDex, its 
overall prototype development and first prototype intervention. AmnioDex (amniocentesis 
decision explorer) is a web-based DESI developed to support and facilitate decision making 
of pregnant women facing a decision to undergo amniocentesis testing.
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7.2 A Theory-Based Decision Support Intervention
As highlighted in Chapter 2, the transfer of theoretical constructs into the design and 
prototype development of DESIs and their components (e.g., deliberation tools) remains rare 
and has posed obstacles. Few decision making theories offer an explicit architecture or 
method for transferring theoretical approaches into practical interventions. Expected utility 
theory provides an explicit and systematic method for achieving such translation: decision 
analysis and the decision tree. This may explain why expected utility theory has been widely 
applied to DESI development (Montgomery et al. 2003; Rothert et al. 1997). However, the 
validity and appropriateness of interventions based on expected utility theory (i.e., using 
decision analysis) are questioned (Elwyn et al. 2001). In healthcare decisions involving high 
stakes, short timeframes and emotional strains; asking patients to process numerical 
information and integrate probabilities with weighted utilities may be too difficult, if not 
impossible. Evidence suggests that the results of utility calculations are often inconsistent 
with the patient’s choice (Pauker and Pauker 1979; Elwyn et al. 2001). Normative theories, 
such as expected utility theory are generally derived from mathematical models and do not 
normally account for the individual’s emotional, cognitive, environmental and/or time 
constraints. By contrast, descriptive theories or models of decision making recognise that 
decision makers have limited reasoning and computational abilities and examine ways of 
overcoming these difficulties. Interventions designed to facilitate decision making processes 
(DESIs and its components) may benefit from building on key concepts of how individuals 
actually make decisions under risk. In the clinical context of amniocentesis testing, where 
high emotional demands and complex information limit people’s capacity to quantify utilities 
of options, the assumption was made that descriptive models of decision making would fit 
this specific context better than normative theories.
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Given the translation difficulties highlighted in Chapter 4 and the lack of literature 
documenting the transfer of theory into practical interventions, a decision was made to use 
theoretical frameworks that had previously guided the development of DESIs or DESI’s 
components. In 2001, Feldman-Stewart et al. developed a DESI and embedded value 
clarification exercise for men diagnosed with early stage prostate cancer, based on the 
differentiation and consolidation theory (DiffCon) by Svenson (Feldman-Stewart et al. 2001; 
Feldman-Stewart et al. 2006). The Ottawa Health Research Institute developed DESIs based 
on prospect theory, a theoretical foundation embedded in the Ottawa decision support 
framework (O'Connor et al. 1999c). Those two theoretical frameworks; DiffCon and prospect 
theory, were chosen to develop amnioDex.
7.2.1 Differentiation and Consolidation Theory
Svenson postulates that pre- and post-decision making processes are intrinsically 
linked and therefore describes two stages of decision making: differentiation (pre-decision) 
and consolidation (post-decision). Differentiation is an active process of gradually 
differentiating competing options until one option is deemed superior to other alternatives to 
allow decision making (Svenson 1992). Differentiation involves a range of strategies and 
rules of reasoning including, for example, the conjunctive, disjunctive or lexicographic rules 
(Svenson 1979). Those rules are used to judge options and their attributes in terms of their 
attractiveness and importance. If none of the offered alternatives is judged superior, the status 
quo is maintained. The conjunctive rule is derived from Simon’s satisficing principle (see 
Chapter 8) and requires the decision maker to specify a set of criteria on the attributes that are 
considered important in making the decision (Simon 1955). The option which meets all or 
most of the criteria will be selected. A disjunctive strategy involves choosing the option with 
one or two highly ranked attributes. The lexicographic rule involves choosing the option 
according to the most important attribute only. In case of attribute ties, the second most
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important attribute will discriminate between options. These strategies considerably overlap 
with Gigerenzer’s “fast and frugal heuristics” (Gigerenzer and Todd 1999) (see Chapter 8). 
Finally, post-decision, the consolidation process occurs to protect the chosen alternative 
against future internal and external threats or decision doubts (Svenson 1992). Differentiation 
and consolidation theory predicts that sufficient restructuring (differentiation and 
consolidation processes) minimises or prevents the occurrence of regret and decisional 
conflict.
Following the prerequisites of differentiation and consolidation theory, information 
should be presented so the differentiation between options is facilitated. The comparison 
between alternatives should therefore be made easier. One method to achieve differentiation 
is the use of comparison tables that allow head to head comparison of attributes, either similar 
across options or unique (Feldman-Stewart et al. 2006). In light of this theoretical work, in 
amnioDex, two features were incorporated to facilitate differentiation. Firstly, a comparison 
table presented the harms and benefits of amniocentesis testing in equal detail. Secondly, 
balanced experiences of accepting and declining amniocentesis testing were provided. Video 
clips of enacted quotes from women’s experiences illustrated all possible consequences of 
having or not having an amniocentesis. The videos were organised in two columns: “I had an 
amniocentesis” and “I said no to amniocentesis” (see Figure 7.1). The assumption was made 
that differentiation between options would be facilitated by providing balanced examples of 
all possible outcomes following the offer of amniocentesis testing (see Section 7.4).
7.2.2 Prospect Theory
Kahneman & Tversky developed prospect theory to offer an alternative model to 
expected utility theory, as they believed that such normative model of rational choice failed
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Figure 7.1 Presentation o f  Video Clips Influenced by Differentiation and Consolidation Theory
Making a  decision about amniooentesis
Z  A M N I O C E N T E S I S
DE C I S I ON EXPLORER
amnioDex
Home r s  Yotx Choce Why amraocenlesn? About Amniocentess Resufts Message Board Contacts
Women’s Stories
The video* are enacted quotes from women's stones
I had mm am nioceateshi... I said no to amniocentesis—
PtayNMeo
I had an amniocentesis and everything was fine
k PlayVMeo
The nsk o f  miscamage was too high for me
to describe human choices under risk (Kahneman and Tversky 1979). They noted that 
individuals systematically failed to match up to the rules of expected utility theory or other 
rational decision models and made use of heuristics (e.g., the influence of loss or gain frames 
and the impact of recently appraised information). Prospect theory postulates that decision 
making involves two phases: an early editing phase and a subsequent phase of evaluation of 
all available options until the option with the highest value is chosen (Tversky and Kahneman 
1981; Tversky and Kahneman 1992). To simplify subsequent evaluation and decision 
making, the editing process consists of reformulating the cues available using several 
operations (e.g., preliminary analysis, framing and simpler presentation of the options by 
using heuristics). According to prospect theory, decision making is influenced by 1) the way 
in which information is presented and risks portrayed (i.e., framing of information), 2) a 
tendency to be risk averse when choosing between gains, and risk seeking when choosing 
between losses (i.e., certainty effect) and 3) the fact that losses generally loom larger than 
gains. Prospect theory posits that the way losses and gains are perceived depends on the
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reference point. In the context of amniocentesis testing, being pregnant is the reference point; 
the loss therefore looms large (i.e., losing the baby).
The effects of information framing, initially characterised in prospect theory, have 
been documented in various contexts, including medical decision making (Kuhberger 1998; 
Marteau 1989; McNeil et al. 1982; Moxey et al. 2003). The framing effects in medical 
decision making imply that crucial treatment or screening decisions may be biased by the 
way in which harms and benefits are described. Framing effects may therefore induce biased 
or less informed decisions and lead to poor decision outcomes (i.e., decisional conflict or 
decision regret) (McNeil et al. 1982). With the aim to facilitate informed decision making and 
reduce decisional conflict, DESIs may include methods for reducing framing biases. It has 
been recognised that framing biases can be minimised by framing information in multiple 
ways: by language, by number (percentages and natural frequencies), by images and by 
diagrams (Edwards et al. 2001). Specifically, diagrams may be used to minimise framing 
effects by representing affected and non-affected icons in a visual diagram (O'Connor et al. 
2005; Lipkus and Hollands 1999). To take account of framing effects, outcome probabilities 
in amnioDex were framed by language, number, and diagrammatic representations (see 
Figure 7.2). This decision was justified by the prerequisites of prospect theory but was also 
based on the results of the needs assessment conducted with pregnant women (Chapter 5), 
where women unanimously highlighted the need to address decision difficulties by presenting 
information in multiple ways. Further, during the needs assessment, pregnant women also 
reported difficulties understanding the screening test result. Therefore, to help women better 
understand their screening test result, and consistent with prospect theory, a functionality 
(“Understanding Your Result") was added that framed women’s individual screening test 
result by language, number, diagrams
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Figure 7.2 Example of Outcome Probabilities Framed by Language, 
Number and Diagram
Why amniocentesis? About Amniocentesis Results Message Board Contacts
Results
The results of the chromosome tests (PCR and karyotype test) can detect Down's 
syndrome or other conditions.
It is estimated that 97% of women who undertake amrvocentesis w f have a healthy 
baby (ref 5).
A chromosome problem wil be aentified  
n  J out of 100 am rvocenteses performed
Figure 7.3 Screenshot o f Understanding Your Result
If you know the result, type your test result here: 1 in | 150 |
Fora 1 m 150 chance 
of having a baby with 
Down's syndrome, 
you have 149 oi< of 
150 chances that the 
baby won't have 
Down's syndrome.
This also means that 
you have 7 out of 
1000 chance of 
having a baby with 
Down's syndrome.
•
%
•
•
•
•
•
•
# t 1*7  « « 4
V « * *
Imagine a jar with 149 coloured balls and 1 white 
bad. Imagine dosing your eyes and picking up a 
ball from the jar. You picking the white ball 
corresponds to your chance of having a baby 
with Down's syndrome.
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and images (see Figure 7.3).Women were asked to enter their individual screening test result. 
Their individual result was subsequently framed negatively and positively, converted into a 
diagram and illustrated using an image and analogy.
7.3 Developing AmnioDex
AmnioDex (amniocentesis decision explorer) was developed by the Decision 
Laboratory at Cardiff University between September 2006 and July 2008, with technical 
support from a web design company. Over the past few decades, DESIs have been developed 
in a variety of formats: paper-based, audio, video, and more recently web-based 
interventions. There has recently been an increasing interest in developing web-based 
interventions (Schwitzer 2002). They offer the potential to individualise the provision of 
information and provide high adaptability and interactivity. In the case of amnioDex, a 
decision was made to develop a web-based intervention in order to include videos and other 
interactive elements, and because it offered great adaptability, reduced the cost of production 
(in the long term), and theoretically increased access and allowed wider dissemination. The 
amnioDex intervention is openly accessible online at www.amniodex.com.
7.3.1 The IPDAS Criteria
The general design and development process of the intervention was initially 
determined according to the quality criteria developed by the IPDAS collaboration and listed 
in the IPDAS instrument (Elwyn et al. 2006; Elwyn et al. 2009c). As described in Chapter 3, 
the IPDAS instrument assesses the quality of existing DESIs at 10 broad domain levels: 
Information, Test, Probabilities, Values, Guidance, Development, Evidence, Disclosure, Plain 
Language and Evaluation. While developing the intervention, an effort was made to fulfil as 
many domain requirements as possible. In compliance with the information domain, 
amnioDex provided comprehensive information about the decision at stake, the options
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available, their harms, benefits, outcomes and potential consequences. The intervention also 
presented information about the specific features of the diagnostic test (amniocentesis) and 
implications of accepting or declining the test (Test domain). AmnioDex provided precise 
and balanced information about the outcome probabilities associated with each option 
(Probabilities domain). AmnioDex also included deliberation tools to facilitate the expression 
and clarification of values (Values domain) (see Chapter 8). In the section “Talking to 
Others ", amnioDex provided structured guidance towards making a decision by including a 
list of questions to discuss with their midwife or obstetrician (Guidance domain). As 
described in Chapters 5, 6, 8 and 9; amnioDex was developed following a systematic 
development process, involving pregnant women and health professionals at all stages of 
development (Development domain). The intervention was written using evidence-based 
information, synthesised from literature review and referenced throughout the website 
(Evidence domain). In section “More About AmnioDex ", the website provided information 
about developers’ credentials and sources of funding used to develop the intervention 
(Disclosure domain). Finally, the intervention was developed using plain language and will 
soon be reviewed by the Plain English Campaign (Plain Language domain).
7.3.2 The AmnioDex Steering Group
A steering group of stakeholders and health professionals from disciplines relevant to 
the amniocentesis decision was created in October 2006 (see Figure 7.4). The amnioDex 
steering group was formed to ensure that the informational content was accurate and 
consistent with current clinical practice. Another objective was to make sure that it covered 
all issues women may have when deciding about amniocentesis while accounting for the 
difficulties health professionals may experience when counselling them. Comments and 
suggestions for improvements of steering group members were systematically examined by a 
stakeholder group of researchers, including the author of this thesis, before rejecting or
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Figure 7.4 Timeline Illustrating the Development of AmnioDex
Oct 06 - AmnioDex steering group formed- Literature review
Steering group meetings 
Mar-Dee 07 Storyboard development
Apr 07-Feb 08 - Needs assessment with pregnant women and health professionals
Jan-Jul OS - uldeo C"PS
- Web development of amnioDex
Jul 08 AmnioDex version 1 ready for field-testing
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implementing suggested changes. The researchers who developed amnioDex retained 
editorial control of the intervention’s content. The steering group consisted of 17 
stakeholders: two consultants in obstetrics and gynaecology, nine midwives or screening 
midwives, one geneticist, three coordinators of the national antenatal screening programme 
(in Wales and England), one director of a national charity and one patient representative. 
Steering group members were initially involved in identifying essential themes and areas to 
be covered in the intervention. They were subsequently asked to review incremental 
prototypes of the intervention. Two steering group meetings were held in March and 
December 2007. Steering group members were frequently consulted via emails.
7.3.3 Textual Content
The content of amnioDex was based on a literature review (see Chapters 2, 3 and 4), 
needs assessment conducted with pregnant women and health professionals (see Chapters 5 
and 6) and steering group meetings, while complying with the IPDAS quality criteria. The 
decision to include or reject specific information, topics or sections was primarily based on 
available scientific evidence, data collected during the needs assessment, steering group 
meetings and theoretical underpinnings. However, the editorial control remained with the 
researchers who developed the amnioDex intervention (author of this thesis, GE and JB). In 
creative design involving multi-stakeholder consultation, such as amnioDex, editorial control 
appeared essential and inevitable.
In March 2007 (see Figure 7.4), a steering group meeting was held to discuss the 
content of the amnioDex intervention and identify critical information and essential topics to 
be covered. In September 2007, a storyboard presenting the informational content and 
graphic-based elements appearing on each page of amnioDex was created. The storyboard 
detailed the provisional layout, navigation structure, interactive elements and informational
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content of the website. In parallel (April 2007-February 2008), a needs assessment was 
conducted with pregnant women and health professionals. The data was simultaneously 
analysed to guide the prototype development of the intervention. In December 2007, a second 
steering group meeting was held to review the storyboard, discuss essential informational 
content and identify areas and themes that needed particular attention. The steering group 
members commented on the wording and clinical accuracy of critical topics (e.g., section 
describing the risks, section about chromosomal abnormalities), on the presentation of 
information (e.g., use of pie charts, diagrams, images), framing of numerical data, general 
design and navigation of the website (as presented on the storyboard). They suggested the 
addition of a section displaying useful contacts and other information resources. Regular 
email exchanges were maintained with the steering group members to keep them updated of 
the changes made to the storyboard and verify the clinical accuracy of specific sections (e.g., 
section describing elective termination of pregnancy, section about the risks of miscarriage).
7.3.4 Web Development
In December 2007, a web design company was selected to develop the amnioDex 
intervention. Between January and March 2008, the video clips of women’s stories and health 
professionals were filmed with actors and deliberation tools developed (see Chapter 8). The 
video clips of women’s stories were developed using enacted quotes of women’s experience 
about their decision to accept or decline amniocentesis testing. Ethical approval was granted 
by the National Research Ethics Service. Scripts were selected from 17 transcripts of 
interviews conducted with women who had been offered an amniocentesis and their partners 
(n=4). Ten actresses and one actor were selected to enact 14 video clips exclusively based on 
the interview transcripts. Two health professionals, a consultant in obstetrics and 
gynaecology (male) and a geneticist (female) were chosen to create 5 video clips addressing: 
the decision to undertake amniocentesis, the procedure, the risk of miscarriage, and
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Figure 7.5 Screenshot o f the AmnioDex Homepage
Demo
How amnioDex 
can help you decide
• ■ a m n io D e x
AA M N I O C E N T E S I SD E C I S I O N  E X P L O R E R
Making a decision about amniocentesis
Home r s  Your Choc* Why amniocentesis? Atooul amniocentesis Results Message Board Contacts
        ■! I I  .— — — — i ^— — — I.
chromosomal abnormalities potentially detected. A video clip of a live amniocentesis 
procedure was filmed and added to the section “About Amniocentesis”. In parallel, the 
storyboard was finalised. The storyboard detailed all textual content appearing on the website 
and layout of all web pages including the message board, glossary and deliberation tools.
In March 2008, the latest version of the storyboard was circulated to all members of the 
steering group for comments. Steering group members were given three weeks to provide 
feedback and suggestions for improvement about the accuracy of the textual content, general 
layout of the website, quality and relevance of interactive elements, images and other 
graphic-based elements. Because of time constraints, the video clips were reviewed by 4 out 
of 17 members of the steering group: two coordinators of the national screening programme, 
one consultant in obstetrics and gynaecology and one geneticist. All video clips were
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approved and uploaded onto the website. Between March and July 2008, the storyboard was 
converted into an interactive web-based intervention.
7.4 The AmnioDex Intervention
AmnioDex is an interactive web-based DESI intended for pregnant women (and 
partners) who have been offered amniocentesis testing, independently of their screening 
pathway (see Figure 7.5). AmnioDex may be used by pregnant women (and partners) who 
have been offered amniocentesis following a higher chance screening test result, an 
abnormality detected on the mid-pregnancy ultrasound scan, an inherited condition or a 
family history of a chromosome disorder.
AmnioDex (www.amniodex.com) featured 63 pages of content divided into 10 
sections. Four sections offered comprehensive information about the choice to be made (“It’s 
Your Choice”), the reasons for being offered an amniocentesis (“Why Amniocentesis?”), the 
amniocentesis procedure (About Amniocentesis), and the results of the chromosome tests 
(“Results”). Consistent with the results of the needs assessment (Chapter 5), where pregnant 
women reported the need for information about the elective termination of pregnancy, the 
section “If a Problem is Found” (in section About Amniocentesis) included information about 
continuing or ending the pregnancy. The section entitled It’s Your Choice, included six web 
pages featuring information about the harms and benefits of amniocentesis testing. Emotional 
and decisional support was provided in the following sections: “Making the Best Decision”, 
“Deciding With a Partner”, “Knowing Enough to Choose” and “Uncertainty and Anxiety”. 
The section entitled Why Amniocentesis? provided information about the reasons for being 
offered the test and included a tool to help users understand their screening test result (see 
Figure 7.1). Users were asked to enter their screening test result, and were subsequently 
shown different ways of framing the risk of chromosomal abnormality (i.e., positive versus
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negative framing, diagram with dots and analogy). The section entitled about amniocentesis 
offered comprehensive information about the amniocentesis procedure (e.g., “What is it?”, 
“How is the Test Done?”, “After the Procedure”), the risks involved, the chromosome tests 
performed on the amniotic fluid and described all options available if an abnormality was 
detected (“Your Choices”, “Being Supported”, “Continuing the Pregnancy”, “Ending the 
Pregnancy”). The section entitled Results provided information about the results of the 
chromosome tests (“Getting the Results”, “Waiting for the Results”) about Down’s 
syndrome, other chromosomal abnormalities tested for and conditions that would not be 
detected following an amniocentesis. AmnioDex included a “Contacts” section with a list of 
relevant charities and alternative information resources available, a glossary and site map. 
The section entitled “More About AmnioDex” provided information about the development 
and authors of amnioDex, and a reference list.
Further, the intervention included several interactive elements and narratives. 
AmnioDex featured 14 video clips of enacted quotes of women’s stories, five videos of 
health professionals, and one video clip of a live amniocentesis procedure. The video clips of 
women’s stories were accessible throughout the website, in sections providing related 
information, or in the section “Personal Stories”, where all 14 video clips were presented 
according to four different themes: “I had an amniocentesis”, “I said no to amniocentesis”, 
“about the procedure” and “I miscarried after amniocentesis”. Five video clips of health 
professionals appeared in the sections: It’s Your Choice, About Amniocentesis and Results. 
To facilitate the expression and clarification of parents’ values with regards to the 
amniocentesis decision, amnioDex featured three deliberation tools: “weighing it up”, “your 
most important reason” and “talking to others”. Weighing it up and your most important 
reason were based on theory and required users to actively participate in the deliberation
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process (see Chapter 8). Talking to others was developed without theoretical underpinnings 
but complied with the IPDAS recommendations by offering a list of questions and printable 
worksheet to discuss with their partners or health professionals. Finally, amnioDex included a 
message board divided into three web forums: “amniocentesis testing”, “making a decision”, 
“I’ve made a decision”.
7.5 The Virtual Reference Group
Prior to evaluating amnioDex in a randomised controlled trial (grant outline submitted, 
see Appendix 5), a virtual reference group was convened to review the intervention after field 
test. In the context of amnioDex, the virtual reference group was a group of health 
professionals that provided advice and expertise by critically appraising the final content and 
presentation of the amnioDex intervention using a virtual review process (i.e., letters, email 
exchanges and telephone conversations). Members of the virtual reference group were 
identified through steering group meetings and contacts in England, Scotland and Wales, 
some of whom had already taken part in the stakeholder analysis (see Chapter 6). A letter was 
sent to 15 health professionals asking them to review the amnioDex website, and to comment 
on its content and format. Ten health professionals agreed to be part of the reference group: 
two consultants in obstetrics and gynaecology, a professor of obstetrics, a trustee from the 
Support Organisation For Trisomy 13/18 (SOFT), a midwife and lecturer in women’s health, 
a screening midwife, the operations director of the Down’s Syndrome Association, the 
director of Antenatal Results and Choices (ARC), a geneticist and the national programme 
director of the NHS Foetal Anomaly Programme.
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Chapter 8
Development and Usability of Heuristic-Based Deliberation
Tools
8.1 Introduction
How best to support people attempting to make difficult health decisions is an area of 
considerable research interest but debate about the methods for supporting and facilitating 
decision making remains. Numerous methods or strategies have been developed to assist 
patients in structuring their preferences to achieve a decision. Those methods propose to 
facilitate the expression and clarification of values so as to subsequently help patients select 
an option consistent with their stated values or preferences (Llewellyn-Thomas 2009). 
However, there is uncertainty and debate around the nature of cognitive processes that might 
help people express and clarify their values and attitudes in order to make informed 
preference-sensitive decisions (Dijksterhuis et al. 2006; O'Connor et al. 2007a; Wilson and 
Schooler 1991). Terms such as value, attribute, preference elicitation methods (Feldman- 
Stewart et al. 2006), value- or preference-clarification exercises (O’Connor et al. 1999b), 
probability-trade off techniques (Llewellyn-Thomas et al. 1996) and coaching or guidance 
methods can be found in the literature (Llewellyn-Thomas 2009). For the purpose of this and 
subsequent chapters, the generic term deliberation tools, was used to describe processes and 
methods that have been embedded into DESIs to facilitate deliberation and decision making. 
Over the past decades, deliberation tools have used a wide range of approaches to help 
patients express and clarify their values. Some have used decision analysis (based on 
expected utility theory) asking users to specify the numerical value of screening or treatment 
outcomes to identify the option with the highest expected utility based on their expressed
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values and attitudes (Llewellyn-Thomas 1997). Other deliberation tools provide checklists, 
worksheets or balance scales for patients to complete, and indicate their values and 
preferences with regards to the decision (O’Connor et al. 1998b). Some feature video clips of 
patient experiences, illustrating the physical, social, and emotional effects of the harms, benefits 
and consequences of each option (Spunt et al. 1996). Some tools suggest a process of 
discussion with relatives or health professionals while others simply provide information 
about the harms and benefits of options, making the process of expressing and clarifying 
values implicit (Levine et al. 1992).
Most theory-based deliberation tools developed over the past decade either derived or 
made assumptions about rationality based on normative theories of decision making (Bekker 
et al. 2004; Holmes-Rovner et al. 1999; Llewellyn-Thomas 1997; Llewellyn-Thomas 2009). 
These theories or models of decision making assume unbounded rationality, that is, unlimited 
knowledge, time and computational capacities (Todd and Gigerenzer 2000). Normative 
theories such as these are derived from optimisation models that do not take account of 
emotional, cognitive, environmental and/or time constraints. People facing complex decisions 
such as those connected to health, often have a limited ability to process information and to 
integrate probabilities with weighted utilities. Bounded rationality models may be better 
suited to medical decisions under uncertainty. These models assume that humans have 
developed simpler adaptive strategies using limited information searching to arrive at 
effective decisions in time-efficient ways despite the aforementioned constraints (Simon 
1956). Paradoxically, models of bounded rationality have rarely been used to develop 
decision support for patients and hence a research gap exists.
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Gigerenzer et al. described a series of simple heuristics, which they called; fast and 
frugal heuristics, based on the theory of probabilistic mental models (Gigerenzer et al. 1991) 
and notions of bounded rationality (Gigerenzer and Goldstein 1996). Fast and frugal 
heuristics are non-compensatory; information search is limited and may be minimal, 
determined by simple stopping rules. The efficiency of heuristic-based methods has been 
evaluated in real world situations, including situations of medical decision making. Green and 
Mehr showed that simple heuristic-based methods outperformed complex rules of reasoning 
and improved physicians’ decisions to admit patients to the coronary care unit (Green and 
Nlehr 1997). There is growing empirical evidence that physicians may rely on fast and frugal 
heuristics without affecting the decision’s quality. Fisher et al. showed that simple heuristic 
rules were successfully used to identify children at risk for pneumonia infections and to 
prescribe antibiotics (Fisher et al. 2002). Comparable results were found with decisions 
affecting prescription of antidepressants (Smith and Gilhooly 2006). The aim of the present 
chapter was to develop deliberation tools based on models of bounded rationality and to field- 
test these tools with researchers, healthcare professionals and pregnant women facing 
amniocentesis testing.
8.2 Methods
The study was divided into four stages: (1) prototype development o f two deliberation 
tools, (2) prototypes field-tested with researchers, (3) prototypes field-tested with health 
professionals, (4) prototypes field-tested with pregnant women facing a decision to undergo 
amniocentesis testing. The study protocol and materials were approved by the research and 
development committees of the participating sites (Cardiff and Vale NHS Trust, Velindre 
NHS trust) and by the National Research Ethics Service.
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8.2.1 Prototype Development
Eight decision algorithms were considered as possible basis for the development of 
deliberation tools. These algorithms included four heuristic-based algorithms (Take the Best, 
Take the Last, Minimalist and Tallying), and four integration algorithms (Unit Weight Linear 
Model, Weighted tallying, Weighted Linear Model and Multiple Regression). In the
literature, these decision algorithms (see Table 8.1) have been compared using simulations of 
performance on real-world questions under conditions of limited knowledge and time 
(Gigerenzer and Goldstein 1996). The criteria for selecting decision algorithms for translation 
into deliberation tools were the specified performance and predictive accuracy on simulated 
decision tasks (Gigerenzer and Goldstein 1996). Findings of that research and currently 
discussed research directions in this area (Wegwarth and Elwyn 2009) suggested that the 
heuristic-based algorithms: “Take the Best” and “Tallying” performed better than complex 
integration algorithms (Gigerenzer 2008). Both heuristic-based algorithms were therefore 
retained to guide the development of two deliberation tools embedded in amnioDex.
Key theoretical constructs of the Take the Best and Tallying heuristic-based
algorithms guided the design of “your most important reason” and “weighing it up”. The 
deliberation tools were developed with technical support from a web-design company and 
collaboration with three researchers, over a period of 12 months. Several prototypes were 
developed for each deliberation tool. Each new prototype was discussed and adapted. 
Informal piloting occurred until the first usable prototype of the deliberation tools was ready 
for field-testing. The cognitive steps of each algorithm were isolated and translated into a 
graphic-based interactive deliberation tool. The first mental step of the Take the Best
algorithm requires that one attribute is found that can discriminate between options
(Gigerenzer and Goldstein 1996). In the second step, each attribute is reviewed, in order of
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Tabic 8.1 Algorithms Considered for the Development of AmnioDex Deliberation Tools
Heuristic-based algorithms Integration algorithms
Take the Best Take the Last Minimalist Tallying Weighted
TaUying
Unit Weight Linear 
Model
Weighted Linear 
Model
Multiple
Regression
■ Cues3 or attributes • The cue that ■ The cues are • For each option, ■ Contrary to ■ This algorithm is ■ This model is ■Multiple
are subjectively discriminated selected in a all positive cues Tallying, where all similar to Tallying, similar to the Unit regression accounts
ranked according to between options random order until are summed up, cues weigh the except that the Weight Linear Model for the different
their the last time a a cue is found to and the option same value, the assignment o f option and Tallying. validities o f the
validity/importance. decision was discriminate with the largest Weighed Tallying a and option b differs However, the value of cues.
made is chosen. between options. number o f positive algorithm involves (sec Gigerenzer and option a and b are
■ The highest cues is chosen. weighing each cue Goldstein 1996). This multiplied by their ■ Multiple
ranking cue (best ■ If this cue does ■The minimalist according to its algorithm has been ecological validity. regression assigns
cue) is retrieved not discriminate, heuristic requires ■All cues have the ecological considered a good weights to each
from memory. the second most even less same value or validity. The approximation of option
recently used cue knowledge than importance with ecological validity weighted linear corresponding to the
■ If the cue is chosen. Take the Best and regards to the specifies the cue’s models (Dawes 1979). covariance between
discriminates Take the Last. decision. predictive power, the cues.
between options, the ■ The process is that is, the
search stops and an repeated until a frequency with
option is chosen. cue is found to 
discriminate.
which the cue 
successfully
■If the cue does not predicts the
discriminate choice.
between options, the (Gigerenzer and
process is repeated Goldstein 1996)
until a cue is found
to discriminate.
3 Cues refer to the attributes o f each option.
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importance, until one attribute is found that can discriminate between options. The Tallying 
algorithm requires that all determining attributes for each option are summed-up (Goldstein 
1994). According to this algorithm, the option with the largest number of attributes will be 
chosen. All attributes have the same value or importance with regards to the decision.
8.2.2 Prototype Testing With Researchers
The first working prototypes o f the deliberation tools; weighing it up version 1 and 
your most important reason version 1, were piloted with a stakeholder group of researchers 
from multi-disciplinary backgrounds: medicine, psychology, health psychology, sociology 
and health informatics (n=15). The sample consisted of two researchers specialising in shared 
decision making, eight researchers specialising in health communication, two researchers 
specialising in health informatics, and three sociologists. A group interview was used to 
discuss each deliberation tool separately. The researchers were asked to comment on the 
design and usability o f each tool. The data was recorded digitally and was analysed using 
thematic content analysis. Weighing it up and your most important reason versions 1 were 
amended following the researchers’ comments to create the second working prototype of the 
deliberation tools (i.e., version 2).
8.2.3 Prototype Testing With Health Professionals
The planned sample of health professionals (n=28) consisted of five consultants in
obstetrics and gynaecology, a sonographer, a clinical nurse specialist, ten midwives, two
geneticists, six coordinators of the national antenatal screening programme in Wales, England
and Scotland, a patient representative and two professionals from national charities offering
information and support during the diagnostic phase of pregnancy (Antenatal Results and
Choices, Down’s Syndrome Association). An email was sent to all 28 individuals, asking
them to review the amnioDex website online, paying attention to the deliberation tools:
weighing it up (version 2) and your most important reason (version 2). They were asked to
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complete a short questionnaire. The 18-item questionnaire was divided into five sections: 
navigation, layout, video clips, deliberation tools and message board. Participants were asked 
to provide written feedbacks on each item. The data was analysed using thematic content 
analysis. For the purpose of this chapter, the analysis was focussed on the items addressing 
the deliberation tools only. The deliberation tools were amended according to the 
professionals’ comments to develop weighing it up and your most important reason versions 
3.
8.2.4 Prototype Testing With Women Facing the Amniocentesis Decision
Pregnant women who had been offered an amniocentesis were invited to use amnioDex 
and the deliberation tools (version 3). In one antenatal clinic (University Hospital of Wales, 
Cardiff), women (any age) who had been offered an amniocentesis after screening tests for 
Down’s syndrome, advanced maternal age or mid-pregnancy ultrasound scan, were informed 
of the study by midwives. Pregnant women were excluded from the study if they could not 
read English. Women who indicated an interest in participating were consented and given an 
interview date. The interview was conducted in two phases. First, participants were asked to 
use the deliberation tools while verbalising their thoughts using the “think-aloud” method 
(Cotton and Gresty 2006; Davison et al. 1997). This method required participants to 
communicate their thoughts as they used the tools, indicating satisfaction, dissatisfaction, 
difficulties encountered and misunderstandings. The think-aloud technique provides insight 
into the usability o f the products and impacts on cognitions and emotions of the steps 
required to navigate new technologies (Ericsson and Simon 1984; Fonteyn and Fisher 1995; 
Funkesson et al. 2007). Second, participants took part in a short semi-structured interview. 
The interview schedule consisted of eight open-ended questions focusing on women’s 
reactions to the deliberation tools, navigation of the website, comprehension of content and 
suggestions for improvement. For the purpose of this chapter, the analysis was focussed on
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their reactions to the deliberation tools. All interviews were recorded digitally and transcribed 
by the same researcher (author of this thesis). The interview data was qualitatively analysed 
using a two-step thematic content analysis (Denzin and Lincoln 2000; Holloway 2005; Pope 
et al. 2000), assisted by the computer software ATLAS-ti (ATLAS-ti 5.2). The deliberation 
tools were amended accordingly and weighing it up and your most important reason versions 
4 were developed.
8.3 Results
8.3.1 Prototype Development
Key theoretical constructs of the Take the Best and Tallying algorithms respectively
guided the design o f your most important reason and weighing it up. To increase
understanding and usability o f the deliberation tools, the terminology was simplified. The
term attributes, commonly used to describe the factors that could help form preferences, was
replaced by the term reasons. The reasons displayed in both tools were selected from
accounts provided in a detailed needs assessment reported in Chapter 5.
Your Most Important Reason
In your most important reason version 1 (see Figure 8.1), users were presented with a
series o f important reasons that were considered influential in arriving at a decision to accept
or decline amniocentesis testing. The reasons were displayed in boxes with clickable
information buttons and more reasons could also be added. Users were asked to choose the
reasons that were relevant to their decision making and to rank them in order of importance.
The first important reason ranked was automatically selected and a short question generated
asking: “Does this reason allow you to make your final decision about amniocentesis?” Users
who chose “yes”, were asked to indicate their decision (yes or no to amniocentesis).
Suggestions of the next steps to be taken were made, such as informing their healthcare
provider, reading more about amniocentesis, printing their deliberation pathway or watching
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Figure 8.1 Screenshot o f Your Most Important Reason Version 1 (Take the Best)
Please choose reasons that are important for 
your decision about amniocentesis. You can 
also add your own reasons. In their order of 
importance, drag and drop reasons into the 
boxes. You don't need to drag all the reasons.
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enacted quotes of women’s stories. Further advice and support was offered to users who 
indicated indecision about amniocentesis (i.e., discuss decision difficulties with health 
professionals, use another deliberation tool, get support from the Antenatal Result and 
Choices helpline or find more information).
Weighing it up
In weighing it up version 1 (see Figure 8.2), users were presented with the same series 
of important reasons as for the previous deliberation tool. Users were asked to select the 
reasons that were relevant to their decision. When selected, a weight appeared on a weighing 
scale, indicating whether the reason acted in favour of, or against having an amniocentesis. 
Users were subsequently asked whether a decision about amniocentesis had been made. 
Users who chose “yes”, were asked to indicate their decision (i.e., yes or no to 
amniocentesis). Suggestions of the next steps to be taken were made. Further advice and 
support was offered to users who indicated indecision about amniocentesis as described 
previously.
8.3.2 Prototype Testing With Researchers
Fifteen researchers were invited and 10 agreed to take part. Most researchers 
positively reacted to both deliberation tools. They did not express preferences towards one 
tool or the other. On the first webpage, three researchers suggested to display the reasons for 
amniocentesis on one side of the page and the reasons against amniocentesis on the other side 
because they believed this would facilitate the differentiation between options. All remaining 
researchers were satisfied with the way reasons were presented and felt that it was 
appropriate to display the reasons in a random order, without making a distinction between 
reasons for and against amniocentesis. To avoid increasing the number of reasons displayed 
or affecting the design and layout, the presentation of reasons was kept unchanged (i.e., 
reasons were presented randomly without distinguishing between reasons for and against
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Figure 8.2 Screenshot o f  Weighing it up Version 1 (Tallying)
Please choose reasons that are important for your decision about amniocentesis. You can also add your own 
reasons. Drag and drop the reasons you think would be in favour of amniocentesis into the green bowl. Drag
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n
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amniocentesis). Most researchers considered that instructions and textual content of weighing 
it up and your most important reason could be improved. The overall textual content and 
instructions appearing on the first page of each tool were amended to increase usability and 
meet the requirements of the Plain English Campaign (Cutts 1995). Furthermore, one 
researcher suggested the addition of a short demo for each deliberation tool, because it could 
not be guaranteed that users would systematically read the instructions before using the tools. 
A short demo was added, accessible after users clicked on the demo button appearing on each 
deliberation tool. All amendments described above were integrated into the deliberation tools 
to produce the second versions of weighing it up and your most important reason.
8.3.3 Prototype Testing With Health Professionals
Twenty eight health professionals were invited and nine professionals agreed to 
review the website and embedded deliberation tools (version 2). The sample consisted of two 
midwives, a consultant in obstetrics and gynaecology, five professionals from the national 
screening programmes in England, Scotland and Wales, and the director o f a national charity 
(Antenatal Results and Choices). Five health professionals expressed concerns regarding the 
clarity and usability o f the tools. For both tools, the instructions were deemed unclear and 
confusing. Five out of nine professionals reported difficulties understanding how to use the 
deliberation tools. Two professionals even questioned the necessity to integrate such tools on 
the website, as they feared the tools would confuse rather than help pregnant women. One out 
of nine professionals reported preferring weighing it up to your most important reason. One 
out of nine professionals reported finding the tools very useful, after having read and 
understood the instructions. Four professionals considered that both deliberation tools would 
prove beneficial in clarifying women’s thoughts and facilitating decision making. Two out of 
nine professionals insisted on the necessity to review the demo before using the tools and 
avoid the initial confusion they experienced. They suggested integrating a mandatory demo in
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each deliberation tool. Following the professionals’ comments, the textual content and 
instructions were amended to increase clarity and usability. The demo button was made more 
obvious to encourage users to watch the demo before using the tools. These changes were 
incorporated into the deliberation tools to produce the third versions.
8.3.4 Prototype Testing With Women Facing the Amniocentesis Decision
In the participating antenatal clinic, 14 pregnant women who had recently been 
offered an amniocentesis were invited to take part and 10 women agreed to be interviewed. 
Pregnant women used the deliberation tools versions 3. Nine participants took part in a phone 
interview and one participant attended a face to face interview. Five women decided to 
undergo amniocentesis and five women declined the test. Interviews lasted between 17 and 
7 5  minutes (29 minutes on average). The mean age of women in the sample was 36.7 years 
(range 34-41 years, standard deviation 2.4). Eight women were British, one woman was 
Filipino, and one woman was Algerian. The mean gestational age, at the time of interview, 
was 18 weeks (range 17-19 weeks, standard deviation 0.5). The demographic characteristics 
of the participants are summarised in Table 8.2. Five themes were identified: benefits of the 
deliberation tools, disadvantages of the deliberation tools, difficulties using the deliberation 
tools, preferences for one tool over the other, suggestions for improvement (see Table 8.3).
All participants used both deliberation tools in no particular order. Seven out of 10 
pregnant women found the deliberation tools helpful: in weighing the pros and cons of 
options (n=4), in making a decision (n=2), confirming the decision made (n=2), providing a 
comprehensive list of reasons (n=2) and generally facilitating understanding (n=l).
"It was good to do that and see that, for me, everything went towards the no, not having it. I mean, it 
[weighing it up] just helped me make the decision basically. It’s just nice to be able to make the 
decision by using different ways o f doing it, just to understand it a little bit more.” (F, age 37, declined 
amniocentesis)
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T able 8.2 Characteristics o f  Women Interviewed (Field Test o f  the Deliberation Tools)
Characteristics Sample size
Amniocentesis
- Accepted 5
- Declined 5
Marital status
- Married or engaged 5
- Living with partner 5
Nationality
- British 8
- Other (Filipino, Algerian) 2
Number of children
-0 2
- 1 6
.  2 2
Existing children with a chromosome disorder 0
Obstetric History
- Previous miscarriage 1
- Previous amniocentesis 0
T able 8.3 Themes Identified in Interviews With Pregnant Women (Field Test o f the Deliberation
Tools)
Themes Sub-themes
B enefits o f  the d e lib e ra tio n  too ls - D ecision  m ak ing  p rocess facilita ted
- D ecision  ou tcom e v isualised
- Increased  c larity
- L ist o f  reasons
D isadvan tages o f  the d e lib era tio n  tools - C om plex ity
- Inco m p atib le  w ith  such em otional decision
- A rtific ia l p rocess
D ifficu lties u sing  the d e lib era tio n  too ls - U sab ility
- U nderstand ing  d ifficu lties
- T echn ica l d ifficu lties
P references fo r one too l o v er the o ther - A dv an tag es o f  w e igh ing  it up
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“1 think it could be quite useful, because, I guess, to look at it nice and clear, it gives you a way o f just 
putting it all in and putting your thoughts down, in front o f  you.” (F, age 37, declined amniocentesis)
Seven out of ten pregnant women felt the instructions were generally clear and the tools easy 
to use. The majority o f users did not watch the demo but nine out of ten users thoroughly read 
the instructions.
“It was fine to use, dead simple!” (F, age 34, undertook amniocentesis)
Two users considered the list of reasons helpful in clarifying their thoughts about 
amniocentesis testing. While they already knew the main reasons/factors for accepting or 
declining an amniocentesis, visualising the list was deemed helpful in achieving decision 
making.
“The best bit which helped compared to the leaflets was those little cartoons down at the bottom 
[weighing it up and your most important reason]. It’s got all the reasons that you were thinking of, in 
your brain, that were all messed up, so it lists it, so you know what those reasons are, you just couldn’t 
think straight at the time.” (F, age 34, undertook amniocentesis)
Furthermore, seven out of ten users expressed preferences towards weighing it up 
over your most important reason.
“I like the weighing scales. I found that one a little better to use, just because it’s more visible as you 
do it rather than, the other one, you’ve got to wait till the end to know what the result is. But, yes, 1 like 
the weighing scales.” (F, age 34, declined amniocentesis).
They felt that weighing it up was more immediate, intuitive and helpful in visualising the 
decision. They perceived the movements of the weighing scales as facilitating the trade off 
between options. Pregnant women considered that weighing it up enabled them to visualise 
their decision making process (e.g., movements of the scales during deliberation) and the 
final outcome, as reflected by the arrow on the weighing scale: leaning towards 
amniocentesis or not.
“I think the first one [weighing it up] was more immediate in, kind of, putting it visually in front o f 
you, in making a decision and putting down the pros and cons. I guess that just depends on how you...
I don’t know. To me, the first one actually was better, the most useful, interesting.” (F, age 37, declined 
amniocentesis)
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Three users indicated that your most important reason was more complex and instructions 
seemed less clear than weighing it up. They felt that your most important reason was less 
immediate and required more effort and focus than weighing it up. Two out of ten pregnant 
women reported difficulties ranking their reasons in order of importance.
Three pregnant women out of ten found the tools unhelpful in making a decision 
about amniocentesis. They felt the tools were overly complex and caused confusion instead 
of facilitating understanding. One woman considered the tools too clinical to use for such an 
important and emotional decision as amniocentesis.
‘i  think it’s such an emotive subject that, you know, in your head you go through it all and you work 
out what you want to do and how you want to deal with the problem if there is a problem. But would I 
like to actually physically weigh the pros and cons and things like that? No, because it feels too clinical 
and you know, I’m not deciding whether to keep a boyfriend or dump a boyfriend, I’m trying to decide 
w hat I ’m going to do if my baby has got a problem.” (F, age 35, undertook amniocentesis)
Three out o f ten women reported difficulties understanding how to use the tools. One woman 
out of three did not read the instructions before using the tools. They all considered that the 
layout and design of the tools were too complex and experienced significant difficulties 
nav igating the tools. They also felt that the tools required a high level of concentration that 
was not necessarily possible at this stage of the pregnancy.
"Especially for people who are not working with computers, they’re going to find that hard. The thing 
is, sometimes when you’re pregnant, you are all over the place, do you see what I mean? My 
concentration is not as good.” (F, age 37, undertook amniocentesis)
Two out o f ten women experienced difficulties dragging and dropping boxes in the column 
(i.e., your most important reason) or on the weighing scales (i.e., weighing it up).
“1 am not sure about that [pointing to the click, drag and drop box] I find that quite complicated and 1 
work on computers but I think until you’re familiar with it...I  find that part quite difficult.” (F, age 37, 
undertook amniocentesis)
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Finally, pregnant women experienced the most difficulty using your most important 
reason. Two out ten women reported difficulties selecting and ranking reasons in order of 
importance. They tended to select all reasons, including those that were not relevant to their 
decision. Both participants suggested to add a box labelled “does not apply” where all 
irrelevant reasons could be placed. The deliberation tools were modified according to 
women’s comments. The action to drag and drop boxes was replaced by a column where 
users ticked the reasons that applied to them. The overall design and layout of the tools was 
simplified to increase usability on the basis of these comments and version 4 of the 
deliberation tools (final version) was created (see Figures 8.3 and 8.4).
8.4 Discussion
The findings showed that heuristic-based algorithms could successfully guide the 
design of interactive deliberation tools but also indicated difficulties and challenges posed by 
the translation of theoretical constructs into usable interactive methods. The evaluation of the 
deliberation tools differed across the stakeholder groups. Most researchers and pregnant 
women positively evaluated the tools while the majority of health professionals expressed 
concerns about their clarity and usability. While your most important reason (Take the Best) 
was based on a simpler and presumably more intuitive decision algorithm, the majority of 
women explicitly preferred weighing it up to your most important reason.
The research findings suggested that the success of this translation largely depended 
on effectively dealing with the challenges this process generated. Translating abstract mental 
steps into an acceptable interactive interface proved difficult for the web designers and 
researchers. Each mental step required extensive discussions and iterative modifications. To 
comply with the principles of bounded rationality, the tools had to remain simple and fast 
while mirroring each algorithm’s cognitive steps. However, creating a graphic
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Figure 8.3 Screenshot o f  Weighing it up Version 4 (Tallying)
asm u■
The scales show you have more 
reasons in favour of not having 
an amniocentesis.
Have you made a decision about 
amniocentesis?
Click here for D<
Among the reasons listed below, choose the ones that are 
important for you. Tick whether the reason is for or against 
amniocentesis. You donY have to tick every box.
To find out if the baby has a 
chromosome problem G 0 □ a
To have options if a problem e  found G □ □ a
1 couldn't cope with a disabled child G □ □ a
Previous chromosomal abnormality G □ □ a
Views of my partner and loved ones G □ □ a
Risk of m ascem ege compared to risk 
of chromosomal abnormality G □ □ a
Risk of imscarnage G □ 0 a
1 am against termmabon O □ □ a
My rebgious beliefs G □ 0 a
Fear of amruocentests O □ 0 a
i
Amniocentesis?
Unsure
I
Am niocentesis?
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Figure 8.4 Screenshot o f  Your Most Important Reason Version 4 (Take the Best)
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representation of the second step of the Take the Best algorithm (where each attribute is 
reviewed in order o f importance until an attribute is found to discriminate between options) 
was complex because it was abstract and ambiguous. While creating a graphic representation 
of the Tallying algorithm was straightforward (i.e., a weighing scale), there was no obvious 
and unequivocal graphic representation of the Take the Best algorithm. The choice was made 
to create a column where important reasons were dragged and dropped (version 1), without 
knowing whether the chosen representation would be optimal in terms of clarity and 
usability.
During the field test, health professionals and pregnant women raised translation 
issues. While only a minority of pregnant women reported concerns about the complexity of 
one of the deliberation tools (your most important reason), complexity was a major concern 
for health professionals. The difference here was likely due to the fact that the tools appraised 
by pregnant women (version 3) had been revised using health professionals’ suggestions for 
improvement and consequently achieved higher usability. Divergent perceptions may also be 
attributed to the differing opinions, interests and information needs of pregnant women and 
health professionals. It was seen in Chapter 6 that health professionals had strong and often 
diverging opinions about the nature and quantity o f information needed on the range of 
chromosomal abnormalities tested, elective termination of pregnancy and risk of miscarriage 
to quote. Given that the deliberation tools provided comprehensive information about 
potentially controversial topics (e.g., elective pregnancy termination) professionals may have 
feared that this resource would be inconsistent and interfere with information received during 
the medical consultation. This finding highlights, as documented in Chapter 6, the 
professionals’ control over information and tendency to adopt paternalistic attitudes. 
Furthermore, processes or informational contents that are not specifically insightful or
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relevant to health professionals may have been perceived as very relevant to decision making 
among pregnant women (e.g., clear list of reasons). The structure and guidance provided by 
the deliberation tools may have offered a form of decision support that health professionals 
did not necessarily identify or consider helpful (e.g., visualising the decision making process 
and outcome on the weighing scale), possibly because of their expertise and greater 
understanding of the consequences and implications. The gap between pregnant women’s and 
health professionals’ perceptions and interests has been documented in the literature and is 
consistent with the present finding (Hunt et al. 2005; St-Jacques et al. 2008).
While stakeholders and health professionals did not express clear preferences towards 
one tool or the other, most pregnant women reported preferences for weighing it up over your 
most important reason. The majority of pregnant women felt that weighing it up offered a 
more immediate and intuitive way of weighing the pros and cons of amniocentesis and 
visualising the decision. The movement of the weighing scales was deemed helpful in 
facilitating the trade off between options. In your most important reason, some women 
reported difficulties ranking the reasons in order o f importance and comprehending the 
instructions. Your most important reason took longer to complete and required more 
concentration than weighing it up. According to the Take the Best algorithm and underlying 
principles of unbounded rationality, the task of ranking attributes (here called reasons) in 
order o f importance and finding an attribute that discriminates between options, should be 
fast, simple and completed with limited cognitive effort. The translation of the Take the Best 
algorithm into your most important reason failed to comply with the above principles. 
Converting the Tallying algorithm into graphic based element resulted in a simple, intuitive 
and visually efficient object: the weighing scale. However, transferring the Take the Best 
heuristic into a simple, fast and intuitive tool proved more difficult. The present findings
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point to a paradox. While the Take the Best heuristic is a simpler decision algorithm and one 
that requires less cognitive effort than Tallying, its translation into your most important 
reason was more complex and less intuitive. This highlights the difficulty of translating 
abstract theoretical constructs into usable tools and points to the necessity to field-test 
complex interventions before assuming that those interventions are appropriate and usable by 
patients/users. Although seven out of ten pregnant women expressed preferences towards 
weighing it up, not all comments concerning your most important reason were negative. 
Therefore, a decision was made to keep your most important reason for further empirical 
testing. Conceptually, and based on its specified performance and predictive accuracy on 
simulated decision tasks (Gigerenzer and Goldstein 1996), the take the best heuristic, which 
guided the development of your most important reason, works. The difficulty seems to lie in 
the translation and operationalisation of the heuristic into an interactive tool. Further work is 
needed to investigate the issues associated with the translation of abstract metal steps into 
usable tools.
In the literature, the development of heuristic-based deliberation tools has not been 
documented. However, one study compared the effectiveness of a heuristic-based DESI 
(Take the Best) with one based on the analytic hierarchy process (method derived from a 
normative theory of decision making) for a decision to undertake colorectal cancer screening 
(Galesic et al. 2008). The analytic hierarchy process DESI described options and attributes 
and consisted of pair-wise comparisons of all options and attributes (Dolan and Frisina 2002). 
The Take the Best version of the DESI described options and attributes and asked users to 
select the most important attribute and identify the option that best satisfied the chosen 
attribute. Participants were asked to read one of the three DESIs and to indicate their current 
screening decision. The results indicated that the Take the Best DESI predicted the final
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decision better than the analytic hierarchy process. Since information about the transfer of the 
Take the Best heuristic into a practical intervention was missing, a comparison with your 
most important reason was not possible. However, the results suggested that heuristic-based 
approaches effectively predicted decision making in the context of health decisions.
The strengths of the study were the innovative approach used in developing 
deliberation tools and the diverse nature of the sample. As far as could be determined, 
heuristic-based algorithms have never been used to develop deliberation tools. The present 
study is pioneering as an attempt to transfer theoretical constructs into usable DESI’s 
components. Furthermore, the deliberation tools were field-tested with three different groups 
of users: researchers, health professionals and potential users (women considering 
amniocentesis testing). One therefore expects that major dysfunctions and understanding 
difficulties would have been addressed from all relevant view points.
A limitation was the comparison difficulties generated by the iterative approach of the 
field test. The groups of users evaluated incremental versions of the deliberation tools, which 
subsequently compromised direct comparisons between the groups. Another possible 
limitation may be the multiple methods used to collect data. However, given stakeholders and 
health professionals’ time constraints and overall recruitment difficulties, adopting methods 
that were convenient for each group seemed essential and non-negotiable.
8.5 Conclusion
The translation o f theoretical constructs into graphic-based deliberation tools was 
possible. However, field-testing revealed that the tool’s usability highly depended on the 
accuracy and feasibility of the translation. The practical transfer of the Tallying algorithm 
into an interactive interface led to the development of weighing it up, which reportedly
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facilitated decision making and complied with the principles of ecological validity. Weighing 
it up may be used in other healthcare contexts where a decision between two treatments or 
screening options has to be made. However, the translation of the Take the Best algorithm 
into your most important reason proved more problematic and pointed to the need to field-test 
complex interventions before evaluation and implementation in clinical settings. The 
translation difficulties inherent in this process may be the major obstacles in designing 
theory-based DESIs. If there is to be success in translating theory into practical interventions, 
there will need to be significant commitment among stakeholders and user-groups to 
eollaboratively develop usable interventions. There is scope for examining the translation 
issues associated with theory-based interactive decision tools. At this stage, it is not possible 
to ascertain whether one approach (i.e., Take the Best or Tallying) is superior to the other. 
Further research is needed to compare how different interactive translations of heuristic- 
based algorithms may influence or even facilitate decision making.
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Chapter 9
Field-Testing of AmnioDex
9.1 Introduction
Field-testing is increasingly recognised as a necessary assessment and validation of 
the quality and usability of DESIs. Field-testing is described as a “live” testing of a prototype 
DESI (Evans et al. 2007) which involves showing the newly developed intervention to 
potential users who comment on its content and usability in order to amend it accordingly. 
The necessity to field-test DESIs prior to evaluating and implementing them has been 
recognised by the IPDAS collaboration (Elwyn et al. 2006). Nevertheless, the value of field- 
testing is yet to be shown as only a minority of shared decision making interventions seem to 
undergo field-testing. As highlighted in Chapter 4, the majority of interventions included in 
the Cochrane systematic review of decision aids did not undergo field-testing prior to 
evaluation. Few studies to date have highlighted the necessity to field-test DESIs (Evans et al. 
2007; Kim et al. 2005) and applied guidelines on how to field-test complex interactive 
interventions are not yet available.
The IPDAS collaboration suggests that DESIs should be field-tested with 
patients/users who are currently facing the decision addressed by the intervention and with 
health professionals from relevant disciplines. However, the IPDAS collaboration does not 
provide guidelines about methods for field-testing DESIs, about the number of users needed 
nor offers a clear definition of field-testing. Evans et al. developed a model of field-testing 
which distinguishes between (1) exploratory field-testing and (2) prototype field-testing 
(Evans et al. 2007). Exploratory field-testing consists o f asking users to look at and comment 
on early prototypes of specific intervention’s components, before the first prototype DESI has
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been developed. During prototype field-testing (stage 2), users are shown successive 
prototypes of the intervention. This model is the most detailed account of field-testing to date 
but does not provide clear guidance as to which methods to use to obtain optimal results.
In the broader context of human-computer interactions and interactive health 
technologies, usability tests are frequently conducted, using various methods and explicit 
guidelines (Gray and Salzman 1998). Both field tests and usability tests are intended to 
increase usability and acceptance of the newly developed intervention. However, field tests 
also examine the relevance and quality of the content and are not limited to web-based 
interventions. Contrary to field tests, usability tests involve specific and well defined expert- 
based or user-based methods. Heuristic evaluations and cognitive walk-through are the most 
widely adopted expert-based methods while the think-aloud technique is considered the most 
popular user-based method (Gray and Salzman 1998; Maguire 2001; Nielsen 1993). Heuristic 
evaluations consist o f assessing an intervention twice against a list of usability principles or 
heuristics. In other words, experts or users are asked to assess and comment on the usability 
of the interface using simple rules or heuristics such as: (1) Does the interface/website use 
simple and natural dialogue? (2) Does it speak the user’s language? (3) Is the language 
consistent throughout the interface? (Jaspers 2009). The cognitive walkthrough is an expert 
evaluation of the cognitive processes required by potential users to navigate the intervention. 
The expert is required to use the intervention without any guidance and behave as a novice 
user. Finally, the think-aloud method is a user-based method that requires users to navigate 
the intervention while systematically verbalising their thoughts (Cotton and Gresty 2006; 
Ericsson and Simon 1984). A study comparing the most common expert and user-based 
methods suggested that an expert-based heuristic evaluation was the simplest and most cost-
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effective method and should be combined with a user-based think-aloud method for optimal 
usability testing (Jaspers 2009).
The objectives of this chapter were to: (1) field-test the entire amnioDex website with 
lay users, healthcare providers and women who had been offered an amniocentesis, (2) assess 
their reactions to the DESI’s content, design and usability, and (3) make progress towards 
elaborating concrete guidelines for field-testing complex interventions.
9.2 Methods
The field test was divided into three independent phases to address issues from a 
technical, professional and user point of view: (1) field-testing with lay users, (2) field-testing 
with health professionals and (3) field-testing with pregnant women who had been offered 
amniocentesis testing. A qualitative approach was adopted. Participants were invited to use 
incremental prototypes of amnioDex and comment on the usability, textual content, potential 
dysfunctions and possible improvements. All findings related to the deliberation tools are 
reported in Chapter 8. An improved version of amnioDex was systematically developed 
before testing the intervention with the next group of users (see Figure 9.1). The study 
protocol and materials were reviewed and approved by the Research and Development 
committees o f the participating sites (Cardiff and Vale NHS Trust, Velindre NHS trust) and 
by the National Research Ethics Service.
9.2.1 AmnioDex Version 1 Field-Tested With Lay Users
In order to mirror the broad characteristics of women facing the amniocentesis 
decision, women aged 25 to 40 were recruited in the Department of Primary Care and Public 
Health (Cardiff University) on a voluntary basis. Lay users were invited to use amnioDex 
version 1 in the presence of a researcher (author of this thesis) and to verbalise their thoughts
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Figure 9.1 Method Used to Field-Test AmnioDex
Lay users 
(women 25-40)
Health
professionals
Pregnant
womenamnioDex 
version 1
amnioDex 
version 2 amnioDex 
version 3
P h a s e  1 P h a se  2 P h a se  3
while navigating the website (think-aloud technique). The think-aloud technique required 
participants to communicate their thoughts while they used the intervention, indicating 
satisfaction, dissatisfaction, difficulties encountered and misunderstandings (Cotton and 
Gresty 2006; Davison et al. 1997). The think-aloud technique was selected for its widely 
recognised efficacy in usability tests of interactive health technologies (Jaspers 2009). Lay 
users were specifically requested to focus on the navigation, design of the website, potential 
dysfunctions, and ways of optimising usability. They were asked not to focus on the textual 
content given this was of low relevance to them. Field notes were taken while lay users 
navigated the website. Lay users were recruited until no new dysfunction was identified or 
new suggestion for improvement made. The data was qualitatively analysed using a thematic 
content analysis assisted by the computer software ATLAS-ti. The website was amended 
according to the lay users’ comments to develop AmnioDex version 2.
9.2.2 AmnioDex Version 2 Field-Tested With Health Professionals
A sample of 28 healthcare providers and professionals from the Policy and Public 
Health sector identified through networking and steering group meetings in England and
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Wales was invited to review the amnioDex website. The planned sample consisted of five 
consultants in obstetrics and gynaecology, one sonographer, one clinical nurse specialist, ten 
midwives or screening midwives, two geneticists, six coordinators of the national antenatal 
screening programme in Wales, England and Scotland, one patient representative and two 
professionals from national charities offering information and support during the diagnostic 
phase of pregnancy. An email was sent to all 28 health professionals, asking them to review 
amnioDex version 2 online and to complete a short questionnaire. The 18-item questionnaire 
was divided into five sections: navigation, layout, video clips, deliberation tools and message 
board. Participants were asked to provide written feedbacks on each item (see questionnaire 
in Appendix 4). The qualitative analysis was as described in section 9.2.1 (p. 149). 
AmnioDex version 2 was modified according to health professionals’ comments and 
suggestions for improvement to develop amnioDex version 3.
9.2.3 AmnioDex Version 3 Field-Tested With Pregnant Women
Pregnant women were identified and approached by midwives or screening midwives 
in one antenatal clinic (University Hospital Wales, Cardiff). All pregnant women (any age) 
who had been offered an amniocentesis after screening tests for Down’s syndrome, advanced 
maternal age or mid-pregnancy ultrasound scan, were informed of the study by midwives. 
Pregnant women were excluded from the study if they could not read English. Women who 
indicated their interest to take part in the study were contacted by research staff to complete a 
consent process and were given an interview date. The interview was conducted in two 
phases. First, women were invited to use amnioDex version 3 while verbalising their thoughts 
using the think-aloud technique. Arrangements were made for them to view the website at 
home in the presence of a researcher, or during a telephone interview. After using amnioDex, 
participants took part in a semi-structured interview (face to face or telephone) investigating 
their reactions to the intervention (satisfaction/dissatisfaction), navigation or understanding
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difficulties and suggestions for improvement. The interview schedule consisted of eight open- 
ended questions investigating women’s reactions to the website, its navigation, design and 
usability. Special attention was given to women’s understanding of information provided and 
suggestions for improving design, navigation and content. All interviews were conducted, 
recorded digitally and transcribed by the author of this thesis (see interview schedule in 
Appendix 4).
9.3 Results
The presentation of results is organised in three sections: 1) amnioDex version 1 field- 
tested with lay users, 2) amnioDex version 2 field-tested with stakeholders and 3) amnioDex 
version 3 field-tested with pregnant women.
9.3.1 AmnioDex Version 1 Field-Tested With Lay Users
Eight women aged 25 to 40 (30.2 years old on average; range 25-38; standard 
deviation 5.1) agreed to navigate amnioDex version 1 using the think-aloud technique (see 
Figure 9.2). They spent between 10 and 45 minutes navigating amnioDex version 1 (28 
minutes on average). Comments were categorised into four themes: design and layout, 
interactive graphic elements, presentation of information and technical difficulties (see Table 
9.1). Six out of eight lay users identified major dysfunctions and suggested improvements. 
Two lay users considered that amnioDex version 1 was a good and user-friendly website and 
did not identify any dysfunctions or elements that needed improving.
Four out o f eight lay users identified basic design and layout elements that needed 
improving: removing gaps and blank spaces (n=4), improving the navigation structure by 
making the bottom and top tabulations more salient (n=2), centring images and aligning the
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Figure 9.2 Screenshot o f  the AmnioDex Homepage Version 1
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Table 9.1 Themes Identified in the Field-Testing With Lay Users
Themes Sub-themes
Design and layout - Im proving basic page lay out
- O ptim ising the navigation
Interactive graphic elem ents - Im proving video clips
- Im proving diagram s
- Im ages
Presentation o f  inform ation - Correcting typographical errors
Technical difficulties - External/internal links
- Interactive elem ents
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video clips with the textual content (n=2). Lay users identified elements of the design that 
could be improved to facilitate navigation and to increase usability: making the links to other 
web pages more salient (n=l), adding back to top buttons on each web page (n=l) and 
decreasing the indent to reduce the length of each page (n=l).
Several lay users identified graphic elements that needed changing. Two lay users 
suggested adding a control bar on the video clips so users have more flexibility watching the 
clips. One participant made the suggestion to display the content of each video clip in text 
version to increase accessibility. Two lay users suggested adding a legend to the diagrams 
with dots. Four out o f eight users felt that the presentation of information could be improved. 
Typographical errors were identified and it was suggested to replace the term content list by 
sitemap. One lay user felt that the font used on the website was difficult to read.
Four out o f eight lay users reported technical difficulties using the website and 
embedded interactive elements: inactive or inaccurate links, internal or external pages linked 
inconsistently across the site, elements partially or incorrectly displayed (e.g., diagram with 
dots, images) and difficulties registering on the message board. Suggestions were made to 
link internal and external pages in a consistent manner by systematically opening the new 
linked page in a separate window and to simplify the registration process by collecting 
minimum information only (i.e., username, email address and password).
9.3.2 Outline of Changes Made
Drawing on lay users’ comments, the design and layout of amnioDex was improved 
by removing all gaps and blank spaces, redesigning the top and bottom tabulations to increase 
salience (e.g., bolder colours, font size etc), aligning all photos with the textual content to 
reduce the length of the page and accentuating internal and external links. A control bar was
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added on each video clip (e.g., demos, women’s stories etc) and all internal and external 
pages (including video clips) were linked in a consistent manner to increase usability (i.e., 
page or video clip systematically opened in a new window). Legends were added to all 
diagrams and the term content list was replaced by site map. The presentation of information 
was improved by proofreading the website and page indents were reduced to decrease the 
size of the pages. Back to top buttons were added where necessary. All technical difficulties 
identified by lay users were addressed. Building on all amendments described above, 
amnioDex version 2 was developed.
9.3.3 AmnioDex Version 2 Field-Tested With Health Professionals
Twenty eight health professionals were invited to take part and nine professionals 
agreed to review the website. The sample consisted of two midwives, a consultant in 
obstetrics and gynaecology, five professionals from the national screening programmes in 
England, Scotland and Wales, and the director of a national charity (Antenatal Results and 
Choices). Health professionals reviewed the website online and returned the 18-item 
questionnaire. Four themes were identified: design and layout, interactive elements, textual 
content, visual elements (see Table 9.2).
Most health professionals positively appraised the overall design and layout of the 
website while a minority identified elements that needed improving. Six out of nine health 
professionals felt the design of the web pages (including the homepage) was efficient and 
inviting. Six health professionals found the website easy to navigate and self-explanatory. 
They felt that the colour schemes were aesthetically pleasing and not offensive nor 
distracting.
“[The website is] colourful enough to be attractive but avoids being distracting.” (F, programme
manager, NHS national services Scotland)
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Table 9.2 Themes Identified in the Field-Testing With Health Professionals
Themes Sub>themes
Design and layout - Overall design and layout
- Aesthetic
- Navigation
Interactive elements - Message board
- Screening test result calculator
Textual content - Typographical errors
- Clarity
Visual elements - Video clips
- Technical difficulties
- Images
Three out of nine health professionals considered that the top tabulation was not sufficiently 
salient, and should be made more prominent. One health professional reported difficulties 
finding a list of references and another felt that usability would be improved by adding a 
short description on the homepage of how to navigate the site (e.g., looking for information in 
the top tabulation, using the deliberation tools etc).
“1 think it might be worth having some text on the first page explaining how you can use the resource. I 
think that as it stands, it’s great if you can hear the demonstration but you may not always be able to 
hear the sound.” (F, programme associate, Foetal Anomaly Screening Programme, England)
With regards to the interactive elements featured in amnioDex (see Chapter 8 for 
findings related to the deliberation tools), most health professionals felt that the message 
board embedded in the website was an excellent resource. They believed that the message 
board would be helpful to pregnant women facing a decision about amniocentesis as well as 
health professionals counselling them. Some professionals insisted on the necessity to 
moderate the message board and ensure that information posted on the forums was clinically 
correct and ethically/morally appropriate and reported concerns about the anonymity of users 
leaving messages on the forums.
“This is an excellent concept - is there any guarantee o f  anonymity in this section?” (F, regional 
coordinator, Antenatal Screening Wales)
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Two out o f nine health professionals felt that the functionality available in Understanding 
Your Result, where the screening result is framed in multiple ways, was extremely helpful 
and should be made more accessible to users.
Minor typographical errors were reported. One health professional felt that it was not 
immediately clear what an amniocentesis was and that textual content should be improved to 
increase clarity. One health professional felt that the website should provide some 
information about CVS (see Chapter 3). Two health professionals questioned the need for 
users to see the screening pathway (see Figure 9.3), as they felt this level of detail was not 
essential when making a decision about amniocentesis testing.
With regards to the visual elements featured on the website, most professionals 
believed that the video clips were an excellent resource, informative and realistic, with a wide 
range of experiences given (n=4).
“I loved the videos; 1 thought they were very heartfelt. I think users would really identify with the 
video clips. They appear to have tried to give a range o f  views to give the tool balance.” (F, programme 
associate, Foetal Anomaly Screening Programme, England)
Several professionals felt that the videos of health professionals could be improved and 
believed that the genetics video was overly technical and complex.
"The only video that I feel is a bit too technical potentially is the one where the geneticist talks about 
microdeletions and how a test might not find everything that is wrong with a baby.” (F, programme 
associate, Foetal Anomaly Screening Programme, England)
One health professional felt that some video clips of health professionals were too subjective 
and should provide factual information about amniocentesis testing rather than the 
professional’s opinion.
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Figure 9.3 Screenshot o f Screening Pathway in AmnioDex Version 2
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“These [video clips o f health professionals] could be improved. For example the one with the geneticist 
needs to be providing the info the women required not just giving her opinion on what women should 
be told.” (F, programme manager, NHS national services Scotland)
Four professionals found the video clip of the amniocentesis procedure useful and 
informative although two of them expressed concerns about the methods used to perform the 
amniocentesis. One health professional felt that a live video of an amniocentesis procedure 
might be too frightening for pregnant women to watch. Several health professionals reported 
technical difficulties watching the video clips (e.g., poor sound quality, slow download) and 
identified video clips where the title needed changing. Finally, most health professionals 
positively reacted to the images displayed on the website although three health professionals 
reported mixed feelings about the use of cartoon images.
“Personally I found the image with the balloons looked like a child and not immediately obvious it was 
meant to be a pregnant woman." (F, programme manager, NHS national services Scotland)
9.3.4 Outline of Changes Made
The majority of health professionals were positive about the design and layout of 
amnioDex version 2. Only minor amendments were made. The top tabulation was made more
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salient and a more consistent font size was used throughout the website. Drawing on health 
professionals’ comments about interactive elements, the registration process of the message 
board was made anonymous and the screening test calculator was made more accessible. 
Ways of moderating the message board were investigated. All typographical errors were 
corrected and a decision was made to keep the screening pathway diagram for the third phase 
of the field test. Given that only a minority of professionals reported mixed feelings about the 
cartoon images, a decision was made to keep the images unchanged for the field test with 
pregnant women. Regarding video clips, a decision was made to keep all videos of health 
professionals unchanged for the third phase of the field test. A “warning” message preceding 
the live amniocentesis video was added: “Warning, this video shows an amniocentesis taking 
place”. All amendments were incorporated into the intervention to develop amnioDex version 
3.
9J.5 AmnioDex Version 3 Field-Tested With Pregnant Women
In the participating antenatal clinics, 24 pregnant women who had recently been 
offered an amniocentesis were invited to take part and 15 women agreed to be interviewed. 
Fourteen participants took part in a phone interview and one participant attended a face to 
face interview. Pregnant women were interviewed between 4 and 20 days following the 
counselling session where amniocentesis testing was offered and discussed (10 days on 
average). The intention was to field-test the website with pregnant women who had not yet 
made a decision about amniocentesis testing. Although pregnant women were contacted on 
the actual day or the day following the higher chance screening test result (and subsequent 
offer of an amniocentesis), all pregnant women interviewed had already made a decision 
about amniocentesis testing at the time of the interview. It was not possible, for practical 
reasons and often because of heightened stress and anxiety, to schedule an interview date 
immediately after pregnant women had been offered an amniocentesis.
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Ten women chose to undergo amniocentesis and five women declined the test. 
Interviews lasted between 17 and 78 minutes (32 minutes on average). Time spent navigating 
the website varied widely. Women spent between 5 and 60 minutes navigating amnioDex. 
The mean age o f women in the sample was 34.9 years (range 27-41 years, standard deviation 
3.7). Eleven women were British, one woman was Filipino, one woman was Chinese, one 
was Indian and one woman was Algerian. The mean gestational age at the time of interview 
was 17.3 weeks. The demographic characteristics of the participants are summarised in Table 
9.3. Four themes were identified during the interview (think-aloud technique and semi- 
structured interview): positive features, negative features, benefits of amnioDex compared to 
routine counselling and suggestions for improvements (see Table 9.4).
Positive Features of the AmnioDex Intervention
Thirteen out o f 15 pregnant women who used amnioDex perceived the website as a 
good and useful resource. Several women believed that amnioDex was an excellent tool, 
which they would recommend to women in a similar situation.
“I think it’s very good. 1 think it’s helpful. It’s quite, sort of, user friendly, and it seems quite 
straightforward and just puts things down fairly simply. Hum, it seems to, kind o f address the key 
things you are worrying about the main things.” (F, age 37, declined amniocentesis)
“It’s good, it’s very good, and if  1 knew, anyone who was in my situation, I would tell them to go and 
have a look at it.” (F, age 35, undertook amniocentesis)
“It’s the most comprehensive website I ’ve seen on amniocentesis, to be honest.” (F, age 35, undertook 
amniocentesis)
Women generally perceived the website as user-friendly. One participant valued the fact that 
amnioDex had been developed in the United Kingdom (as opposed to the United States) and 
was therefore better tailored to her needs.
“It’s nice, it’s inviting and it doesn’t look American, because when you look on the websites, you’re 
just trying to Find something that relates to you, and what you’re going through, and you know, you’re 
happy to chat with people who are from abroad and all the rest o f  it, but actually, what you want to 
know is what are the things that happen in Wales and in England and what your choices are?” (F, age 
35, undertook amniocentesis)
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Table 9.3 Characteristics o f Women Interviewed (Field-Testing)
Characteristics Sample size
Amniocentesis
- Accepted 10
- Declined 5
Marital status
- Married or engaged 8
- Living with partner 6
- Single 1
Nationality
- British 11
- Other (Filipino, Chinese, Indian 4
Algerian)
Number of children
-0 4
- 1 9
-2 2
Existing children with a chromosome disorder 0
Obstetric history
- Previous miscarriage 1
- Previous amniocentesis 0
Table 9.4 Themes Identified in the Field-Testing With Pregnant Women
Themes Sub-themes
Positive features - AmnioDex in general
- Information
- Layout and navigation
- Graphic-based elements (images, videos, 
message board etc)
Negative features - Information
- Layout and navigation
- Technical dysfunctions
Suggestions for improvements - AmnioDex in general
- Graphic-based elements
- Implementation
Benefits compared to routine counselling - AmnioDex in general
- Information
- Video clips
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With regards to the informational content, all participants found the information clear 
and easy to understand. Specifically, information was deemed simple, balanced and easily 
accessible. Most pregnant women found the information very comprehensive and detailed, 
and highlighted the quality and value of information addressing the risk of miscarriage and 
range of chromosomal abnormalities tested for.
“No, as I said, it seems to cover everything, all possible avenues on this. It’s simple to use as well, you 
don’t have to be a rocket scientist or anything to figure it all out, no I think it’s really good as it is.” (F, 
age 34, declined amniocentesis)
“I think it’s useful, yeah, no, it’s user friendly, it’s balanced, it’s not too clinical.” (F, age 34, undertook 
amniocentesis)
Eight out of 15 participants found the website aesthetically pleasing and attractive 
with a good layout and inviting colour schemes. Most participants (n=12/15) praised the 
navigation structure and organisation of information sections. They found the website easy to 
navigate and did not report difficulties finding specific information or simply browsing 
general information.
“I think that the website is very clean and very easy to navigate and you know, it’s a good resource 
really.” (F, age 35, undertook amniocentesis)
Concerning graphic-based elements, the majority of pregnant women positively 
reacted to video clips available on amnioDex, especially videos of women’s stories 
(n=12/15).
“I think maybe, by using this, especially by listening to women’s stories, you can see why people have 
it, why people don’t have it. I think it made me understand a little bit more.” (F, age 37, declined 
amniocentesis)
They felt that videos of women’s stories offered varied and balanced examples of women’s 
decisions with regards to amniocentesis testing. This feature was considered helpful in 
making a decision about amniocentesis.
“I watched them. It was good to see all the different kinds o f opinions, views o f why they wouldn’t do 
things and obviously some of the women had a Down’s syndrome baby and things like that, that was 
quite good. It did make you think.” (F, age 37, declined amniocentesis)
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“I like the videos on there as well, people who have already had it or who haven’t and have decided 
against it. So it gives you an all round opinion.” (F, age 34, declined amniocentesis)
Six women considered that the functionality specifically developed to help them understand 
their screening test result was helpful.
“There’s a section where they give you, your sort o f percentage, one in 170 and you can write it in. 
That was the best, that was the most useful. Understanding your results, that was it.” (F, age 37, 
declined amniocentesis)
A minority of women commented on the message board, live video of the amniocentesis 
procedure and diagrams. They perceived the live amniocentesis video as a good resource 
(n=3) and felt that the message board (n=4) was a good feature provided messages were 
posted on the forums. The multiple framing of outcome probabilities and diagrams with dots 
was considered helpful by several pregnant women.
Negative Features
With regards to the informational content, one out of 15 participants considered that 
amnioDex did not provide comprehensive information.
“It does give you information, if  you don’t know anything at all, it doesn’t give you comprehensive 
details, but then that’s not the aim is it? From there, you can go on to research more yourself. The 
questions [refers to talking to others] were unhelpful and annoying.” (F, age 34, undertook 
amniocentesis)
“[referring to the section about the karyotype test results] No it doesn’t really help, it doesn’t really say 
anything.” (F, age 34, undertook amniocentesis)
A minority of participants felt that the section describing the karyotype test results (n=2) 
could be clearer. One participant reported confusion regarding the different risks of 
miscarriage communicated in the antenatal clinic (i.e., national rate and rate of the hospital 
where the procedure is performed) and expected amnioDex to provide explicit information 
about which risk to trust. The need for further information about cystic fibrosis, about 
possible developments of non-invasive prenatal diagnostic tests and about the tests available
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after declining an amniocentesis were reported by isolated participants. Finally, one 
participant reported the need for specific information about the difficulties encountered when 
deciding about amniocentesis (e.g., balancing the risk of miscarriage, against the risk of 
foetal abnormality, making a decision with uncertain outcomes).
“It should be specific. You should give some examples, hum, why people have difficulties making a 
decision, because they have to think, ok, you may lose the baby, you have to make a choice, like, if  you 
have an abnormal baby, what’s your choice? My risk was 1 in 232. This is not high risk you know, 
because the normal cut off is 1 in 250, so my risk is not very high, and the national risk of miscarriage 
is 1%, so this is double, the risk is double, so I have to think, ok, should I take this risk, if  I take this 
risk, losing my baby is a higher risk than my baby having down’s syndrome and I have to balance this.” 
(F, age 27, undertook amniocentesis)
A minority of participants reported technical difficulties using amnioDex and 
watching the video clips or other functionalities involving Flash Player. Three participants 
reported difficulties navigating the website (e.g., difficulty closing and opening video clip 
windows). Finally, a minority of participants experienced difficulties using the think-aloud 
technique while navigating the website and recurrently prompted the researcher for guidance 
of what to do next, for the researcher’s help or opinion.
“Hum, I ’m finished with this now. So where shall I go?” (F, age 41, declined amniocentesis)
Suggestions for Improvement
On the homepage, participants suggested to specify the meaning of the acronym 
amnioDex (amniocentesis decision explorer), to add relevant branding (i.e., logo of Cardiff 
University), and a short paragraph describing the decision at stake, the aims of the website 
and the principal functionalities.
“I mean, you wouldn’t have to put aims and objectives but to say, this website has been put together to 
try and help you make an informed decision, there’s no right or wrong answer but hopefully the 
information will help you map out your thoughts, whatever you want to phrase it, but it might be quite 
useful to sort o f have that on the homepage.” (F, age 34, undertook amniocentesis)
A suggestion was made to add a search box and to provide further information about the 
developers of amnioDex (e.g., occupations, relevant expertise).
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With regards to graphic-based elements, participants suggested to shorten the video of 
the amniocentesis procedure and to add an explanation indicating that all videos clips were 
quotes from women’s stories enacted by actresses. A suggestion was made to modify the 
order of the video clips so all “negative outcomes” (i.e., detection of abnormality, 
miscarriage) were not presented consecutively, as some participants feared this might be 
daunting to watch.
Finally, participants suggested ways of facilitating access to and implementation of 
amnioDex. Several participants felt that the web address should be given prior to the 
counselling session.
“The point I think you need to have the information is perhaps, either when you are given the results, 
over the phone, or at the point o f having the test initially actually, when having the blood test. Probably 
having the blood test is too soon, because obviously, at that point, hopefully you’re not having a high 
risk result, so maybe at the time when you get that initial call, it’s at that point I would be wanting this 
kind o f website.” (F, age 37, declined amniocentesis)
Benefits of AmnioDex Compared to Routine Counselling
Compared to routine counselling, six out of fifteen participants felt that amnioDex 
facilitated decision making or reinforced their decision. Several participants considered that 
amnioDex offered more comprehensive information than usual practice.
“If  you haven’t made a decision, I ’m sure you can go and spend absolutely ages looking though 
everything to give you the best possible help in your decision.” (F, age 34, declined amniocentesis)
Several pregnant women praised the fact that amnioDex provided information that they could 
assimilate at their own pace and consult at different stages of the decision making process.
“Because when you’re told about it, when you’re told about the amniocentesis, then more than just 
having a leaflet that you can go through, you’d like to research it on the net, you’d like to see what 
happens to other women and their opinions, you’d like to get as much information as you possibly 
can.” (F, age 35, undertook amniocentesis)
“It’s easier to look at something rather than have a conversation with someone over the phone or even 
sit in a surgery because sometimes you just forget to ask things or you don’t understand things 
properly, here you can go back and keep looking at it and it’s quite simple to understand.” (F, age 37, 
declined amniocentesis)
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“Because you’re so stressed, not that much of it went in I don’t think. If  I ’d had this, it would probably 
have been more helpful.” (F, age 29, undertook amniocentesis)
Eight out of fifteen participants felt that amnioDex would be beneficial in addition to routine 
counselling, as it provided balanced examples of women’s experiences (i.e., video clips).
“You know, it’s being able to make an informed decision, having a resource that you can use, that 
shows you what’s gonna happen, when it’s gonna happen and what other people have been through.” 
(F, age 35, undertook amniocentesis)
The majority of pregnant women (n=14/15) would have used amnioDex if the resource had 
been available to them.
9.3.6 Outline of Changes Made
AmnioDex version 3, field-tested with pregnant women, was amended to develop the 
final version of the intervention (see Figure 9.4). The top tabulation was redesigned and a 
dual navigation system was added to improve the navigation structure (i.e., sub-menus 
appeared on the left hand side of the page and on the top tabulation) (see Figure 9.5). A 
search box, relevant logos and the words; amniocentesis decision explorer, were added on the 
homepage. The video of the amniocentesis procedure was shortened. A disclaimer was added 
in the section Personal Stories: “The videos are enacted quotes from women’s stories”, and 
the order of the clips was modified following participants’ feedbacks. Technical difficulties 
associated with the video clips were addressed. Information contents perceived unclear or too 
brief were discussed with the steering group and some sections were amended.
9.4 Discussion
While all stakeholder groups positively received amnioDex, substantial amendments 
were needed to increase usability and acceptability. Lay users made most criticisms. 
Suggestions for improvements and criticisms generally applied to the navigation structure 
and graphic-based elements. Health professionals and pregnant women positively reacted to
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Figure 9.4 Screenshot o f the AmnioDex Homepage Version 4
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the design, graphic-based elements (e.g., video clips, diagrams, images) and informational 
content (clarity and accuracy).
Both pregnant women and health professionals perceived amnioDex as a useful 
resource in adjunct to existing counselling. Video clips of women stories were considered 
particularly helpful and informative by professionals and pregnant women. Interactive 
elements such as the message board were positively reviewed by most stakeholder groups 
and deemed helpful in making a decision by pregnant women. There is documented evidence 
that speaking to others in a similar situation (e.g., via a message board) or hearing 
experiences of women facing similar dilemma can be comforting to women facing prenatal 
testing (Moyer et al. 1999; St-Jacques et al. 2008). Watching testimonials or reading 
messages of others in a similar situation may help pregnant women imagine the consequences 
and implications of all possible outcomes of amniocentesis testing. The tendency to think 
through all possible scenarios has been previously described as “imagining coping”, and may 
be facilitated by the presence of deliberation tools or balanced narratives (Potter et al. 2008).
A new navigation structure, search box, improved layout, and technical improvements 
were the main changes made to amnioDex. Most criticisms were made with regards to 
graphic-based elements and navigation structure, across all stakeholder groups. The latter 
finding is consistent with previous account of field-testing (Evans et al. 2007), where the 
navigation was considered most problematic. This highlights the need to thoroughly 
investigate usability issues associated with web-based interventions and to draw on existing 
methods used in usability studies such as the think-aloud technique (Dumas and Redish 
1999). Field-testing web-based interventions with lay users prior to potential users (i.e., 
pregnant women and professionals) appeared essential in identifying basic technical and
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usability issues. Pregnant women and health professionals were therefore able to focus on the 
informational content and interactive elements of the website without being distracted by 
basic usability issues (previously picked-up by lay users). Health professionals expressed 
divergent opinions regarding the video of the amniocentesis procedure, the videos of health 
professionals and raised concerns regarding the lack of control over the content of the 
message board. As highlighted in previous chapters, health professionals generally held 
strong opinions and fairly controlling or paternalistic attitudes about the nature and quantity 
of information needed prior to deciding about amniocentesis testing. A message board or 
video of the procedure may have threatened, to some extent, the physicians’ sense of control 
over information. Health professionals’ influence or authority surrounding prenatal testing 
has been extensively documented (Marteau 1993; Marteau et al. 1992). A study of women’s 
reasons for undertaking prenatal testing showed that the decision to undertake maternal serum 
screening tests seemed imposed upon women and influenced by the physician’s authority 
(Chiang et al. 2006). Further research revealed that healthcare providers tended to shape the 
meaning and purpose of prenatal testing (Press and Browner 1997). DESIs such as amnioDex 
may be effective in balancing the physicians’ influence and authority.
Compared to routine counselling, amnioDex offered practical accounts of women 
facing a similar dilemma and comprehensive information about the risk of miscarriage and 
the chromosomal abnormalities tested for. Pregnant women believed that amnioDex was the 
most comprehensive web-based resource available on amniocentesis testing and a useful 
supplement to usual practice. Nevertheless, pregnant women raised issues associated with the 
implementation of amnioDex. Several women believed that amnioDex should be accessible 
at an early stage of the decision making process (i.e., when undergoing screening tests or 
receiving the results) to ensure that women can access the resource before making a decision.
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Accessibility and lack of awareness of existing interventions have been described as 
significant barriers to the implementation of DESIs and recommendations have been made to 
increase accessibility (Graham et al. 2003; O'Donnell et al. 2006).
The present study offers some insight into practical ways of field-testing web-based 
DESIs. The think-aloud technique, widely used in cognitive psychology research and 
usability tests of computer-based interfaces, provided understanding into the navigation and 
understanding difficulties encountered while using amnioDex (Gray and Salzman 1998). This 
method highlighted usability issues which would not have been uncovered by observation or 
semi-structured interview alone. The majority of participants positively reacted to this 
approach. However, several pregnant women experienced difficulties continuously 
articulating their thoughts and prompted the researcher for guidance and instructions. The 
think-aloud technique has been described as highly adaptable (Davison et al. 1997). This 
method may therefore be adjusted to fit the requirements of DESI field-testing in order to 
overcome the methodological issues raised in the present study. Based on the amnioDex 
findings and previous research on the evaluation of e-leaming, the level of guidance given to 
participants when using the think-aloud technique needs to be increased (Cotton and Gresty 
2006). While Ericsson and Simon’s methodology for the think-aloud approach provided 
minimum instructions, a more flexible use of instructions may be necessary to resolve 
methodological issues described above (Ericsson and Simon 1984). For instance, prompts 
may be used to collect specific data: “What do you think of this section?”, “Why have you 
decided to go in this section?” Similar prompts were piloted by Cotton and Gresty (2006) and 
were considered useful in generating data. Finally, a short interview used in conjunction with 
the think-aloud technique may be essential in ensuring that all key issues are covered, as has
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been documented previously (Cotton and Gresty 2006; Johnson et al. 2005; Peleg et al. 
2009).
Strengths of this study were the methodological approach used to field-test amnioDex 
and heterogeneity of the sample. The think-aloud method seemed to provide more insight into 
the intervention’s usability than classic observational techniques. In spite of minor 
methodological limitations, this method appeared versatile enough to be adapted to DESI 
field-testing.
This study may be criticised for the limited number of pregnant women recruited to 
field-test the intervention. Considerable recruitment difficulties were encountered throughout 
the field test. Many women approached by midwives in the antenatal clinic declined to take 
part in the study. As highlighted in Chapter 8, a further limitation may be the iterative 
approach of the field test. The stakeholder groups evaluated incremental versions of the 
deliberation tools, which subsequently compromised direct comparisons between the groups.
9.5 Conclusion
Pregnant women and health professionals positively appraised the amnioDex 
intervention. The website was deemed useful, clear and comprehensive. Usability was 
considerably increased by criticisms and suggestions made by lay users. Field-testing is a 
fundamental assessment of the DESI’s acceptability and usability prior to evaluation and 
dissemination, and becomes especially relevant when developing web-based interventions. 
Finally, this study provided some insight into possible methods for field-testing web-based 
interventions. Field-testing with lay users, professionals as well as potential users may be 
required as each stakeholder group identified different dysfunctions or potential 
improvements. Previous research into usability testing of interactive healthcare interfaces
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suggests that the think-aloud method may be adapted and combined with qualitative methods 
to yield optimum results.
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Chapter 10
General Discussion
The studies described in this thesis aimed to assess information and decision support 
needs of women facing amniocentesis testing in order to develop and field-test, in 
collaboration with them and their healthcare professionals, an interactive theory-based DESI. 
This chapter presents an overview of the principal findings, discusses strengths and 
weaknesses of the methodological approach, and considers clinical implications and future 
research.
10.1 Translating Theory Into Practical Interventions
There is an apparent lack of conceptual and theoretical underpinnings to the 
development of DESIs. The majority of DESIs included for review did not build on models 
or theories of decision making (Chapter 2). The findings highlighted the difficulty to transfer 
abstract theoretical constructs into the practical development and evaluation of DESIs. There 
may be several interpretations to the lack of theoretical underpinnings underlying DESI 
development; difficulty translating abstract theoretical constructs into practical interventions, 
lack of empirical evidence of the efficiency of theory-based interventions or time constraints 
and cost-effectiveness imperatives. It is worth noting that the IPDAS instrument does not 
assess whether the DESI development was informed by theory (Elwyn et al. 2009c). The 
theoretical and research work presented in this thesis advances the field by describing a 
developmental pathway that can be followed to design a DESI that is acceptable to patients 
and health care professionals.
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Chapter 7 and 8 described the transfer of descriptive decision making theories and 
heuristic-based algorithms into the design of amnioDex and interactive deliberation tools. 
The findings indicated that carefully selected theoretical frameworks can successfully guide 
the development of interactive interventions but also underlined conceptual and technical 
challenges generated by this innovative and abstract translation. Prospect theory influenced 
the framing of information (e.g., risk of miscarriage, chance of chromosomal abnormality) 
and motivated the development of the screening test result calculator. To comply with the 
principles of differentiation and consolidation theory (DiffCon theory), information was 
presented in a way that facilitated differentiation (i.e., head to head comparison, balanced 
examples of women’s stories presented in adjacent columns). The development of those 
theory-based elements was guided by existing attempts at integrating Prospect and DiffCon 
theories into decision aid design (Feldman-Stewart et al. 2001; O'Connor et al. 1999c). The 
transfer of theory into practice was also facilitated by the fact that only selected elements of 
the intervention were guided by the aforementioned theories. All elements developed 
according to prospect and DiffCon theories were positively reviewed by the majority of users 
involved in the field test (Chapter 9). However, the subjective and equivocal nature of the 
transfer of theory into DESI development means the value of translational work needs to be 
monitored. First, there is a need for in-depth evaluation of the effect of theory-based 
components on selected decision outcomes. Second, the impact of theory-based components 
or interventions on decision outcomes needs to be evaluated against atheoretical interventions 
or routine care as empirical evidence in this area is currently missing. Third, there is scope for 
developing theory-derived outcome measurements to examine whether theory-based 
components achieve their stated aims (Elwyn et al. 2009d). The lack of well validated and 
widely accepted measures of DESI effectiveness is a considerable obstacle to DESI 
evaluation and implementation. Although multiple measures of DESI effectiveness exist
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(Simon et al. 2007), there is no consensus on the most relevant constructs or criteria on which 
their effectiveness should be assessed (Kennedy 2003; Ratliff et al. 1999; Dy 2007). Theories 
or models of decision making could provide useful indications of relevant constructs to 
measure when assessing the quality of decisions and DESIs’ effectiveness.
While the transfer of prospect and DiffCon theories into DESI elements was 
straightforward and fairly systematic, translation difficulties arose when attempting to 
develop heuristic-based deliberation tools. Fast and frugal heuristics are simple rules of 
reasoning that have demonstrated the same or superior predictive accuracy compared to 
complex mathematical models in similar decision tasks (Green and Mehr 1997; Todd and 
Gigerenzer 2000). Heuristic-based algorithms are fast and non-compensatory rules of 
reasoning broken down into simple cognitive steps. One would therefore expect the transfer 
of heuristics into deliberation components to be intuitive and unequivocal. This research 
showed that transferring heuristics into graphic-based elements was a difficult and iterative 
process where the usability of deliberation components was dependent on the accuracy of the 
translation (Chapter 8). Although heuristic cognitive steps provided some degree of guidance 
for designing the deliberation tools, there was ambiguity regarding how best to graphically 
represent each step. There is evidence that the Take the Best algorithm, when tested on real- 
world questions under conditions of limited knowledge and time, performs as well as the 
Tallying algorithm (Gigerenzer and Goldstein 1996). One would therefore expect the 
deliberation tools derived from the Take the Best and Tallying heuristic-based algorithms to 
be equally usable and efficient. Paradoxically, the simplest algorithm (i.e., Take the Best), 
when transferred into a graphic interface, was least usable. The difficulty therefore seemed to 
arise from the translation and operationalisation of these algorithms, and of the Take the Best 
algorithm in particular. There is scope for investigating alternative ways to operationalise the
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Take the Best heuristic-based algorithm, and create an interface which is more intuitive and 
usable. One way of addressing this issue would be to use brainstorming techniques with web 
design experts as well as lay people (possibly pregnant women considering amniocentesis 
testing) to envisage novel ways of translating the algorithm’s abstract mental steps into 
graphic-based elements.
In spite of translation difficulties, field-testing with pregnant women facing 
amniocentesis showed that when translation was accurate (e.g., weighing it up), theory-driven 
deliberation components were favourably appraised by stakeholders (Chapter 8). The 
structure provided by the tools (e.g., a clear list of reasons, an efficient visual analogy; the 
weighing scale) was deemed helpful in achieving a decision. Although deliberation 
components may be helpful in eliciting values and making a decision, the deliberative 
processes of decision making remain poorly understood. Further research is needed to clarify 
deliberation processes and identify ways of facilitating it.
Finally, the findings highlighted a significant theory-practice gap. Most theories or 
models of decision making have focused on explaining or describing how humans cognitively 
approach and achieve a decision rather than on how tools could be designed to help them 
make decisions. Crossing the bridge from decision theories to the design of usable and 
effective interventions presents important translation difficulties and challenges that have not 
yet been resolved. Based on the experience of developing amnioDex, it appears that no single 
theory or model alone can guide the design of all DESI components (i.e., information 
component, deliberation component and outcome measurements). Some theories provide a 
relevant framework for designing information components (e.g., prospect theory) while 
others can be used to inform the development of deliberation tools (e.g., heuristic-based
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algorithms) or outcome measurements. If the translation of theory into practice is to become 
widespread and systematic, there is a need for developing a taxonomy of theoretical 
constructs transferable into practice and elaborating possible methods for achieving this 
ambitious translation (Elwyn et al. 2009d). Such taxonomy exists for behavioural 
interventions (Abraham and Michie 2008). However, there is currently no taxonomy of 
decision making theories used in DESI development and the translation of decision making 
theories or models into usable interventions has rarely been documented (Feldman-Stewart et 
al. 2001). Finally, usability issues highlighted in the field test of heuristic-based deliberation 
components entail sustained collaboration between patients and principal stakeholders to 
develop interventions that are acceptable and usable while providing structured guidance to 
clarify values and achieve decision making.
10.2 Information and Decision Support Needs of Women Facing Amniocentesis
It is widely recognised that deciding whether or not to undergo amniocentesis should be 
the result of an informed choice (General Medical Council 1999; Marteau 1995), namely, 
“one that is based on relevant knowledge, consistent with the decision maker’s values and 
behaviourally implemented” (Dormandy et al. 2002, p.l). Achieving informed choice 
promotes patients’ autonomy and patient centred care, and reduces medico legal costs. It has 
therefore become a cornerstone of the British National Health System. There are documented 
concerns that existing information and decision support available in the UK does not enable 
pregnant women to make informed decisions about amniocentesis testing (Chapter 3), and 
that the information provided does not address their own interests (Hunt et al. 2005; Rostant 
et al. 2003; Cederholm et al. 1999; Jaques et al. 2004; Marteau 1995). In situations of 
equipoise such as amniocentesis testing, DESIs have been shown to increase knowledge, 
improve the perception of risks and involvement in decision making (O’Connor et al. 2006). 
Six DESIs for amniocentesis of variable quality and limited effectiveness were identified
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(Chapter 4), none of which are currently available in the UK. Most interventions were 
developed without systematic input from principal stakeholders (pregnant women and health 
professionals) and rarely field-tested or piloted with pregnant women and health 
professionals. The apparent tendency to empirically develop interventions without a 
systematic development process casts doubt on the clinical accuracy and reliability of those 
interventions. Those findings emphasised the need to involve patients and health 
professionals at all stages of the development process. The necessity to involve relevant 
stakeholders prior to developing (needs assessment) and evaluating interventions (field- 
testing) has been recognised by the IPDAS collaboration (Elwyn et al. 2006).
The needs assessment conducted with pregnant women and health professionals 
(Chapters 5 and 6) exposed unmet needs for information, emotion and decision support and 
highlighted the gap between the professionals’ assessment and women’s reported needs. 
Women repeatedly expressed the need for information about the range of abnormalities tested 
and potential consequences of amniocentesis testing (e.g., elective termination of pregnancy), 
while professionals focussed on describing the amniocentesis procedure, and explaining the 
risks of foetal abnormality and pregnancy loss. Healthcare providers expressed divergent 
opinions regarding the nature and quantity of information needed about chromosomal 
abnormalities potentially detected and elective termination of pregnancy. Several 
professionals believed that the sensitive issue of pregnancy termination and detailed 
information about abnormalities should only be raised and discussed when a problem was 
found, post-amniocentesis. Recorded observations of 25 routine antenatal consultations for 
amniocentesis testing suggested that obstetricians focussed on describing the risks of 
abnormality and miscarriage and provided little or no information about the conditions tested 
for and about the possibility of terminating the pregnancy (Marteau et al. 1993). Down’s
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syndrome was mentioned in most consultations but was never described. Other conditions 
were mentioned in only a third of the consultations. It has been argued that providing 
sufficient information about abnormalities potentially detected and implications of an 
amniocentesis could reduce confusion and distress experienced in the diagnostic phase of 
pregnancy (Marteau et al. 1993). The lack of time and lack of specialised knowledge reported 
by health professionals most probably influenced the presentation of information and 
tendency not to discuss those sensitive topics. Health professionals’ influence on the 
presentation of information can be balanced by a DESI for amniocentesis, such as amnioDex, 
which presents comprehensive information in a neutral manner, and provides balanced 
examples of women’s decisions about amniocentesis.
Further, health professionals tended to focus expertise and energy on the provision of 
information, at the expense of emotional and decisional support. By contrast, pregnant 
women reported high emotional strain and anxiety and emphasised the need for reinforced 
emotional support. Until relatively recently, emotion has been viewed as an impediment to 
effective decision making, at best a distraction and at worst a source of bias. This view is 
being challenged (Damasio 1994; Evans 2002; Mameli 2004). The role of emotions in 
decision making is increasingly advocated (Anderson 2003; Wilson and Gilbert 2005). The 
Attend, React, Explain, Adapt (AREA) model of affective forecasting developed by Wilson 
et al. assumes that decision making is strongly influenced by how individuals anticipate their 
emotional reactions to future events, namely affective forecasts. Research indicates that 
affective forecasts are generally flawed, and that individuals often overestimate the impact of 
negative events and the intensity of related emotional reactions (Gilbert et al. 2000; Gilbert et 
al. 2004; Wilson et al. 2005). Further research is needed to examine the extent to which 
affective forecast errors can be addressed in DESIs.
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The present study suggested that healthcare providers exerted an explicit and almost 
paternalistic control over specific information topics. Information related to the range of 
chromosomal abnormalities detected, the elective termination of pregnancy and the 
miscarriage rate appeared controversial and not systematically addressed by all professionals. 
The present findings are consistent with those of Bernhardt et al. (1998) and Marteau et al. 
(1993). It is worth noting that the professionals’ control over information was also reflected 
in the steering group meetings held with health professionals prior to developing amnioDex 
(Chapter 7). Professionals involved in the steering group and stakeholder analysis (Chapter 6) 
expressed views which frequently differed with women’s reported information and decision 
support needs. The question arose as to which view should be integrated into the intervention. 
Although editorial control remained with the researchers who developed amnioDex, deciding 
whether to present information requested by pregnant women (e.g., information about the 
elective termination of pregnancy, local miscarriage rate) or to follow health professionals’ 
opinions was difficult. On the basis that amnioDex was specifically designed for pregnant 
women deciding about amniocentesis, a decision was made to prioritise women’s information 
needs over the professionals’ views. However, prioritising women’s views or legitimate 
information at odds with local practice may have significant repercussions on the 
implementation and dissemination of amnioDex in the NHS (see section 10.5, p. 183 for 
further discussion).
Finally, several pregnant women reported feeling pressured into undertaking prenatal 
testing (i.e., screening tests and amniocentesis), some of whom experienced regret about their 
screening decision. Pressures to undertake prenatal testing are inconsistent with current 
policies and standards advocating informed choice prior to undertaking prenatal screening or 
diagnostic tests (General Medical Council 1999). Health professionals’ directiveness with
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regards to prenatal testing has been extensively documented (Al-Jader et al. 2000; Press and 
Browner 1997; Santalahti et al. 1998; Marteau et al. 1993; Sjogren and Uddenberg 1987). 
Clarke (1997) argued that despite significant ethical and societal objections, prenatal genetic 
screening tests have become routine and are often undertaken by pregnant women who do not 
realise the objectives and implications of these tests (Williams 1995; Press and Browner 
1997). It has been assumed that offering routine prenatal screening to a low risk population 
would be helpful to prospective parents. Routine prenatal screening may be in line with 
societal norms and ideals but is not necessarily beneficial at the individual level. It has also 
been argued that offering routine prenatal genetic screening may have reinforced negative 
attitudes towards disability in the general population (Shakespeare 1998). Most pregnant 
women undertaking screening tests for Down’s syndrome are not aware of the objectives of 
the screening programme (including cost effectiveness objectives) and do not normally 
reflect on the overall usefulness of the test. Almost half of pregnant women interviewed 
during the needs assessment of amnioDex would have liked more information about the 
screening tests available prior to amniocentesis testing (Chapter 5). Reflecting on the 
objectives of genetic screening and considering its usefulness at the individual level may 
limit regret when receiving a higher chance result and promote informed choice. AmnioDex 
was specifically developed for women who had been offered amniocentesis testing, and 
although screening tests are mentioned and described in the section Why Amniocentesis? it 
does not specifically address the decision to undertake prenatal genetic screening. Although 
screening and testing for Down’s syndrome are related issues, deciding whether to undertake 
screening tests for Down’s syndrome or whether to undertake amniocentesis are two separate 
decisions which cannot be addressed in the same intervention. Addressing the decision to 
undertake screening tests in amnioDex did not seem appropriate or achievable and was 
beyond the scope of this thesis. There is therefore room for developing a DESI for prenatal
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screening that describes the objectives and implications of screening and helps women 
consider the relevance of the test with regards to their values, attitudes and preferences. 
Increasing knowledge about prenatal screening is not sufficient; prospective parents should 
be aware of the objectives, limitations and underlying motives for offering prenatal genetic 
screening to pregnant women who have a low risk of foetal chromosomal abnormality 
(Clarke 1997).
10.3 Field-Testing Complex Interventions Prior to Evaluation
Findings of this research suggested (Chapter 2 and 4) that only a minority of existing 
DESIs underwent field-testing or piloting prior to evaluation and dissemination (Drake et al. 
1999; Evans et al. 2007; Nagle et al. 2008). There is a tendency to develop DESIs without 
ensuring that those interventions are usable and acceptable to users. The qualitative field- 
testing of amnioDex revealed that the intervention was deemed acceptable by principal 
stakeholders (i.e., pregnant women considering amniocentesis and health professionals), 
although the navigation, layout and graphic-based elements needed to be modified to address 
their comments (Chapter 9). This study is the first to carry out field-testing of a web-based 
DESI with three relevant user groups: lay users, health professionals and pregnant women 
facing a decision to undergo amniocentesis. Field-testing the intervention with lay users 
proved beneficial in identifying essential usability issues prior to field-testing amnioDex with 
principal stakeholder groups. Pregnant women and health professionals specifically praised 
the video clips of women’s stories offering balanced examples of women’s (and their 
partners’) decisions about amniocentesis testing. All interactive elements embedded in the 
website, such as the message board, the screening test calculator or the deliberation tools 
were deemed helpful by pregnant women. Schwitzer et al. conducted a review of health 
decision support tools (Schwitzer 2002) and identified four key functionalities distinguishing 
web-based DESIs from other media: videos of patient stories, online community network
(e.g., message board), user-specific outcomes data (e.g., screening test result calculator) and 
public access. It is worth noting that amnioDex has all these key functionalities (Chapter 7). 
By contrast, Schwitzer established that none of the web-based interventions included for 
review delivered all four key functionalities and suggested that patients would benefit from 
more comprehensive web-based interventions.
Little is known about specific methods for field-testing DESIs. This research provided 
some insight into practical guidelines for field-testing web-based DESIs (Chapter 9). The 
findings suggested that web-based interventions should be tested with principal stakeholders 
(i.e., professionals and patients) as well as lay users as they critically appraised the website 
from three different angles: usability, clinical relevance and users’ acceptability. The think- 
aloud technique may be used to investigate the process of cognition and emotions while users 
navigate the intervention. The field test of amnioDex and previous accounts of usability tests 
(Cotton and Gresty 2006) indicated that this method should be adjusted to better fit the 
requirements of DESI field-testing. More guidance should be given to participants prior to 
using the intervention and clear prompts may be used to collect specific data or attract users’ 
attention to specific sections of the website. Further, evidence suggests that combining 
qualitative methods with the think-aloud technique would yield optimal results (Cotton and 
Gresty 2006; Peleg et al. 2009). For instance, a semi-structured interview addressing general 
usability and acceptability issues may be used after participants navigate the website using 
the think-aloud technique. Finally, the necessity to field-test complex interventions has been 
recognised by the IPDAS collaboration, but is also consistent with the Medical Research 
Council (MRC) framework for the design and evaluation of complex interventions to 
improve health (Campbell et al. 2000). The new MRC guidance recommends greater 
attention to the development process and piloting phase (i.e., field-testing) (Craig et al. 2008).
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10.4 Strengths and Weaknesses
The research methods were specifically selected to examine and address information, 
emotions and decision support needs associated with amniocentesis testing, following the 
MRC complex intervention framework and IPDAS quality criteria. Two literature reviews 
were conducted: a theoretical review and systematic literature review. The theoretical review 
examined the conceptual and theoretical frameworks underlying the conception, prototype 
development and evaluation of DESIs included in a Cochrane systematic review. The second 
literature review investigated the principal characteristics, quality, effectiveness and 
implementation of existing DESIs for amniocentesis testing. Interventions included for 
review were rated against the 10 domains of the IPDAS instrument. Qualitative research 
methods were chosen to capture women’s experiences of deciding about amniocentesis and 
professionals’ assessment of pregnant women’s needs. Semi-structured interviews were 
conducted with pregnant women facing a decision to undertake amniocentesis and health 
professionals from relevant disciplines. The amnioDex intervention was subsequently 
developed using an iterative approach with multi-disciplinary input. Building on existing 
methods of usability testing of interactive healthcare interfaces, amnioDex and embedded 
deliberation components were field-tested using the think-aloud technique and semi­
structured interviews. This study was the first to translate heuristic-based algorithms (Take 
the Best and Tallying) into interactive deliberation tools. Finally, strengths of this study were 
the novel approach adopted to integrate theory into the practical development of an 
interactive intervention and embedded deliberation components.
This research may be criticised for the low number of pregnant women recruited in the 
needs assessment and field-testing of amnioDex. Significant recruitment difficulties were 
encountered throughout the study. Women facing amniocentesis testing are a very small
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proportion of pregnant women in the UK (5 to 10%) and generally experience extreme stress 
and anxiety when deciding about amniocentesis and waiting for the results (Susanne et al. 
2006; Tercyak et al. 2001). Pregnant women approached in the participating antenatal clinics 
frequently declined to take part or withdrew from the study pre-interview due to stress and 
anxiety triggered by the amniocentesis decision, a finding which further strengthens the need 
to develop DESIs. Another limitation may be the low participation of male partners in the 
needs assessment and field-testing of amnioDex. Although this finding is consistent with 
male participation rates in other reproductive health contexts (Bunting and Boivin 2007), it 
nevertheless points to a need for more effort to be directed at recruiting men in future 
research of this type. The decision to undertake amniocentesis is shared and determined by 
the values and preferences of the pregnant woman as well as those of her partner, and the 
partner’s influence in deciding about prenatal testing has been previously documented 
(Carroll et al. 2000; Jaques et al. 2004). A systematic review of decisional needs related to 
prenatal testing (St-Jacques et al. 2008) revealed that partners’ decisional needs have rarely 
been assessed. Although only four partners participated in the needs assessment, their 
perceptions and preferences about amniocentesis testing were indirectly investigated by 
asking (in the partner’s absence) pregnant women about their partner’s views. A final 
limitation is that it would have been desirable to conduct a large scale online evaluation of the 
amnioDex intervention but this was beyond the scope of this project. Given considerable 
recruitment difficulties encountered during the field-testing of amnioDex (data collected until 
May 2009), it was not practically possible to set up an online trial. However, a proposal to 
evaluate amnioDex in a randomised controlled trial was developed. A grant funding 
application was submitted to HTA Clinical Evaluation and Trials (see Appendix 5 for outline 
protocol).
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10.5 Clinical Implications and Future Research Directions
The findings of this thesis indicated that a collaborative approach between researchers, 
potential users and health professionals can successfully lead to an intervention that is both 
usable and acceptable. If complex interventions such as amnioDex are to be accepted by 
patients and health professionals, the needs and concerns of those involved as well as 
practical considerations of the medical setting have to be taken into account. A systematic 
development process involving regular input from stakeholders and systematic piloting may 
facilitate usability and acceptability.
It transpires from the literature and experience of developing amnioDex, that the 
greatest challenge of all is to move from successful DESI development to implementing those 
interventions in clinical settings. Difficulties disseminating and implementing innovative 
healthcare interventions, of which DESIs are part, have been widely documented 
(Greenhalgh et al. 2004; Holmes-Rovner et al. 2000; Silvia et al. 2008). The most commonly 
reported barriers to implementation are the lack of awareness and support from health 
professionals and difficulties organising the DESI distribution in primary or secondary care 
settings (e.g., time constraints, lack of resources) (Silvia et al. 2008). Based on the experience 
of developing amnioDex, the disagreement between pregnant women (or patients in general) 
and health professionals as to what information should be provided in the DESI may have 
repercussions on whether and how a DESI is implemented and whether it actually meets the 
needs of those using it. For example, if the intervention provides information that health 
professionals judge unnecessary, disturbing or confusing, they may be less willing to 
implement the DESI, even if women want this information. A collaborative approach that 
reinforces the fit between professionals and patients by equal representation in the steering 
group, or awareness raising activities between health professionals and patients, seem
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promising ways of ensuring that a DESI is acceptable to all. Second, as noted previously 
(Silvia et al. 2008), implementation may be limited by the lack of structure and resources 
available to identify potential users and distribute DESIs when patients need it most. Indeed, 
pregnant women indicated that the timing of amnioDex delivery was crucial. They believed 
that the intervention should be available early on, before or immediately after receiving the 
screening tests results, or else they would not use it.
Further, a study reporting the assessment of an educational intervention for prenatal 
screening indicated that implementing computer-based interventions in clinical settings 
potentially disrupted the flow of patients (Griffith et al. 2005). There may be less disruptive 
ways to implement DESIs, such as allowing out-of-office online access to the intervention, 
which would not require resources or time commitment from health professionals. However, 
this would have drawbacks in terms of access for those without computers. Increasing 
awareness about DESIs could be achieved by advertising the intervention in secondary care 
settings (e.g., cards advertising amnioDex distributed in antenatal clinics) and through 
existing online platforms (e.g., NHS Choices, pregnancy websites). Clearly preliminary 
discussions about DESIs need to take into account such practical considerations if they are to 
have any realistic chance of implementation.
The development and implementation of DESIs is in line with current trends in the 
NHS to promote patient autonomy, informed choice and access to services (Department of 
Health 2000). NHS Choices is a prime example of the NHS willingness to develop patient 
autonomy and involvement in healthcare. The NHS Choices website provides information 
about over 750 conditions and treatments, current health related topics and services available, 
with the aim of increasing patients, as well as the general population’s, control of their
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healthcare (NHS Choices 2009). Further, the NHS white paper our health, our care, our say: 
a new direction for community services emphasises the patients’ rights to be informed and 
involved in their health related decisions: “You will be in charge of your own health. You 
will get better information so you can make choices about staying healthy and well” 
(Department of Health 2006, p. 7). However, those tools primarily provide information but 
do not currently offer the much needed decisional or emotional support. There is therefore an 
opportunity to reinforce NHS aims if DESIs can become routinely available to those who 
wish to be actively involved in their care. The difficulty here is to negotiate access to the 
NHS, which can best be obtained by collaboration with health professionals and NHS 
stakeholders at the early stage of the DESI design and development.
10.6 Conclusions
The research presented in this thesis provided a developmental pathway for the design 
of a DESI for amniocentesis testing, demonstrating that it was possible to develop a theory- 
driven intervention that was ultimately acceptable to pregnant women and professionals alike. 
Given implementation and dissemination difficulties inherent to this field, it is imperative to 
involve health professionals and potential users in an attempt to maximise the clinical 
accuracy, relevance, usability and acceptability of those interventions to patients. While 
stakeholder involvement and iterative testing are no guarantee of successful DESI 
implementation, it will facilitate the dissemination process by accounting for practical 
requirements and specific needs of users and professionals while increasing professionals’ 
awareness.
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International Patient Decision Aids Standards Instrument
Domain Information Strongly agree 4
Agree
3
Disagree
2
Strongly disagree 
1 Score Comments
1. T he decision  aid d e sc r ib e s  th e  health  
condition or problem  (intervention, p rocedu re  
or investigation) for which th e  index decis ion  is 
required.
There is a detailed 
description o f the health 
condition or problem
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description of 
the health condition or 
problem at all
2. T he decision  aid d e sc r ib e s  th e  decision  tha t 
n e e d s  to be  con sid ered  (the index decision).
The decision, that the 
decision aid addresses, is 
specifically stated
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description o f 
the index decision
3. T he decision  aid d e sc r ib e s  th e  options 
available for th e  index decision.
A comprehensive list o f 
options related to the 
decision is provided
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description o f 
the available options
4. T he decision  aid d e sc r ib e s  th e  natural 
co u rse  of th e  health  condition o r problem , if no 
action is taken .
There is a description of 
how the untreated 
condition is expected to 
develop if no action is 
taken
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description o f 
the natural course o f the 
health condition or 
problem
5. T he decision  aid d e sc rib e s  th e  positive 
fe a tu re s  (benefits or ad v an ta g es) of each  
option.
A comprehensive list o f 
benefits and/or 
advantages o f each option 
is provided
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description the 
potential benefits or 
advantages of the options
6. T he decision  aid d e sc r ib e s  negative 
fe a tu re s  (harm s, side  effects or 
d isad v an tag es ) of e a c h  option.
A comprehensive list of 
harms and/or side effects 
and/or disadvantages o f 
each option is provided
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description the 
potential harms or side 
effects or disadvantages 
of the options
7. T he decision  aid m ak es  it po ssib le  to 
co m p are  th e  positive an d  negative  fe a tu re s  of 
th e  available options.
Potential harms and 
potential benefits are 
presented in a head-to- 
head comparison
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
The presentation o f 
potential harms and 
potential benefits does not 
allow fora head-to-head 
comparison
8. T he decision  aid show s th e  negative  and  
positive fe a tu re s  of op tions with equal detail 
(for exam ple  using sim ilar fonts, order, and  
d isplay  of statistical information).
The negative and positive 
features are presented  
with equal detail by using 
the sam e font, order, and 
display o f statistical 
information
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
The negative and positive 
features o f the options are 
not shown with equal 
detail -  leading to a 
perceived favouring or 
disfavouring o f a specific 
option
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Domain Test Strongly agree 4
Agree
3
Disagree
2
Strongly disagree 
1 Score Comments
1. T he decision  aid d e sc r ib e s  w hat th e  
te s t is d esig n ed  to m easu re .
The test is described in detail to 
provide the user with a complete 
picture o f what it is designed to 
measure
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The test is only included as 
a label
2. T he decision  aid includes information 
ab o u t th e  c h a n c e s  of having a  true 
positive te s t result.
The natural frequency (event 
rate) o f having a true positive 
test result is included
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the probability o f 
having a true positive test 
result
3. T he decision  aid includes information 
ab o u t th e  c h a n c e s  of having a  true 
negative  te s t result.
The natural frequency (event 
rate) o f having a true negative 
test result is included
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the probability o f 
having a true negative test 
result
4. T he decision  aid includes information 
ab o u t th e  c h a n c e s  of having a  fa lse  
positive te s t  result.
The natural frequency (event 
rate) o f having a false positive 
test result is included
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the probability o f 
having a false positive test 
result
5. T he decision  aid includes information 
ab o u t the  c h a n c e s  of having a  fa lse  
negative  te s t result.
The natural frequency (event 
rate) o f having a false negative 
test result is included
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the probability o f 
having a false negative 
test result
6. If th e  te s t d e te c ts  th e  condition or 
problem , th e  decision  aid d e sc r ib e s  the  
next s te p s  typically taken .
There is information about 
possible follow-up actions when 
the condition or problem is 
detected
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about possible next steps 
when the condition or 
problem is detected
7. T he decision  aid d e sc r ib e s  th e  next 
s te p s  if th e  condition or problem  is not 
d e tec ted .
There is information about 
possible follow-up actions when 
the condition or problem is not 
detected
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about possible next steps 
when the condition or 
problem is not detected
8. T he decision  aid d e sc rib e s  th e  
c h a n c e s  th a t th e  d is e a se  is d e tec ted  with 
and  w ithout th e  u se  of th e  tes t.
The probability o f detecting the 
target condition both with and 
without screening is presented
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the probability o f 
detecting the target 
condition
9. T he decision  aid h a s  information ab o u t 
th e  c o n se q u e n c e s  of de tec ting  th e  
condition or d is e a se  th a t would never 
have  c a u se d  p rob lem s if sc reen in g  had  
not b een  d o n e  (lead tim e bias).
There is explicit information 
about the possibility of 
screening leading to the 
detection and treatment o f the 
condition or disease that might 
never have caused symptoms 
had it not been for the screening
Use this rating if you think the 
patient decision aid fulfils the 
criterion but there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no information 
about the possibility 
screening leading to the 
detection o f a condition or 
disease that m ay never 
have become symptomatic
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Domain Probabilities Strongly agree 4 3
Disagree
■ ■ ■ ■ 2
Strongly disagree 
1 Score Comments
1. T he decision  aid p rov ides inform ation 
ab o u t ou tcom e probabilities a sso c ia te d  
with th e  op tions (i.e. th e  likely 
c o n se q u e n c e s  of decis ions).
The decision aid clearly 
presents probabilities for 
all relevant outcomes of 
the options
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no reference to 
the magnitude (absolute or 
relative) o f the likelihood of 
positive or negative 
outcomes
2. T he decision  aid spec ifie s th e  defined 
group  (re fe rence  c la ss)  of pa tien ts  for 
which th e  ou tcom e probabilities apply.
th e  decision aid provides 
a clear definition o f the 
population for which the 
outcome probabilities 
apply
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no definition at all 
of the population for which 
the outcome probabilities 
apply
3. T he decis ion  aid spec ifie s th e  ev en t 
ra te s  for th e  o u tcom e probabilities (in 
natural frequenc ies).
Event rates for each of the 
positive and negative 
outcomes are presented
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no reference to 
event rates for positive or 
negative outcomes
4. T he decision  aid spec ifie s th e  tim e 
period over which th e  ou tcom e 
probabilities apply.
The decision aid provides 
a clear definition o f the 
time period for the given 
event rates
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no description o f 
the time period for the 
given event rates
5. T he decision  aid allow s th e  u se r  to 
co m p are  ou tcom e probabilities a c ro s s  
op tions using th e  s a m e  denom ina to r and  
tim e period.
The decision aid uses 
constant denominators 
and the sam e time frame 
for the outcome 
probabilities o f the options
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
The denominators for the 
risk events or the time 
frames for the outcomes 
vary across the options
6. T he decis ion  aid p rovides information 
ab o u t th e  levels of uncertain ty  around  
ev en t or o u tcom e probabilities (e.g . by 
giving a  ran g e  or by using p h ra s e s  such  
a s  ‘ou r b e s t e s tim a te  is’).
The uncertainty around 
the probability estimates is 
conveyed through ranges, 
95% confidence intervals, 
or phrasing such as "our 
best estimate is ...”
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
There is no
acknowledgement o f the 
uncertainty in the 
probability estimates or 
there is a failure to round 
off numbers -  giving the 
false illusion o f precision
7. T he decision  aid prov ides m ore than  
o n e  w ay of viewing th e  probabilities (e.g. 
w ords, num bers, and  d iagram s).
More than one method is 
used to present all o f the 
outcome probabilities
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
Multiple methods to view 
the probabilities are not 
included in any instance
8. T he decision  aid prov ides information 
ab o u t ev en t o r ou tcom e probabilities by 
using m ore th an  o n e  fram ing m ethod  (e.g. 
positive or negative  fram es, lo ss or gain 
fram es).
Outcome probabilities are 
presented with more than 
one framing method
Use this rating if you think 
the patient decision aid 
fulfils the criterion but 
there is room for 
improvement
Use this rating if you do 
not think that the patient 
decision aid fulfils this 
criterion or if unclear
More than one framing 
method to view the 
probabilities is not 
included in any instance
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Domain Values Strongly agree4 ■ ■
Agree
3
Disagree
2
Strongly disagree 
1 Score Comments
1. T he decision  aid d e sc r ib e s  th e  
fea tu re s  of op tions to  help pa tien ts 
im agine w hat it is like to ex p e rien ce  the  
physical effects.
The decision aid provides clear 
detail (through personal stories or 
in the main narrative o f the 
decision aid) about the possible 
impact o f harms and benefits on 
som eone’s  physical life
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
Harms and benefits are brief, 
factual descriptions or labels only
2. T he decision  aid d e sc rib e s  th e  
fea tu re s  of op tions to  help pa tien ts 
im agine w hat it is like to expe rien ce  th e  
psychological effects.
The decision aid provides clear 
detail (through personal stories or 
in the main narrative o f the 
decision aid) about the possible 
impact o f harms and benefits on 
som eone's psychological life
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
Harms and benefits are brief, 
factual descriptions or labels only
3. T he decision  aid d e sc rib e s  the  
fea tu re s  of options to help patien ts 
im agine w hat it is like to exp erien ce  the  
social effects.
The decision aid provides clear 
detail (through personal stories or 
in the main narrative o f the 
decision aid) about the possible 
impact o f harms and benefits on 
som eone’s  social life
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
Harms and benefits are brief, 
factual descriptions or labels only
4. T he patien t decision  aid a sk s  
pa tien ts to  think ab o u t which positive 
and  negative  fea tu re s  of th e  options 
m atter m ost to them .
The decision aid provides clear 
direction to consider personal 
preferences in making the 
decision. (This m ay be achieved 
through balanced examples of 
how others value the features o f 
each option in order to illustrate 
how different values may lead to 
different choices or through 
explicitly measured values guiding 
patients to rate or trade-off 
different features o f options)
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The discussion o f harms and 
benefits does not include 
reference to the personal 
importance o f harms and benefits 
(only providing the chances o f the 
outcomes happening)
5. T he decision  aid su g g e s ts  w ays for 
p a tien ts com m unicate  w hat m atters 
m ost to them  to o th e rs  involved in the  
decision  (e.g. health  pro fessionals, 
family m em bers).
The decision aid provides clear 
strategies to facilitate 
communication o f personal values
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not 
provided direction or suggestions 
of how to share personal values 
with others involved in the 
decision
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Domain Guidance Strongly agree' 4 •
Agree
3
Disagree
■ ■ ■. 2
Strongly d isagree S core Comments
1. T he patien t decision  aid provides a  
s tep -b y -s tep  w ay to  m ake  a  decision .
The decision aid provides clear 
guidance to the decision- making 
process through one o f the 
following methods:
(a) the structure o f the decision 
aid is stepwise (implicit guidance); 
or,
(b) there is explicit guidance in the 
form o f a worksheet or specified 
steps; or,
(c) there is a thought experiment 
e.g. Im agine that you have 
chosen option A, write down your 
expectations o f the outcomes and 
how you would feel about them  
and share this with your 
practitioner*; or,
(d) strategies are included for 
making/progressing with the 
decision e.g. an action plan for 
progressing with the decision
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not 
provided any features o f 
structured guidance
2. T he patien t decision  aid includes 
tools like w o rk sh ee ts  or lists of 
q u estio n s to  u se  w hen  d iscussing  
options with a  practitioner.
The decision aid provides a 
worksheet or list o f questions that 
is clearly intended to be shared 
with others involved in the 
decision
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not 
provided any m eans to facilitate 
communication o f views/situation 
to others
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Domain Development Strongly agree ■ 4
Agree
3
Disagree
2
Strongly disagree Score Comments
1. T he deve lopm en t p ro c e s s  included 
finding ou t w hat c lien ts’ / p a tien ts’ n eed  
to d iscu ss  op tions or d ec id e  on c o u rse s  
of action.
The decision aid provides or 
supporting documentation provides 
clear evidence o f a clients’/  
patients’ needs assessm ent or 
involvement in topic selection
Use this rating if you  
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid or supporting 
documentation does not provided 
any information about clients’/  
patients’ involvement in the 
development process
2. T he deve lopm en t p ro c e s s  included 
finding ou t w hat health  p ro fessio n a ls’ 
need  to d iscu ss  op tions or d ec id e  on 
co u rse s  of action.
The decision aid provides or 
supporting documentation provides 
clear evidence o f a health 
professionals' needs assessm ent 
or involvement in topic selection
Use this rating if you  
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid or supporting 
documentation does not provided 
any information about health 
professionals’ involvement in the 
development process
3. T he d eve lopm en t p ro c e s s  included 
expert review  by c lien ts’ / p a tien ts’ not 
involved in producing th e  decision  aid.
The decision aid provides clear 
information about review of the 
decision aid by clients’/ patients’ 
not involved in the development 
process
Use this rating if you  
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid was not reviewed 
by clients’/ patients’ or does not 
provide any information about 
review
4. T he deve lopm en t p ro c e s s  included 
expert review  by health  p ro fessionals 
not involved in producing th e  decision  
aid.
The decision aid provides clear 
information about review o f the 
decision aid by health 
professionals’ not involved in the 
development process
Use this rating if you 
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid was not reviewed 
by health professionals' or does 
not provide any information about 
review
5. T he decision  aid w as field-tested  with 
patien ts w ho w ere  facing th e  decision .
The decision aid provides clear 
information about field-testing the 
decision aid among patients who 
were facing the decision
Use this rating if you  
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid was not field- 
tested or does not provide any 
information on field-testing
6. T he decision  aid w as  field-tested  with 
practitioners w ho counse l pa tien ts w ho 
face  th e  decision .
The decision aid provides clear 
information about field-testing the 
decision aid among practitioners 
who counsel patients facing the 
decision
Use this rating if you 
think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid was not field- 
tested or does not provide any 
information on field-testing
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Domain Evidence Strongly agree 4
Agree
3
Disagree
2
Strongly disagree 
1 Score Comments
1. T he decision  aid (or available 
technical docum enta tion ) p rovides 
citations to  th e  s tu d ies  se lec ted .
The decision aid or supporting 
documentation provides citations 
to the scientific evidence used
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any information on the scientific 
references
2. T he decision  aid (or available 
technical docum enta tion ) d e sc r ib e s  
how  re sea rch  ev id en ce  w as  se lec ted  or 
sy n th esised .
The decision aid or supporting 
documentation explicitly describes 
the methods for identifying and 
appraising the evidence
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any description o f the 
methodology for collection and 
appraisal o f evidence
3. T he decision  aid (or available 
technical docum enta tion ) p rovides a  
production or publication da te .
The decision aid or supporting 
documentation clearly states the 
date o f last update
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
a date o f last update
4. T he decision  aid (or available 
technical docum entation) p rovides 
information ab o u t th e  p roposed  u p d a te  
policy.
The decision aid or supporting 
documentation provides clear 
information on the procedure for 
updating the evidence
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any information on the update 
policy
5. T he decision  aid (or available 
technical docum enta tion ) d e sc rib e s  the  
quality of th e  re se a rc h  ev id en ce  u sed .
The decision aid or supporting 
documentation provides an 
explicit rating o f the quality o f the 
scientific evidence used to 
describe the benefits and risks
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any description o f the quality o f 
the scientific evidence
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Disclosure and transparency 
(Disclosure)
Strongly agree 
4
Agree
3
Disagree
2
Strongly disagree
. 1 ■. Score Comments
1. T he decision  aid (or openly  available 
technical docum enta tion ) p rovides 
information ab o u t th e  funding u sed  for 
developm ent.
The decision aid or supporting 
documentation explicitly states 
sources o f funding for 
development o f the decision aid
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any information about sources o f 
funding
2. T he decision  aid includes a u th o rs ’ / 
d ev e lo p e rs’ c reden tia ls  o r qualifications.
The credentials o f individual 
developers are given clearly in the 
decision aid itself OR if the 
credentials o f those individuals 
directly responsible for the 
development and content o f the 
decision aid are given clearly in 
supporting materials
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any information about credentials 
o f the authors /  developers
Using plain language Strongly agree Agree Disagree2
Strongly disagree Score Comments
1. T he decision  aid (or available 
technical docum ent) reports readability 
levels (using o n e  or m ore of th e  
availab le  sca le s) .
The decision aid or supporting 
documentation clearly reports its 
readability level
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid does not provide 
any information about readability 
level
Evaluation (Evaluation) Strongly agree 4
Agree
3
Disagree
2
Strongly disagree 
1 Score Comments
1. T here  is ev id en ce  th a t th e  decision  
aid im proves th e  m atch  b e tw een  th e  
fea tu re s  th a t m atte r m ost to  the  
inform ed patien t and  the  option th a t is 
ch o sen
The decision aid or supporting 
documentation clearly reports that 
evaluation study results 
demonstrate an improved match 
between values and choice
Use this rating if 
you think the patient 
decision aid fulfils 
the criterion but 
there is room for 
improvement
Use this rating if you do not 
think that the patient 
decision aid fulfils this 
criterion or if unclear
The decision aid or supporting 
documentation does not provide 
evidence o f evaluation or fails to 
demonstrate evidence o f 
improved match between values 
and choice
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Professor Glyn Elwyn 
Centre for Health Sciences Research 
Department of General Practice 
Cardiff University 
Neuadd Meirionnydd 
Heath Park 
Cardiff 
CF14 4YS
E: elwyng@cardiff.ac.uk 
T: 0044 (0) 29 20 68 71 95
Participant code:
D a te :__________
Date of birth:__________________
Obstetric history:
Previous p reg n an c ies:____________
Number of children:______________  Children with a  chrom osom e disorder:
Previous experience with am n io cen tes is :______________
Patient Interview Schedule (User Perspective)
•  Introduction to the research topic and aims
“Thank you very much for agreeing to participate in the research. By participating, you are 
helping us design a tool that will help pregnant women who are faced with a decision to 
undergo amniocentesis. By creating a decision tool, we aim to give them accurate 
information about the options they are offered and see how they react to the support 
provided”.
•  Anonymity and informed consent
“The interview will last between 30 and 60 minutes. I am recording it in order to analyse it 
afterwards. Your names will remain anonymous and all the information collected during the 
interview will be kept strictly confidential."
I am working within the rules and regulations that Cardiff University has set. ”
Occupation: _ 
Marital status:
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3  Before we start, do you have any questions about this interview and its aim, or 
something you would like to have more explanation about?
1. Could you now tell me about your experience of having the blood tests for Down’s 
syndrome?
(Probes: Did you understand the process? Do you know why this test is done?)
2. Could you tell me what you were told about the results of the blood tests for Down’s 
syndrome?
(Probes: What did you understand about those results? How did you interpret the 
information about the risk?)
3. What sort of information do you think women need about the blood test?
4. How do you think this information should be given?
(Probes: Using diagrams or graphics which illustrate the risk?)
5. How were you introduced to the offer of an amniocentesis? 
(Probes: Did you understand why you were offered amniocentesis?)
6. What did you already know about the amniocentesis procedure?
7. What are the issues, preferences, or factors that you took into account when you had to 
make a decision regarding amniocentesis?
(Probes: How did you come to this decision? What helped you make this decision?)
8. We are also interested in your partner's views about this decision. What were the issues, 
preferences, or factors which he brought up when you discussed amniocentesis testing?
9. How do you feel about your decision regarding amniocentesis?
10. What sort of information do you think women need about amniocentesis?
11. Amniocentesis carries a risk of miscarriage, what information do you think women need 
regarding this risk?
12. How do you think this information should be given?
(Probes: Using diagrams, graphics or decision trees which illustrate this risk?)
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13. Do you have any further questions you would like answered or comments you would like 
to make regarding this study?
“Thank you very much for your time and participation".
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Interview patient 8
R: So, could you te l me about your experience of having the blood test fen: Down syndrome?
I: Rigid, hum, we had the, I had the blood test at 16 weeks, hum, basically, it’s just a normal blood test, went for it, the results came back, I had a 
telephone cal and then, die lady just explamed everything, Ike my results and everything to come in and see her and that was the initial blood test.
R: Did you understand why that test was done for?
1:1 did understand, but this being my first chid, I don’t think I probably understood die consequences, hum, and, die worry that.. .basically 
R: You had enough information.
L yes, information was fine.
R: What about the results, what were you told?
I: Hum, when they phoned me up and gave me die message I thought tat was quite distressing really, the lady on the other end of the phone said to me 
that die result had come back high and that I needed to come in and see her straight away, hum, which obv I was worried about. I was quite 
devastated about it to be honest and then when I got to the hospital to speak to the specialist, it was a totally different baSgame, there was no need for 
me to worry that much when she went into all details, hum, so 1 wasn’t very happy at first with the inkial phone call.
R: How did you interpret this information, what did you think, what were your thoughts when she told you you’re at risk?
L My initial thoughts were straight away. Right, where do I stand? Am I gonna be having a DS children, not maybe I am having one, I thought straight 
away, yes I am gonna be having one. Hum, I didn’t really understand it all to be honest with you. Looking back now, I sometimes regret having this 
screening test, htan, because obv of the worry that I’ve got now.
R: What sort o f information do you think women need about this blood test?
I: The paper work was fine, I had the opportunities to ask questions as well. I just don’t feel that I did. Hum, I don’t feel that I asked, (...) , but being 
young, being like my first child, it’s all exciting, I mean, it’s the last thing that you want to think about realty. But, I mean I should have asked a few 
more questions.
R: How do you think this information should be given to women?
I: I don’t think the results should be given over the phone. I don’t think that should be done. But, there again I don’t think it should be given by a letter 
either cause I don’t think that would be very nice. Hum, it’s a noone situation really about the results. As for information, I don’t know really. I mean I 
had a one meeting with a midwife before I had the blood test and as 1 said, I should have just asked more questions really, or with knowing that it was 
my first child, maybe she could went in with a little bit more detail for us. Cause she didn’t ask if it was my first child She obviously knew it by my 
notes and everything, but if she had have asked I suppose she might have knew' that I was a bit vulnerable real)'.
R: What about the numerical data, the risk in itself, do you think it would help if it was presented using, pictures or?
Hum, she did, she had a little graph, 250 spots on and in the middle was one red spot. Now, as soon as I ‘ve seen that my mind was totally, not totally 
at ease, but was eased a lot more than what it was when she said, look this is your result over the phone, my result was 206 so when she showed me 
these dots and everything I did feel a lot better. But, when she said over the phone, see I didn’t know if it was 1 in 206 ,1 didn’t know how the ratio 
worked, you see, straight away, initially, so yeah, I mean, I was pretty worried at first. But, Htan, I like the dots idea, that was good. I Kked foal.
difficulty: did not consider implications of screenin
satisfaction: information provided
( J  emotions: panic/stress/upset after "high chance* 
££ emotions: awful experience, highly (^stressing
Q  information needs: immediate information when
I perception: High chance result = baby has D£ 
| perception: parents seem to consider Ihe wor
j  decision: recurrent anxiety after having dedr 
Q  emotion: regret re screening test
{ J  diffiaity: did not consider implications of screenin
Q  information needs: screening test purposes and c
Q  framing of information: visuals needed
framing of information: visuals needed ££ emo
223
List of Codes (User Perspective)
Amniocentesis results: anxiety diminished after 1st result 
Amniocentesis: uncomfortable but not painful 
Attitude: did not expect to get a high chance result 
Attitude: laid back about screening test because 3rd pregnancy 
Creating sense about why screening test came back positive 
Decision support: husband supported her decision 
Decision support: more counselling available if a problem is found 
Decision support: need for more decision support 
Decision support: professionals with unbiased/neutral opinions 
Decision support: support from relevant associations 
Decision support: taking enough time to make a decision 
Decision support: talking to others (family, professionals)
Decision: agreement between partners
Decision: differing opinions within the couple (conflicts)
Decision: immediate decision was to have amniocentesis/ then changed her mind 
Decision: recurrent anxiety after having declined amniocentesis
Decision: satisfied declined amniocentesis (no regret) even after child born with Down’s 
syndrome
Decision: satisfied had amniocentesis (even after diagnosis of Down’s syndrome)
Decision: satisfied not to have had amniocentesis although moments of anxiety 
Decision: satisfied with decision to have had amniocentesis 
Decision: shared with husband
Difficulty: balancing the risk of miscarriage against the risk of Down’s syndrome
Difficulty: conflicts between local/national miscarriage rate
Difficulty: felt forced into having an amniocentesis
Difficulty: making a decision in a short time window
Difficulty: interpreting/understanding the numerical value
Difficulty: to make a decision based on probabilities
Difficulty: did not anticipate/prepare for a high chance result
Difficulty: did not consider implications of screening test
Difficulty: did not get enough information on screening tests
Difficulty: did not realise that the screening test result was not certain.
Difficulty: did not what she would do with the results if problem was found 
Difficulty: high chance result is misleading
Difficulty: hospital unable to provide updated leaflets about Down's syndrome 
Difficulty: information overload 
Difficulty: lack of information
Difficulty: lack of information and support about Down’s syndrome 
Difficulty: lack of neutral, unbiased information from medical staff 
Difficulty: lack of understanding around risk of miscarriage (foreign patient)
Difficulty: lack of understanding of what the results (PCR + karyotype) mean 
Difficulty: lack of understanding screening test result 
Difficulty: poor knowledge about amniocentesis before screening 
Difficulty: rushed into making a decision
Difficulty: strong stereotypes around children with down's syndrome
Difficulty: total lack of support re continuing pregnancy
Difficulty: total lack of tact from medical staff
Difficulty: very biased information, pro-termination
Difficulty: very difficult decision
Difficulty: waiting for results
Difficulty: not informed about possibility of nuchal translucency scan
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Dissatisfaction: medical team judgemental, insulting about child with chromosome Disorder
Dissatisfaction: amniocentesis results given over the phone
Dissatisfaction: delay re-amniocentesis results
Dissatisfaction: no real choice as to continue/terminate pregnancy
Dissatisfaction: offered amniocentesis over the phone
Dissatisfaction: pressure to have a termination
Dissatisfaction: pressure to opt for screening test + amniocentesis
Dissatisfaction: professional's attitude, choice was not offered, professional's views imposed 
on her
Dissatisfaction: standard of care received in hospital
Dissatisfaction: total lack of professionalism from healthcare professionals
Emotion: regret re screening test
Emotions: affective forecasting
Emotions: anxiety decreased after PCR
Emotions: awful experience, highly distressing
Emotions: felt guilty for not having screening test
Emotions: no regret re amniocentesis
Emotions: no regret re not having amniocentesis
Emotions: panic, shock after diagnostic of Down’s syndrome
Emotions: panic/stress/upset after "high chance" result
Emotions: stress, emotions, vulnerability in deciding
Emotions: too emotional to take information in
Emotions: very emotional decision
Emotions: very upsetting time
Framing of information: convert risk of Down’s syndrome into a number out of 100
Framing of information: multiple ways of presenting the data (to account for individual
differences)
Framing of information: verbal information needed 
Framing of information: visuals needed 
Framing of information: written information needed 
High chance result: did not feel directly concerned 
High chance result: panic, stress 
High chance result: sense of urgency=stress 
High chance result: too little immediate information
Information given: was given local miscarriage rate as well as national miscarriage rate
Information needs: impact of IVF on screening test results
Information needs: address emotional aspects, difficulty in deciding
Information needs: adjust/personalise information to individual differences and background
Information needs: amniocentesis does not guarantee a healthy baby
Information needs: average Down’s syndrome risk in similar age group
Information needs: balanced examples of other people's experiences
Information needs: be given a choice
Information needs: being called back to clinic after high chance result is a routine procedure
Information needs: benefits, joys of having a child with a chromosome problem
Information needs: consequences of amniocentesis
Information needs: detailed information about risk of miscarriage
Information needs: finding a balance in the quantity of information given
Information needs: for analogies (lottery) (men especially)
Information needs: forum, local support group, message board 
Information needs: hard facts
Information needs: how the amniocentesis procedure is done 
Information needs: immediate information when given high chance result 
Information needs: infections do not always result in miscarriage (antibiotics etc)
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Information needs: information about pain during procedure 
Information needs: information about range of problems detected 
Information needs: information about what amniocentesis does not detect 
Information needs: information around results, implications etc 
Information needs: information given before screening test 
Information needs: information should be optional (e.g., video of procedure)
Information needs: information to take home
Information needs: karyotype test result and problems detected
Information needs: local miscarriage rate
Information needs: more information about what screening test is looking at 
Information needs: multiple ways of framing information 
Information needs: neutral, balanced information
Information needs: No detailed information about screening test process (chemicals in the 
blood etc)
Information needs: No need for overload of information about consequences of 
amniocentesis, termination etc.
Information needs: number of women who have child with Down’s syndrome after high 
chance result
Information needs: out of all women who are given high chance result, how many undertake 
amniocentesis
Information needs: practical aspects, arrangements around amniocentesis 
Information needs: professionals' opinions 
Information needs: range of screening tests available
Information needs: reasons why they are having screening test/amniocentesis 
Information needs: reliable information 
Information needs: risk factors for miscarriage 
Information needs: risks involved
Information needs: screening test purposes and consequences
Information needs: screening test results
Information needs: screening test results are not definite
Information needs: characteristics of IVF pregnancies in relation to amniocentesis
Information needs: understand the screening test results
Information needs: videos (procedure), visuals
Information: read about amniocentesis
Information: search on internet
Information: understood the information
Knowledge: knew a little about amniocentesis before
Perception: amniocentesis is uncomfortable nut not painful
Perception: does not know why had screening test
Perception: enough information given before screening test
Perception: experienced pains after the procedure
Perception: extremely reassured by local rate
Perception: High chance result = baby has Down’s syndrome
Perception: leaflets were useful but did not help her make a decision
Perception: national average misleading
Perception: negative stereotypes, images on children with Down’s syndrome 
Perception: never think that screening test result will come back high chance 
Perception: painful procedure
Perception: parents seem to consider the worst case scenario: Down’s syndrome baby or
miscarriage of healthy baby
Perception: risk of miscarriage minimised
Perception: very quick decision
Perceptions: amniocentesis as a reassurance for the parents not the baby
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Professional's tendency: systematic provisional amniocentesis booking 
Reason: avoid anything that may harm baby 
Reason: being able to prepare if problem is found 
Reason: age
Reason: anomalies detected on the mid-pregnancy scan 
Reason: compare adjusted risk with cut-off limit 
Reason: difficulty getting pregnant
Reason: does not want to be confronted with other difficult decisions (pregnancy termination) 
Reason: existing child
Reason: existing child with Down's syndrome (no to amniocentesis)
Reason: family history of chromosome disorders 
Reason: have the option to terminate pregnancy 
Reason: husband away, not here to support her
Reason: knowledge, understanding, experience of children with Down’s syndrome 
Reason: medical complication (no amniocentesis)
Reason: no termination if a problem was found 
Reason: not wanting to look after a disabled child 
Reason: obstetric history 
Reason: partner's views
Reason: practical reasons, being able (or not) to rest for two days
Reason: previous experience of amniocentesis
Reason: previous miscarriage
Reason: reassured by obstetrician expertise
Reason: religious beliefs, faith
Reason: risk for her age compared to risk in similar age group 
Reason: risk of infection 
Reason: risk of miscarriage
Reason: risk of miscarriage compared to risk of a problem
Reason: stress of not knowing
Reason: the numerical value, the risk of a problem
Reason: to find out, definite answer
Reason: views of friends, family etc
Satisfaction: visuals (diagram with dots)
Satisfaction: information around amniocentesis procedure
Satisfaction: overall information and support
Satisfaction: amniocentesis was a positive experience: extra scan...
Satisfaction: being able to decide straight away
Satisfaction: good information about Down's syndrome
Satisfaction: good risk communication
Satisfaction: information around screening test
Satisfaction: information leaflets
Satisfaction: information provided
Satisfaction: the diagram with dots
Satisfaction: timeline for results
Satisfaction: understanding of screening test purposes
Screening test: understood why was offered the test
Support: friends
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Professor Glyn Elwyn 
Centre for Health Sciences Research 
Department of General Practice 
Cardiff University 
Neuadd Meirionnydd 
Heath Park 
Cardiff 
CF14 4YS
E: elwyng@cardiff.ac.uk 
T: 0044 (0) 29 20 68 71 95
Participant code:______  Position occupied:___________
Date:___________
Interview Schedule (Stakeholder Analysis)
•  Introduction to the research topic and aims
“ Thank you very much for agreeing to participate in the research. By participating, you are 
helping us design a tool that will help pregnant women who are faced with a decision to 
undergo amniocentesis. By creating a decision tool, we aim to give them accurate 
information about the options they are offered and see how they react to the support 
provided”.
•  Anonymity and informed consent
“The interview will last between 30 and 60 minutes. I am recording it in order to analyse it 
afterwards. Your names will remain anonymous and all the information collected during the 
interview will be kept strictly confidential.
I am working within the rules and regulations that Cardiff University has set. ”
O Before we start, do you have any questions about this interview and its aim, or 
something you would like to have more explanation about?
1. What sort of information do you think women need regarding the result of the 
screening test for Down’s syndrome?
2. In what way do you think this information is best presented?
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3. What important issues, preferences or factors influence women when they have to 
make a decision regarding amniocentesis?
4. What difficulties do women come to you with?
5. If there is one thing that women ask you, what is-it?
6. What is the best way to describe and explain the risk of having a baby with Down’s 
syndrome and the false positive and false negative results associated?
7. How do you think this information should be given?
(Probes: Using charts, diagrams, decision trees? Using number or words?)
8. What sort of information do you think women need regarding the amniocentesis 
procedure?
6. What do they need to know regarding the PCR test and the karyotyping procedure?
7. What sort of information do you think women need about the risk of miscarriage?
8. How do you think this information should be given?
(Probes: using diagrams or charts which illustrate this risk? Using number or words?)
9. What do they need to know regarding the results of the amniocentesis and its 
implications?
10. How do you think this information should be given? 
(Probes: using decision trees, or charts?)
11. Do you have any further questions, or comments you would like to make regarding 
women’s information needs when they are offered amniocentesis?
“Thank you very much for your time and participation”
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I Interview  transcript B  Beattie
R: "What sort o f  info do you  think w om en  about the results o f  the b lo o d  test for D S ?
I: The triple test, I  think they n eed  to  k n o w  w hat their age related risk o f  having a D S  bab y w ou ld  be and 
then w hat the adjusted risk is. I  think one o f  the problem  is to  try to put that into som e sort o f  
prospective and it is useful to use analogies like for a risk o f  1 in 3 6 0  yo u  could say som ething like. I f  i 
p ick  one day in the next year and you  can guess the sam e date it gives them  a better idea o f  w hat the 
con cep t o f  1 in 3 6 0  is. The other thing is that som etim es w e  use cards with dots on them  to try and give  
an idea  o f  w hat the risk w ou ld  be. H um , percentages are not particularly helpful b e  the risk seen  o f  1 in 
2 0 0 , 1 in 3 0 0 , p eo p le  find I think difficult to  understand the con cep t o f  half a percent, a third o f  a 
percent, so  it is probably easier to use overall numbers. The problem  that they usually have is trying to  
m ake a decision about w hether to g o  ahead with the am niocentesis so  I  think an equally important part of 
that is understanding the con cep t o f  the risk o f  miscarriage from the amnio and I w ou ld  often draw them  
a set o f  skills and sh ow  that on the one hand, y o u  are balancing the risk o f  miscarriage if  they have the 
amnio, and the other hand, the risk o f  m issing a bab y with D S  if  you  don’t, and tell them  to  try and m ake  
that judgem ent
R: o k  , Y ou  m entioned the percentages and the dots, h o w  do yo u  think this info is b est  presented  
I; I  think depends on the patients. The dots I  think are w idely  u sed  b y  the m idw ives, the screening  
m idw ives, I  tend to think o f  it, I  use the analogy o f  days o f  the w e ek , or days o f  the month, or days o f  
the year. I  think a lot o f  p eop le  find that a lot easier to  follow .
R: ok,
I: D ep en d s on the patients. I f  som eb od y  is a solicitor, a law yer, high intelligent, they m ay b e  quite happy  
just with ro w  figures.
R: "What important issues or factors or preferences do y o u  think w om en  take into account w hen  they  
have to m ake this decision  about going for am niocentesis?
I: O ne o f  the big problem s is that a lot don’t understand fully w hat D S  is, so  a simple thing is to review  
with them  w hat their understanding o f  w hat the condition is, hum, be if  they consider that D S  is 
som ething w hich is very serious then they are m ore likely to have an am niocentesis. I f  on the other hand 
they think that it’s som ething with a very variable presentation and they m ay have even  have experience  
o f  another child w h o has D S  in the family or as a neighbour and they m ay have different view s. I  think it 
is important that they understand w hat D S  is and that even  if  w e  diagnose it on an am niocentesis, w e  
can’t predict the severity o f  the outcom e.
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List of Codes (Stakeholder Analysis)
Couple's decision: couple come together
Couple's decision: disagreement within couple
Couple's decision: men tend to follow/support their partner's decision
Decision support: consider the impact of child with Down’s syndrome for the long term
Decision support: anticipate what will do if problem is found (termination of pregnancy)
Decision support: consider impact of disabled child on family
Decision support: couple need to decide why they are having amniocentesis (reassurance, 
to be able to terminate...)
Decision support: leave them time to decide
Decision support: parents need to be reassured about amniocentesis
Decision support: parents need to know what the worst outcome is (having an affected
child/losing a healthy baby)
Decision support: tendency to seek professional's advice
Decision support: to facilitate discussion within couple
Decision support: discuss condition with specialist
Difficulty: understanding numerical value because no fixed denominator
Difficulty: lack of understanding of what amniocentesis is testing for
Difficulty: understanding false positive/false negative results
Difficulty: "putting the pregnancy at risk”
Difficulty: accessing the information anytime
Difficulty: balancing the risk of miscarriage against the risk of a problem 
Difficulty: being rushed into making a decision
Difficulty: couples/women have to make a difficult decision (responsibility in deciding)
Difficulty: dealing with statistics
Difficulty: emotional arousal, understanding gaps
Difficulty: emotional difficulty in deciding
Difficulty: information overload
Difficulty: limitations of amniocentesis testing (no prediction of Down’s syndrome severity)
Difficulty: making a decision without knowing the outcome
Difficulty: risk of Down’s syndrome is equivalent to risk of miscarriage
Difficulty: understanding the full implications of amniocentesis
Emotions: very emotional and difficult decision
Emotions: emotional upheaval (hormonal changes etc)
Emotions: high chance screening test very emotional "panic, horror"
Emotions: high stress and anxiety levels
Emotions: very emotional when called in for counselling session, difficulty assimilating 
information
Framing of information: analogies are better than flow charts
Framing of information: analogies facilitate understanding
Framing of information: diagram and flow charts are not appropriate
Framing of information: different sources of information and formats needed
Framing of information: face to face discussion
Framing of information: interactive information (internet)
Framing of information: multiple ways/formats to present information
Framing of information: need for illustrations
Framing of information: numerical data framed in different ways
Framing of information: visuals, pictorials (i.e., diagrams, flowchart) needed
Framing of information: written information to take away
Information needs: practical and detailed information around procedure
Information needs: to describe Down’s syndrome condition
Information needs: understanding potential implications of screening/amniocentesis
Information
Information
Information
Information
problems
Information
Information
Information
Information
Information
Information
Information
Information
syndrome
Information
Information
Information
Information
Information
Information
etc)
Information
Information
offered)
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
Information
needs: accounting for the individual variability, personalised information 
needs: accounting for individual variability in interpreting numerical value 
needs: addressing screening issues in amnioDex 
needs: amniocentesis cannot guarantee healthy baby, does not detect all
needs: amniocentesis does not only test for Down's syndrome 
needs: anticipate consequences of each option 
needs: benefits of having amniocentesis
needs: both men and women information needs should be addressed 
needs: chromosome test can reveal gender of the baby 
needs: consistent information across professionals
needs: describe (brief overview) range of abnormalities that may be detected 
needs: describe the different degrees of impairment of people with Down’s
needs: detailed information about risk of miscarriage (who miscarries, why?)
needs: give balanced, neutral information
needs: give national miscarriage rate only
needs: having enough time to decide
needs: how the screening result is calculated
needs: inform women about limitations of local rate (scientific validity, little data 
needs: information given before screening test
needs: information needs to be optional/gradual (different levels of information
needs: know all options available (possibility of changing their minds)
needs: make sure crucial information is understood
needs: making sense of the risk/of the statistical chance
needs: mention and explain termination
needs: mention the range of abnormalities
needs: need to consider worst case scenario
needs: need to explain complete package of screening
needs: no detailed description about chromosome problems potentially detected
needs: no detailed explanation about termination
needs: no mention of termination
needs: provide numerical value (screening test)
needs: risk to lose a healthy baby
needs: screening test does not give a definite answer
needs: screening test is not 100% accurate
needs: show the pathway post-screening test
needs: timescale of amniocentesis, results etc
needs: to communicate false negative and false positive results
needs: to distinguish screening and diagnostic tests
needs: to explain and understand Down’s syndrome
needs: to give adjusted numerical risk of Down’s syndrome + age related
needs: to give the local AND national miscarriage rate
needs: to know what is detected by the karyotype test
needs: to know what the PCR test detects (+ timescale)
needs: to understand risks involved and where difficulties may arise
needs: to understand the limitations of screening
needs: understand implications of a positive amniocentesis result
needs: understand implications of high chance result
needs: understand purposes of screening test
needs: understand screening test results
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Information needs: understanding the risk of miscarriage 
Information needs: updated information
Information needs: use of analogies to communicate numerical risk 
Information needs: use very precise and appropriate language 
Information needs: verbal information backed up with written material 
Information: internet search 
Information: simple written English (plain language)
Information: tailor the information to man/women's needs
Information: mention termination but do not give details
Miscarriage rate: tendency to rely more on local rate than national rate
Perception: some women want more information
Perception: people assimilate more if not rushed in making a decision
Perception/miscarriage rate: no value to the Wales national figure
Perception/miscarriage rate: operator's rate more relevant than welsh national figure
Perception/professionals' difficulties: practical demands determine quantity of information
given
"clever individuals understand row figures" 
amniocentesis is a straightforward procedure 
amniocentesis is the woman's decision
amniocentesis is useful in order to prepare (when termination is not an option) 
better to give information verbally 
conflict between husband and wife 
decision rushed in the past (bad practice) 
describing what the test picks up is too much information 
false positive and negatives are not explained to patients 
good understanding of Down’s syndrome 
good understanding of amniocentesis procedure 
in general, understanding of screening test result 
increase in uptake of screening test (lack of information pre-screening) 
information acquired and understood progressively 
karyotype + PCR detect everything (100%) 
the majority of women are very upset, cry 
male partner needs to be involved in decision 
men tend to leave the responsibility to decide to the women 
miscarriage is less traumatic than having a baby with Down’s syndrome 
no need for a lot of verbal info about amniocentesis 
no need to describe termination
no need to discuss the condition with specialist if decision to terminate 
is made
no value in communication of false positive and false negative estimates 
not essential to describe Edwards’ and Patau’s syndromes 
numerical data (risk) influences decision 
poor understanding/knowledge of what Down's syndrome is 
pregnancy termination is not the only reason for amniocentesis 
risk of miscarriage depends on operator 
some people feel insulted by analogies 
the decision should be shared within the couple 
the karyotype test result is misleading, 
video is not necessarily the right way to convey information 
women are aware of what Down’s syndrome is 
women are given too much information 
women are satisfied with quantity of information 
women better informed
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
Percept 
pregnancy 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception 
Perception
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
on
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Perception: women carry the main burden of care
Perception: women have amniocentesis for reassurance
Perception: women mainly rely on the PCR test results
Perception: women more inclined to undertake amniocentesis
Perception: women need to be reassured by the consultant's expertise
Perception: women never anticipate getting a high chance result "it can't be me"
Perception: women undertake screening tests without thinking about implications 
Perception: detailed information about Down's syndrome should be given after problem 
found only
Perception: information and decision support hugely improved in the past five years 
Perception: local rate should be used very carefully (little research data available)
Perception: local rates should not be used
Perception: men and women have different information needs (i.e., different ways of 
interpreting numerical value)
Perception: overall numbers easier than percentages 
Perception: the majority undertake amniocentesis for reassurance
Perception: couples not worried about procedure but about consequences (i.e., miscarriage) 
Perception: most people have amniocentesis to be able to terminate if problem 
Professionals' difficulties: confusion regarding definition of false positive and negative results 
Professionals' difficulties: specific and complex information provided by professionals who 
lack the expertise (ex: limited expertise in genetics)
Professionals' difficulties: conflicting screening procedures (NHS/private sector) 
Professionals' difficulties: describing Down’s syndrome in enough details in a consultation 
Professionals' difficulties: lack of information about factors causing miscarriage or 
consequences of amniocentesis 
Professionals' difficulties: lack of neutral judgement
Professionals' difficulties: more knowledge about Down’s syndrome than other conditions
Professionals' difficulties: time constraints
Professionals' difficulties: which screening test to recommend
Professionals' difficulties: lack of expertise around genetic problems (especially midwives)
Professionals' difficulties: too much information is perceived as paternalistic
Professionals' role: to make sure that people understand
Reason: impact of a disabled baby on life, family etc
Reason: existing children
Reason: against pregnancy termination
Reason: age
Reason: concerned about people's reactions to their decision
Reason: contact with, understanding of Down’s syndrome
Reason: couple's stability
Reason: cultural characteristics
Reason: desire to be prepared
Reason: difficulty getting pregnant
Reason: existing child with disability
Reason: find out if there is a problem
Reason: gut feeling, personal values, experience
Reason: how to cope with a disabled child
Reason: knowledge about amniocentesis
Reason: obstetrician's experience
Reason: partner's views
Reason: previous experience of amniocentesis
Reason: previous history of genetic abnormality
Reason: previous miscarriage, abortion
Reason: previous obstetric history
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Reason: professionals' influence 
Reason: religious beliefs 
Reason: risk of miscarriage
Reason: risk of miscarriage compared to risk of a problem 
Reason: to be given options if problem found (i.e., termination)
Reason: to prepare if baby has problem 
Reason: view on termination 
Reason: opinions of family and friends
Risk of miscarriage: realistic evaluation about local miscarriage rate 
Risk of miscarriage: relevance of operator miscarriage rate 
Screening test/ emotions: regret
Screening test/difficulty: lack of understanding of screening test purposes
Screening test: acceptance without understanding it
Should people be offered alternatives to NHS screening procedure?
Women's concern: operator's expertise
Women's concern: pain during procedure
Women's concern: risk of miscarriage
Women's concern: why people miscarry (predisposing factors?)
Women’s/ couples' attitudes: seek assurance that making the right decision
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Questionnaire (Field-Testing With Health Professionals)
a m n io D e x  v e rs io n  1
www.amniodex.com 
We are looking at the:
C o m m e n ts  
( +  suggestions for improvements)
1 .  Navigation
- Is th e  w e b s i te  e a s y  to  n a v ig a t e ?
- Is th e  s t ru c tu r e  o f  n a v ig a t io n  s e l f - e x p la n a to r y ?
- A ny  c o m m e n ts  o n  th e  d e m o  o r  c o n te n t s  lis t?
- O th e r  c o m m e n ts  o r  s u g g e s t i o n s . . .
2. Design/Layout
- W h a t  d o  y o u  th in k  o f  th e  h o m e p a g e ?
- W h a t  d o  y o u  th in k  o f  th e  c o lo u r s  u s e d ?
- W h a t  d o  y o u  th in k  o f  th e  im a g e s ?
- W h a t  d o  y o u  th in k  o f  t h e  g e n e r a l  d e s ig n  o f  th e  
w e b s i t e ?
- O th e r  c o m m e n ts  o r  s u g g e s t i o n s . ..
3. Video clips
- W h a t  d o  y o u  th in k  o f  th e  v id e o  c lip s  o f  w o m e n ’s  
s to r ie s ?
- W h a t d o  y o u  th in k  o f  t h e  v id e o s  o f  h e a l th  
p ro f e s s io n a ls ?
- W h a t d o  y o u  th in k  o f  t h e  v id e o  o f  th e  
a m n io c e n te s is  p r o c e d u r e ?
- O th e r  c o m m e n ts  o r  s u g g e s t i o n s . ..
4. Deliberation tools
-W e ig h in g  it up ;
- Y o u r m o s t  im p o r ta n t  r e a s o n ;
- T a lk in g  to  o th e r s .
- O th e r  c o m m e n ts  o r  s u g g e s t io n s . . .
5. Message board
- C o m m e n ts  o r  s u g g e s t io n s . . .
238
asi
Professor Glyn Elwyn 
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T: 0044 (0) 29 20 68 71 95
Interview Schedule (Field-Testing With Pregnant Women)
Participant code:______  Occupation:
Date:_______________  Marital status:
Amniocentesis:______________
Date of birth:
Obstetric history:
Previous pregnancies:
Number of children:_____________ Children with a chromosome disorder:
Previous experience with amniocentesis:____________
Number of weeks pregnant:_______________
•  Introduction to the research topic and aims
“Thank you very much for agreeing to participate in the research. By participating, you are 
helping us pilot a tool that will help pregnant women who are faced with a decision to 
undergo amniocentesis. By creating a decision tool, we aim to give women accurate 
information about the options they are offered and see how they react to the support 
provided”.
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Anonymity and informed consent
“The interview will last between 30 and 60 minutes. I am recording it in order to analyse it 
afterwards. Your name will remain anonymous and all the information collected during the 
interview will be kept strictly confidential.
I am working within the rules and regulations that Cardiff University has set. ”
O Before we start, do you have any questions about this interview and its aim, or 
something you would like to have more explanation about?
1. I am going to show you the decision tool for amniocentesis, amnioDex. Would you 
please have a look at it?
O The researcher will observe how amnioDex is used. The “think-aloud” technique will 
be used as the user navigates through the website. Users will be asked to describe their 
thoughts as they use the intervention.
2. What do you think about this decision tool?
3. Do you find it easy to use and understand?
(Probes: is the content clear and easy to follow? Is the information regarding risks 
comprehensible and well presented?)
4. In what way do you think it can help women who are offered amniocentesis?
(Probes: What are the advantages of this decision tool?)
5. Are there areas in this decision tool that need changing?
(Probes: language, graphic elements, information clarity, risk information, navigation?)
6. Do you think that the information presented in this decision tool is easily
understandable for all women who are offered amniocentesis testing?
7. Do you have any suggestions about ways of improving this decision tool?
8. Do you have any further questions you would like answered or comments you would
like to make?
“ Thank you very much for your time and participation".
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Example of Coded Interview Transcript (Field-Testing With Pregnant Women)
?  field testing phase 2+ - ATLAS.ti
File Edit Documents Quotations Codes Memos' Networks Views Tools Extras Windows Help
- n  BI -*£ M | G?| cS «  •  - * «■ - \
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I: yeah. I’ve got it.
R: what I’d like you to do, if that’s ok with you, is to take a look at the website, as if you hasn’t made a decision yet and look at the sections that are of 
interest to you. and tell what you’re doing and what you think- when you’re doing it. It’s called the think aloud technique, so, I’m just asking you to think- 
aloud, whenever you’re doing something on the website. Does it make sense?
I: yeah
R: you’ve made a decision about amniocentesis already haven’t you?
I: yeah. You should have let me know the website three days before. It may have helped me make a decision.
R: did you have the amniocentesis?
I: yes I have
R: so just tell me what you’re doing when you’re doing it aid  then, when you’ve seen enough, I’H ask you a  few questions. So, where are you now?
I: I am in the first section, it’s your choice. Harms and benefits.
R: ok, so if you tell me what you think about the information, or whether anything could be improved, feat would be great.
I: Hum, I think it’s quite straightforward, easy to read, information is simple and clear. Hum, not Eke I mean, not like most research, I mean Eke, what’s 
that called, professional knowledge feat people may not understand fully because it’s just simply, it’s clear what amniocentesis is. (long silence)
d  Instructions: think aloud technique
Using amnioDex: yes n=9 (2,3,4,5,6,9,11,11
Q  Instructions: think aloud technique
| satisfaction: easy to understand, dear infc
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List of Codes (Field-Testing With Pregnant Women)
Benefits of amnioDex: deliberation tools
Benefits of amnioDex: facilitate/increase understanding
Benefits of amnioDex: information tailored to UK population
Benefits of amnioDex: informed decision + reinforces decision
Benefits of amnioDex: more information than a leaflet (e.g., other conditions detected)
Benefits of amnioDex: possibility of looking for information at your own pace
Benefits of amnioDex: simple information, easy to understand
Benefits of amnioDex: testimonials from people in similar situation
Benefits of amnioDex: balanced information
Benefits of amnioDex: the message board
Benefits of amnioDex: very comprehensive information
Deliberation tools: too clinical
Deliberation tools: weighing it up helps visualising the decision 
Deliberation tools: decision is too important to use tools 
Deliberation tools: difficulty dragging, dropping 
Deliberation tools: beneficial to have both tools 
Deliberation tools: clear instructions, easy to use 
Deliberation tools: cover all important reasons 
Deliberation tools: difficulty using your most important reason 
Deliberation tools: difficulty using weighing it up
Deliberation tools: emotional subject, not inclined to weight pros and cons 
Deliberation tools: facilitate understanding
Deliberation tools: getting as much information as possible is crucial 
Deliberation tools: help making a decision 
Deliberation tools: helpful to have reasons listed 
Deliberation tools: helpful to weight up pros and cons 
Deliberation tools: helpful/confirmed decision
Deliberation tools: it takes longer to work out your most important reason 
Deliberation tools: your most important reason is confusing 
Deliberation tools: your most important reason: good concept
Deliberation tools: your most important reason: too complex/understanding difficulties 
Deliberation tools: need to have a demo built in 
Deliberation tools: preferred weighing it up 
Deliberation tools: quite useful
Deliberation tools: unable to use the tool independently 
Deliberation tools: weighing it up is more immediate 
Deliberation tools: weighing it up is more intuitive/more useful 
Deliberation tools: weighing it up = useful tool 
Deliberation tools: weighing it up increases clarity 
Difficulty: think-aloud technique
Difficulty: general navigation (e.g., closing new windows)
Difficulty: technical difficulty (e.g., flash was not installed on user’s computer)
Difficulty: technical difficulty, (e.g., too slow, difficulty loading video clips)
Difficulty: top tabulation not salient enough
Difficulty: two different miscarriage rates
Difficulty: seeing scroll bar in personal stories
Dissatisfaction: deliberation tools
Dissatisfaction: list of reasons is not comprehensive
Dissatisfaction: information about karyotype test is not sufficient
Dissatisfaction: It's your choice too general
Dissatisfaction: no "doesn't apply" box
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Dissatisfaction: not enough information 
Dissatisfaction: some sections were too brief
Improvement: add information about developers' credentials/occupations 
Improvement: add information about non-invasive diagnostic procedures 
Improvement: add information about residual risk of miscarriage 
Improvement: blurb on homepage with aims of website 
Improvement: mention cultural differences 
Improvement: more information about cystic fibrosis 
Improvement: more information about risk of miscarriage 
Improvement: more specific information 
Improvement: not clear what talking to others is for?
Improvement: professional on message board
Improvement: specific information, examples of difficulties encountered 
Improvement: video of woman who declined amniocentesis, positive outcome 
Improvement: add a pop-up demo
Improvement: add branding to the website so users can trust this resource
Improvement: advertise website during Down's screening or after high chance
Improvement: amniocentesis procedure clip shorter
Improvement: change order of videos
Improvement: disclaim about video clips
Improvement: email talking to others
Improvement: info about blood sample potentially taken if contamination of amniotic fluid
Improvement: information about chromosomes test could be clearer
Improvement: more generic information about amniocentesis on homepage
Improvement: need to specify meaning of amnioDex
Improvement: instructions of weighing it up
Improvement: search box
Improvement: there need to be messages on the message board 
Improvement: titles in top tabulation could be improved 
Improvement: what's next after said no to amniocentesis 
Limitations of think-aloud technique
Needs: information about what specifically happens in the UK
Needs: make an informed decision
Needs: more information (internet search etc)
Opinion: no new information on amnioDex compared to leaflets 
Opinion: the leaflet covers a lot
Opinion: website does not replace face to face interaction 
Opinion: website would have been useful if no leaflets given 
Opinion: videos are interesting but not necessarily helpful 
Satisfaction: section about conditions that will not be detected 
Satisfaction realistic pictures of people 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction 
Satisfaction
addresses the most important issues 
aesthetically pleasing
comprehensive info about chromosome problems 
comprehensive information about risk miscarriage 
contacts (ARC, Down's Syndrome Association) 
double navigation structure (top/side) 
easy to navigate
easy to understand/clear information
good information
good layout
good/useful resource
inviting website
section talking to others
message board
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Satisfaction: multiple ways of framing information (e.g., diagram with dots)
Satisfaction: nice colours
Satisfaction: right amount of information
Satisfaction: screening test result calculation (very helpful)
Satisfaction: section “frequently asked questions” very good 
Satisfaction: the website is not US based 
Satisfaction: user friendly, not too medical or clinical 
Satisfaction: very comprehensive information 
Satisfaction: very good resource
Satisfaction: very good, would recommend to women in similar situation 
Satisfaction: video amniocentesis procedure 
Satisfaction: videos clips
Satisfaction: videos offer varied examples, balanced opinions 
Satisfaction: written plain English
Satisfaction: you can relate to the website/identify with women 
Using amnioDex: had partner using it as well 
Using amnioDex: no 
Using amnioDex: yes
Using amnioDex: yes (provided the tool is available at the right time)
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Outline Protocol of the AmnioDex Randomised Controlled Trial
Principal Invetigator: Glyn Elwyn
1. Specification of research question:
Please state in one sentence the research question to be addressed.
Does a web-based decision support intervention increase informed choice for women offered amniocentesis 
compared to usual practice?
2. Importance of the health problem to the NHS:
Please describe the frequency of the health problem in the population and its impact on patients and the NHS.
A COMMON INVASIVE PROCEDURE WITH RISK OF MISCARRIAGE.
Amniocentesis is an invasive procedure that is offered to approximately 60,000 individuals I year in the UK and 
there is evidence that women are not sufficiently informed or supported prior to making a decision. 
Amniocentesis involves collecting amniotic fluid in order to obtain foetal cells so that DNA analysis and 
karyotyping can occur. The procedure is offered to between 5 -10% of women who are calculated to have a 1 in 
250 risk of foetal anomaly from ante natal screening tests (blood test), or because of advanced maternal age, 
history of chromosomal abnormality or anomaly detected on ultrasound. Screening tests for Down’s syndrome 
are offered to all pregnant women in the United Kingdom. Undergoing amniocentesis is an emotionally charged 
decision, at a time of increased vulnerability, time pressure and with variable, often unsatisfactory support. The 
procedure leads to high levels of anxiety and stress because it is associated with an estimated 1 % loss of normal 
pregnancies (post-procedure abortion) (Gaudry et al. 2008) and, in approximately 4% of women undergoing 
amniocentesis, a positive amniocentesis result (anomaly detection) will lead to a decision of whether or not to 
continue the pregnancy. However, the trade-off between the 1 % miscarriage risk and the gain in information for 
4% of women is not available in the current information to patients and there has been a general concern that 
more support is required to help women and their partners arrive at informed decisions.
LACK OF INFORMED CHOICE.
Achieving informed choice is a key principle in the NHS: it respects individual autonomy, demonstrates patient- 
centred care, reduces medico legal costs and potentially avoids unnecessary resource use where patients 
perceive inappropriate care. There are documented concerns that offers of amniocentesis either leave patients 
feeling unsupported in attempting to make a decision or that the procedure is regarded as routine, i.e. not 
requiring deliberation (Van Den Berg et al. 2006). In addition, there is evidence of health inequality: low health 
literacy leading to less opportunity to engage with information. The proposed intervention aims to address these 
problems.
3. A description of the technology and its possible effect on health status:
You should also discuss current and projected use in the NHS, with approximate costs.
DESCRIPTION: AmnioDex is a web-based decision support intervention designed to support women I partners 
to arrive at informed decisions about amniocentesis. AmnioDex has been developed and field-tested using 
multidisciplinary inputs over the last three years, using the MRC complex intervention framework, including 
theory, modeling, stakeholder needs assessment and evaluation (see URL www.amniodex.com). AmnioDex 
contains information about the procedure, the risks, the potential results and the implications. It contains 14 
patient videos and interactive elements to help patients consider harms and benefits. The intervention fulfils the 
International Patient Decision Aids Standards (IPDAS) (Elwyn et al. 2006).
PROJECTED USE: by women after antenatal staff referral. Costs are minimal, limited to update and 
dissemination activities (e.g. web links). Systematic reviews of decision support indicates that text / video 
versions of these interventions, when used alongside routine clinical support, increase knowledge, decision 
quality and increase the accuracy of risk perception (O’Connor et al. 2007)
4. Summary of the current evidence:
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Please describe the current knowledge and outline other research taking place in this area. You should discuss 
how the proposed research will add to the existing evidence base. You must also consider any relevant 
published or ongoing HTA programme projects.
The Cochrane Review of patient decision aids contains the results from 55 randomised trials (O’Connor et al. 
2007). These trials have been conducted over the last decade or so and the interventions have been either 
information booklets or videotapes (recently DVDs). These interventions are normally used as adjuncts to 
professional care. The results have been consistent: patients in the active arms achieve greater knowledge, 
greater accuracy of risk perceptions, greater involvement in decision making and improved decision quality. 
However, there is an increasing trend for these interventions to become web-based, thus reducing the cost of 
production (in the long term), and theoretically increasing access and allowing wider dissemination. A review of 
existing interventions for amniocentesis (Durand et al. 2008) identified six decision support interventions for 
amniocentesis worldwide, of variable quality and limited effectiveness, none of which are actively implemented in 
clinical settings. Two, US-based tools, are web-based. None are in current use in the UK. It is not known whether 
the beneficial effects demonstrated in the trials (across clinical domains) of decision support leaflets I linear 
videos can be replicated when these interventions move to the web, given potential barriers such as differential 
access and a variation in interest in using web-based materials and the lack of concurrent professional support 
and advocacy. Nevertheless, we know that there are significant concerns about individuals’ ability to achieve 
informed choice and a recognised need to improve the availability of decision support. There is insufficient 
access under current arrangements to high quality evidence-based information about the decision to have or not 
have amniocentesis. This is complicated by the fact that the choice should ideally be made by the parents -to-be 
and not assumed to be a choice that a woman makes alone. Web-based resources allow much greater 
opportunity for partners and family members to review the information and arrive at an agreed decision, rather 
than a choice that a woman has to face alone in clinic as often occurs. We recognise though that in some 
situations this will require helping people gain web access via community based locations. This trial would aim to 
produce evidence that well-designed web-based decision support interventions are able to achieve: 1) decisions 
about undergoing amniocentesis that are deliberated, well-informed and better aligned with user preferences 
(informed choice); 2) that it is feasible to deliver information about a difficult choice by using an online medium, 
and; 3) that it is possible, by designing tools that are accessible and interactive, to reduce inequality attributable 
to low levels of health literacy. In addition, 4) the trial would provide data about the costs of the intervention and 
the gain in informed choice compared to current practice.
5. What outcomes will be measured?
1. The primary outcome is the construct of informed choice (Marteau et al. 2001). This measure postulates that 
informed choice is defined by a consistent and congruent attitude to the uptake (intention I behaviour) of the 
procedure, provided the individual has high knowledge; positive attitudes to the test and taking the test, or vice 
versa. Informed Choice will therefore be assessed using an adapted version of the Multidimensional Measure of 
Informed Choice that includes Attitudes and Knowledge subscales adapted from Goel (Goel et al. 2001).
2. Anxiety: Anxiety will be measured using the validated six-item short form of the Spielberger (State) Anxiety 
Inventory.
3. Amniocentesis uptake and reported service use.
4. Decision Regret (Brehaut et al. 2003). This is an important measure of decision outcome, which we will repeat 
at follow up.
5. A process measure (delibeRATE), a scale developed by the research team to estimate the level of 
deliberation achieved.
6. Summary for the Non-Expert
Please provide a summary of sections 1 to 5. This summary should enable the non-expert reviewer to 
understand how the proposal addresses a question important to the NHS, how and where the research will be 
carried out, what outcomes will be used to assess the success of the research, what if any, are the ethical issues 
involved in this study and arrangements for handling these, why this team is well placed to carry out the research 
and provide justification for the costs requested (including any NHS costs).
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PROBLEM: Every year, 60,000 pregnant women in the UK are offered amniocentesis, where amniotic fluid from 
the uterus is examined for foetal abnormalities, specifically Down’s, Patau’s or Edwards’ syndromes. If an 
affected baby is identified, women are given a choice to continue or terminate the pregnancy. However, 
amniocentesis carries a 1 % risk of a miscarriage. The decisions -  to have an amniocentesis with the possible 
decision about continuing the pregnancy -  are both difficult and stressful. Many women report a lack of 
information and support at this time (Van Den Berg et al. 2006). INTERVENTION: Decision aids for patients have 
been developed to help individuals face difficult decisions. These interventions, when used alongside clinical 
services, increase knowledge, improve the accuracy of risk perception and increase informed choice. AmnioDex 
is designed to support women and their partners to decide whether or not to have amniocentesis -  see 
www.amniodex.com. The tool contains information about the procedure, the risks, the expected test results, the 
abnormalities detected and the potential implications. HOW & WHERE: Women offered amniocentesis will be 
invited, consented, and randomised to usual practice or offered access to AmnioDex, at home, at the antenatal 
clinic or at community locations. At the point where they decide about the procedure, we will measure to what 
extent their choice is informed and aligned with their preferences. One month after the decision to have 
amniocentesis or not we again assess regret, anxiety and well-being. ETHICAL ISSUES: Patients who view 
amnioDex may become more aware of the dilemma and be more anxious. However, the NHS and the General 
Medical Council stresses the importance of informing patients of procedural harms as well as benefits.The 
patients will continue to have access to the counselling provided by the antenatal services. TEAM: The team has 
an international reputation for the design and evaluation of decision support interventions and is composed of 
obstetricians, midwives and psychologists who are experts in the field. Collaborators include UK-level policy 
advice (Foetal Anomaly Screening Programme), Antenatal Results and Choices (ARC) and Down’s Association. 
COST: The intervention has already been designed and field-tested but requires evaluation in the NHS context. 
Costs are for a multi-site randomised trial in six antenatal services and the task of recruiting women.
Objectives Please note: The following sections (D onwards) of the form are used (along with those earlier) 
in the second stage of the assessm ent process where the study design and scientific merit are also 
scrutinised. You should provide a clear explanation of your intended study.
Provide a clear summary of your research objectives.
The objectives are:
1) To assess whether providing access to amnioDex, a web-based decision support intervention, leads to 
increased levels of informed choice (primary outcome) for people offered an amniocentesis. Informed choice will 
be based on the conceptualisation that when knowledge is high and where attitudes and intentions (or 
behaviours) are aligned with each other, then informed choice can be assumed, and will be assessed using the 
Multidimensional Measure of Informed Choice (Marteau et al. 2001).
2) To assess to what degree people who are offered the amnioDex resource, access it, use it and gain benefit 
(measured by web-log analysis, informed choice and secondary outcomes such as reduced decisional regret 
and the degree of deliberation achieved).
3) To gain information about the costs of developing, maintaining and updating a web-based decision support 
and whether the levels of access and the effects obtained are achievable and cost-effective.
Summary of Project
Please provide a summary of your proposed research using the headings listed in the Guidance Notes.
DESIGN: A multi-centre randomised controlled trial with randomisation of women to intervention (access to 
amnioDex) versus usual practice trial arms (see flow chart).
SETTING: Hospital outpatients, specifically antenatal clinics, with access to intervention at home, antenatal clinic 
or by arrangements in other community locations.
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EVIDENCE REVIEW: The Cochrane systematic review of decision aids has summarised the effects of 55 
randomised controlled trials to date (O’Connor et al. 2007), although only three are of web-based tools. We have 
conducted a systematic review of decision support for amniocentesis, which shows a clear need for the 
development of better decision support that can be accessed with ease (Durand et al. 2008). A clear research 
gap exists.
TARGET POPULATION: Women offered amniocentesis are the target population. This target group is c. 6% of 
all women who undertake antenatal screening tests. Women are offered amniocentesis when antenatal serum 
screen identifies a women at ‘high risk’ (typically a 1 in 250 risk) of having a baby with a major chromosomal 
abnormality. Women offered amniocentesis after ultrasound scans (between 14-24 weeks) or because of 
advanced maternal age are also eligible for inclusion in the trial.
HEALTH TECHNOLOGY: The technology in this proposal is web-based decision support and has been 
developed after formal needs assessment (Durand et al. 2009) and extensive field-testing (see 
www.amniodex.com). It contains 54 pages of information, 14 short videos giving patient experiences, two 
deliberation tools to support preference clarification and a users web-forum. We aim to compare the impact of 
this intervention against usual practice, i.e. the existing information and support. Decision support interventions 
are defined as interventions that describe and justify the conditions where clinical equipoise exist, they provide 
information about options and about the short, intermediate and long-term outcomes which have relevant and 
important consequences for decision-makers (Elwyn et al. 2006).
MEASUREMENT OF COSTS & OUTCOMES: Although the costs of developing the web-based intervention have 
already been incurred, these would be included in a cost-model, including the projected costs of decision support 
dissemination, of updating, maintaining and hosting the website over time. The primary outcome of the work will 
be the assessment of informed choice: Multidimensional Measure of Informed Choice. This measure is based on 
Marteau’s conceptualisation that when knowledge is high (Marteau et al. 2001), and where attitudes and 
intentions (or behaviours) are aligned with each other, then informed choice can be assumed. Clearly, it is not 
our objective to reduce or increase amniocentesis rates, merely to ensure informed uptake. We would however 
hypothesise that, secondary outcomes, such as decision regret will be lowered. Data collection by call centre 
applied questionnaires (existing infrastructure at Cardiff University).
SAMPLE SIZE: In order to detect an improvement in informed choice from 50% to 65% with 90% power at a 5% 
significance level, a total of 460 women are required. In order to allow for loss to follow-up of 20% a total number 
of 575 women offered amniocentesis will be recruited. There is little evidence on the current level of informed 
choice in this group using this measure. Therefore a conservative value of 50% has been used.
PROJECT TIMETABLES: Total study duration 33 months. Months (M) 0-6: trial set up, recruitment of project 
staff and obtaining the involvement of 6 x 0.5 FTE NHS Trust research midwives to recruit patients, ethical and 
research and governance approval in the 6 NHS antenatal clinics required. In addition, the identification of local 
community locations for allowing women who have limited or no internet access alternative access points for 
AmnioDex. M 7-21: recruitment of women offered amniocentesis. Follow up: M 7-23. Data clean: M 7-25. 
Statistical analysis: M 25-30. Report writing: M 27-33.
RECRUITMENT RATE: We calculate the need to be able to include antenatal units that, over the recruitment 
period of 15 months, would care for 30,000 pregnant women, giving us an estimated 1,800 who would be offered 
amniocentesis. We have the support of six antenatal units (in the South West, Cardiff, Newport and Bristol, and 
around the West Midlands (South), including University Hospital of Coventry and Warwickshire, where co­
applicants (Profs Fiander and Thornton) have existing collaborations and research infrastructure, comprising 
experienced research midwives. We therefore estimate 30-40% recruitment rate (600) and so are we confident of 
achieving the target sample of 575 women during the 15 month recruitment window.
Please provide details about any related (planned or active) grants held by any member of your research 
team in this or similar research areas. You should include a clear explanation of how the research being 
proposed in this application will fit.
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This proposed work builds on two three year grants from CR UK to build decision support interventions for men 
considering PSA (see www.prosdex.com), now in web-based clinical trial and for women facing breast surgery 
choices (see www.bresdex.com), under development and evaluation. Glyn Elwyn co-leads the International 
Patient Decision Aids Standards Collaboration (IPDAS) and the decision laboratory at Cardiff University 
www.decisionlaboratorv.com. AmnioDex represents a more sophisticated yet simple to use intervention and 
we wish to investigate whether this potentially very low cost method of dissemination can yield informed choice 
for women at a stressful time in their lives.
SEWTU is currently coordinating the Building Blocks trial, which is recruiting 2400 teenage mothers from 
maternity services across England to evaluate the Family Nurse Partnership. It also has a full submission with 
the NPRI for a trial of a lifestyle intervention for pregnant women who are obese. Neither of these studies 
competes with this trial, but this trial will build on the established working relationships of the unit with maternity 
and midwifery services across England and Wales.
Please say with which of the UK Clinical Research Networks (http://www.ukcrn.orq.uk) you intend to link 
for this research
The proposal will be supported by CLRNs in England & CRC Cymru. Prof Thornton, Clinical Director, West 
Midland CLRN, will mobilise a management and midwifery team to aid set-up and trial recruitment.
Please list any benefits you may have identified from working with the network(s).
The CLRNs and CRC Cymru will provide help and guidance for study set-up and recruitment. The outline will be 
considered by the Specialty Group for Reproductive Health and will enrol additional sites and access CLRN 
support if these are required outside Wales and West Midlands (South). The benefits have been our ability to 
identify and obtain the co-operation of two clusters of ante-natal centres, and the advantage of being able to 
access the infrastructure support of research midwives.
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